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List of abbreviations 
 
Ala Alanine 
Asn Asparagine 
Asp(OcHex) Cyclohexyl-aspartic acid 
Boc Benzyloxycarbonyl- 
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HBTU O-(benzotriazol-1-yl)-N,N,N′,N′-tetramethyl-uronium hexafluorophosphate 
HPLC High-performance liquid chromatography 
Imz Imidazolidin-2-one-4-carboxylate 
MD Molecular Dynamic 
NMR Nuclear magnetic resonance 
Oxd 4-carboxy-5-methyl-oxazolidin-2-one 
Phe Phenylalanine 
POPC 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine 
TEA Triethylamine 
TFA Trifluoroacetic acid 
Val Valine 
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1 Introduction 
 
1.1 Build up the molecules of life: from amino acids to proteins 
 
The complex and interrelated reactions which make up living processes are dependent upon the 
presence of proteins, not only as catalyst, but in their role as structural molecules, as storage and 
carrier molecules, and as molecular motors. Nature uses a very limited set of building blocks—e.g. 
twenty amino acids in proteins and four nucleobases in DNA —with specific abilities to impart 
well-defined folds. However, these building blocks emerged not only because they are well suited, 
but also because they complied with evolutionary constraints, in particular the initial obligation to 
be within a few steps of prebiotic chemicals. 
The presence of chiral molecules is widespread in biological systems, which are primarily 
homochiral systems. For example, almost exclusively L-amino acids form proteins, while DNA is 
made up primarily of D-deoxyribose. The naturally occurring L-amino acids predominantly form 
right-handed helices, while their stereoisomers D-amino acids favor left-handed helices. 
 
1.1.1 Folding in protein structure 
 
Two amino acids can undergo a condensation reaction, where the free amine group reacts with 
the carbonyl unit of a carboxyl group of another amino acid. The formation of this peptide bond 
produces a dipeptide and a H2O molecule. Adding additional amino acids to the growing peptide 
chain (always form N-term to C-term direction in living cells) it is produced a polypeptide chain or 
protein.  
All of these functions require that the nascent amino-acid chain correctly folds into the biologically 
active, three-dimensional structure of the native state. In pioneering studies, Christian Boehmer 
Anfisen (Nobel Prize in Chemistry in 1972) showed that all the necessary information for the 
nascent chain to fold into the native structure is contained in the sequence of amino acids.1 In his 
Thermodynamic Hypothesis he assumed that a native protein adopts the thermodynamically most 
stable conformation in a given solvent at a particular temperature. In order for proteins to fold 
                                               
1
 Anfisen, C. B. “Principles that govern the folding of protein chains” Science, 1973, 181, 223-230. 
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spontaneously into their native state, the native state must be lower in Gibbs energy than the 
unfolded state.  
The nature of contribution of various interactions to protein folding and stability has been of 
interest for some time. In 1990, Ken Dill confirmed the theory proposed by Walter Kauzmann in 
1959. 
Summarizing their papers, it is possible to conclude that the interactions which are consider to 
dominate protein stability are the hydrophobic effect (i), hydrogen bonding (ii) and configurational 
entropy (iii).2 
 
i. Hydrophobic effect: As proteins are the subject of this section, it is possible to define the 
hydrophobic effect as the energetic process associated with the transfer of hydrophobic 
surface from the protein interior to water, the medium of the cell. This includes the 
energetic associated with changes in Van der Waals interactions experienced by the 
hydrophobic groups, as well as the energetic associated with the restructuring of water 
which takes place upon hydrating hydrophobic groups. 
 
ii. Hydrogen bonding: Hydrogen bonding refers to the partial sharing of a hydrogen atom 
between a donor atom to which it is covalently bound, and an acceptor atom which has a 
lone pair of electrons. In proteins, the intramolecular hydrogen bond competes with 
hydrogen bond to water molecules. It is this completion that determines the contribution 
of hydrogen bonding to protein stability. Hydrogen-bond strength, which depends on the 
electronegativity and orientation of the bonding atoms, is in the range of 2-10 kcal/mol. 
 
iii. Configurational entropy: In an unfolded protein, the polypeptide chain can adopt different 
rotomeric position around φ and ψ torsional angles, and side chains can adopt different 
rotamers around χ angles. Upon adopting the native state, nearly all φ and ψ torsional 
angles are restricted to a single position, as the majority of χ angles. This loss of degrees of 
freedom translates into a loss of configurational entropy. It is the loss of configurational 
entropy which must be overcome by favorable interactions in order to fold a stable 
protein. 
 
                                               
2
 Dill, K. A. “Dominant forces in protein folding” Biochemistry, 1990, 29, 7133-7155. 
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Proteins are complex biomacromolecules that can be constituted until thousands of amino acid 
residues. To describe and understand this kind of biopolymer, the structures are approached at 
several levels of complexity, arranged in a kind of conceptual hierarchy. Four levels of protein 
structure are commonly defined.  
Primary structure: in biochemistry the primary structure of a biomolecule is the description of its 
atom and bond composition. Dealing with a linear biomolecule (proteins or nucleotidic acids), the 
primary structure is the sequence of amino acids along their backbone. However, proteins can 
become cross-linked, most commonly by disulfide bonds, and the primary structure also requires 
specifying the cross-linking atoms. Secondary structure refers to particularly stable arrangements 
of amino acid residues giving rise to recurring structural patterns. The tertiary structure of a 
protein describes the folding of its secondary structural elements and specifies the positions of 
each atom in the protein, including those of its side chains. The known protein structures have 
come to light through X-ray crystallographic or nuclear magnetic resonance (NMR) studies.  
When a protein has two or more polypeptide subunits, their arrangement in space is referred to as 
quaternary structure (Figure 1). 
 
 
Figure 1. Peptide structures. 
 
Immersed in water, a polypeptide chain will not stay in an elongated form, but fold up according 
to the polarity of the side chains which it contains and the rotation of peptide backbone bond 
angles largely determined by Van der Waals radii of side chains.  
The geometrical character of the peptide bond is that of a rigid plane between the two flanking α-
carbon atoms. The reason for this structural stability (there is no rotation around the C-N bond) 
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can be explained by the electronic resonance character of the O=C-N structure. The double bond 
character changes between the O-C and C-N bonds (Figure 2).  
 
 
Figure 2. Electronic resonance character of peptide bond due to the  -like molecular orbital that extends over all 3 
atoms (O-C-N). 
 
Evidence for this structure comes from X-ray crystallographic studies of simple peptides showing 
that the N-Cα bond length is 1.46 Å as expected for a single bond. The C-N peptide bond is 1.33 Å 
long, only a little longer than the value of 1.27 Å for the average C=N bond length in model 
compounds (Figure 3). Similar X-ray studies show that the six atoms CαNHCOCα are very close to 
be co-planar. 
 
 
Figure 3. Bond length in peptide backbone. 
 
To understand protein structures it is necessary to consider two torsion angles (also called 
dihedral angles) in the backbone which define the tilt between two neighboring amide planes (the 
plane of the peptide bond) with the Cα at the center of rotation:  
 
ϕ: 
 
 ψ: 
 
Figure 4. The two torsion (dihedral) angles in the peptide backbone. 
 
With those dihedral angles it is possible to predict the allowed backbone conformations of a 
peptide through interplay of rotation around the bonds defined by the torsion angles Phi (φ) and 
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Psi (ψ) and the steric hindrance of side groups determined by their Van der Waals radii (Figure 5). 
The resulting conformational map is called Ramachandran plot.  
 
 
Figure 5. Peptide backbone and torsion angles. 
 
Most areas of the Ramachandran diagram represent forbidden conformations of a polypeptide 
chain. Sterically forbidden conformations have φ and ψ values that would bring atoms closer than 
the corresponding Van der Waals distance (the distance of closest contact between nonbonded 
atoms). 
Only three small regions of the diagram are physically accessible to most residues. The observed φ 
and ψ values of accurately determined structures nearly always fall within these allowed regions 
of the Ramachandran plot (Figure 6). There are, however, some notable exceptions: 
1. The cyclic side chain of Pro limits its range of f values to angles of around 260°, making it, not 
surprisingly, the most conformationally restricted amino acid residue; 
2. Gly, the only residue without a side chain, is much less sterically hindered than the other amino 
acid residues. Hence, its permissible range of f and c covers a larger area of the Ramachandran 
diagram. At Gly residues, polypeptide chains often assume conformations that are forbidden to 
other residues. 
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Figure 6. Ramachandran plot for all residues except Gly and Pro. 
 
Three important regions of the Ramachandran plot describe the most commonly found secondary 
structures in proteins:  
 
α -helix: a right handed helical structure with average torsion angles 
β -sheet: parallel or anti-parallel pleated sheet structures  
β -turn: minimal loop structures of 3 to 4 amino acids with defined torsion angles  
  
The α -helix  
 
The α-helix is one of two secondary structures (the other being the β-sheet) predicted and 
discovered by Linus Pauling and Robert B. Corey in 1951.3 It is a right-handed helix with the 
following spatial parameters:  
 
φ = -57°  
ψ = -47°  
n = 3.6 (number of residues per turn)  
pitch = 0.54 nm (or 5.4 Å)  
                                               
3 Pauling, L.; Corey, R. B. “Configurations of polypeptide chains with favored orientations around single bonds” Proc 
Nat. Acad. Sci. 1951, 37, 729-740. 
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The helix has a specific hydrogen bonding pattern, where the backbone C=O group of residue n 
binds with the N-H of residue n+4. The atomic distance between the N and O measures 0.28 nm. 
The H-bonds are almost parallel to the helix axis and the total dipole moment gives the helix a 
dipole moment that points from the N-term (+) to the C-term (-). This helix dipole is important in 
the interaction of neighboring helices in the packing of secondary structural motifs into the 3-D 
structure. The core of the helix is packed. The backbone atoms are in Van der Waals contact with 
each other across the helix axis.  
As a real example, in Figure 7 there’s the 35-residue peptide corresponding to the very 
hydrophobic transmembrane region of the tyrosine kinase receptor neu, NeuTM35.4 
 
 
 
Figure 7. Balls and sticks model showing the helical arrangement of one of the chains of NeuTM35: (a) top view, (b) 
view along the c axis.  
 
The β -strand and β-pleated sheet  
 
In 1952, Pauling and Corey predicted the β-pleated sheet structure as an alternative secondary 
structure to the α -helix in proteins. β-strands are elongated peptide segments with atomic 
distances from side chain n to side chain n+2 of 0.7 nm. In the  conformation the backbone of the 
                                               
4
 DOI:10.2210/pdb1iij/pdb 
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polypeptide chain is extended into a zigzag rather than helical structure. The zigzag polypeptide 
chains can be arranged side by side to form a structure resembling a series of pleats. In this 
arrangement, hydrogen bonds form between adjacent segments of polypeptide chain. 
The individual segments that form a β sheet are usually nearby on the polypeptide chain, but can 
also be quite distant from each other in the linear sequence of the polypeptide; they may even be 
in different polypeptide chains. The R groups of adjacent amino acids protrude from the zigzag 
structure in opposite directions. The adjacent polypeptide chains in a β-sheet can be either 
parallel or antiparallel (having the same or opposite amino-to-carboxyl orientations, respectively) 
(Figure 8). 
 
 
Figure 8. Backbone of parallel (a) and antiparallel (b) β-sheet. 
 
More than two strands can form into sheets which form extended right-handed twists. Such 
extended β -pleated sheets (called super secondary structures) can often be found in the cores of 
proteins. Alternatively, bundles of 4 closely packed α -helices (so called α -helical bundles) are also 
found at the center of globular proteins.    
 
The β-turns  
 
To combine helices and sheets in their various combinations, protein structures must contain 
turns that allow the peptide backbone to fold back. In Figure 9 two types of β-turns are reported. 
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Figure 9. Backbone of Type-I β-bend and Type-II β-bend. 
 
These turns can be found almost always on the surface of proteins and often contain Pro and/or 
Gly. Proline gives the backbone a special rigidity (fixed φ torsion angle at -60°, Ca -N) and glycine 
has a high flexibility because of its hydrogen substituent. Turn structures are also stabilized 
through H-bond formation. 
Figure 10 elucidates the role of -turns, where, two different tryptophan zippers (trpzip) are 
presented. On the left, the first peptide is represented in both cartoon model type (Figure 10a) and 
balls and sticks type (Figure 10b) where, to permit a better view, all residues are hidden.5 In this first 
peptide, a type-I -turn links two antiparallel -bend (Figure 10a). In a similar fashion, in the second 
peptide (Figure 10b) a type-II -turn links two antiparallel -bends.6  
 
                                               
5 DOI:10.2210/pdb1le0/pdb 
6
 DOI:10.2210/pdb1le1/pdb 
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Figure 10. It is shown how two different secondary structures can coexist: in (a) type-I -turn links two antiparallel -
bend, while in (b) a type-II -turn links two antiparallel -bend. 
 
1.1.2 The role of proline in protein folding 
 
Proline is unique among the natural amino acids in that its side chain is cyclized to the backbone, 
restricting its backbone dihedral angle to φ = -75°, giving proline an exceptional rigidity and a 
considerably restricted conformational space.  
The structural role of proline depends on the position it occupies in a protein. When in the middle 
of α helices and β sheets, proline acts as a structural disruptor, but it is generally found at the 
beginning of α helices and edge of β sheets, as well as in turns. It has been noted that cis-trans 
isomerization of X-Pro peptide groups is one of the rate-determining steps for folding and 
unfolding of various proteins and several studies have investigated the cis-trans isomerization of 
proline-containing peptides.  
Polyproline is known to form helical structures with two well-characterized conformations: a left-
handed polyproline helix (PPII) is formed when the sequential residues all adopt backbone 
dihedral angles (φ, ψ) of (-75°, 146°), with all prolyl bonds in the trans-isomer conformation (i.e. 
backbone dihedral angle ω = 180) with 3 residues per turn; and a more compact right-handed 
polyproline helix (PPI) is formed with all sequential residues adopting dihedral angles of roughly (-
75, 160) and all prolyl bonds assume a cis-isomer conformation (i.e. backbone dihedral angle ω = 
0) with 3.3 residues per turn (Figure 11). Of the 20 natural amino acids, only proline is 
“comfortable” in the cis-isomer conformation, and proline seems to be quite effective in stabilizing 
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left-handed helices. The probability distribution for cis-trans prolyl bonds is affected by 
neighboring amino acids, pH and ionic strength, solvent and chain length.  
 
Poly-L-Pro I 
φ = -75, ψ = 160, ω = 0 
 
 
 
 
 
Poly-L-Pro II 
φ = -75, ψ = 146, ω = 180 
 
 
 
 
Figure 11. Balls and sticks model showing the helical arrangement of one of Poly-L-Pro I and Poly-L-Pro II. 
 
It has been noted experimentally that the PPII structure is favored in water, benzyl alcohol, and 
most of the other solvents, while the PPI structure is favored in the presence of aliphatic alcohols 
like propanol. It is now known that the prolyl ring can flip between its two states irrespective of 
the cis-trans nature of the peptide bond. 
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1.2 Foldamers: the scientific answer to natural folding 
 
As it was stated in the previous chapter, folding is the process nature has selected to control the 
conformation of its biomacromolecules allowing fundamental chemical functions such as enzyme 
catalysis, information storage and duplication in nucleic acids, as well as energy capture and 
conversion. In contrast, chemists can make molecules that escape evolutionary pressure. Over the 
years, they have worked to expand the registry of structures and functions of folded biopolymers 
through the use of non-natural building blocks, or through the arrangement of natural building 
blocks into non-natural sequences. This broad ensemble of “artificial folded molecular 
architectures” has been defined as “foldamers”.7 
The word “foldamers” was coined by Samuel H. Gellman in 19968 to describe discrete artificial 
oligomers that adopt specific and stable conformations similar to those seen among proteins and 
nucleic acids.  
This neologism means “folding molecules” and refers mainly to medium size molecules (about 
500-5000 amu) that fold into definite secondary structures (i.e. helices, turns and sheets), thus 
being able to mimic biomacromolecules despite their smaller size. The remarkable range of 
chemical capabilities of biomacromolecules suggests that it might be possible to design analogous 
capabilities into unnatural polymers that fold into compact and specific conformations. Therefore, 
realization of the potential of folding polymers may be limited more by the human imagination 
than by physical barriers. The essential requirement of a foldamer is to possess a well defined, 
repetitive secondary structure, imparted by conformational restrictions of the monomeric unit.  
Before the term ‘‘foldamer’’ was coined, many nucleic acid analogues and peptide analogues had 
already been successfully designed to mimic the structures and, potentially, the biological 
properties of their natural counterparts. Typical examples are peptide nucleic acids (PNAs)9 and N-
substituted oligoglycines (peptoids).10 The motivations behind such efforts are varied, but these 
studies suggest a collective, emerging realization that control over oligomer and polymer folding 
could lead to new types of molecules with useful properties. 
                                               
7
 Hecht, S.; Huc, I. “Foldamers: structure, properties and applications” Wiley-VCH, Weinheim, 2007. 
8 Gellman, S. H. "Foldamers: a manifesto" Acc. Chem. Res. 1998, 31, 173-180. 
9 Nielsen, P. E.; Egholm, M.; Berg, R. H.; Buchardt, O. “Sequence-selective recognition of DNA by strand displacement 
with a thymine-substituted polyamide” Science, 1991, 254, 1497-1500. 
10
 Simon, R. J.; Kania, R. S.; Zuckermann, R. N.; Huebner, V. D.; Jewell, D. A.; Banville, S.; Ng, S.; Wang, L.; Rosenberg, S.; 
Marlowe, C. K.; Spellmeyer, D. C.; Tan, R.; Frankel, A. D.; Santi, D. V.; Cohen, F. E.; Bartlett, P. A. “Peptoids: a modular 
approach to drug discovery” Proc. Natl. Acad. Sci. U. S. A. 1992, 89, 9367-9371. 
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Over the last seventeen years, the field has rapidly expanded away from early efforts in 
peptidomimetics and nucleic acid analogues towards a systematic exploration of folding in a 
diverse range of structures. 
This research sector is nowadays particularly developed because of a number of factors. The first 
is the desire to achieve chemical functions matching those of nature. Then, thanks’ to technical 
improvements, biopolymers are a level of complexity that chemists can now routinely address.  
To have an idea of the steady increase of this research topic, Figure 12 shows the number of 
papers published in the period 1996 to 2012.  
 
 
Figure 12. Number of papers which deal with foldamers published in the period 1996 to 2012. 
 
The path to creating useful foldamers involves several steps:  
i. One must identify new polymeric backbones with suitable folding propensities. This goal 
includes developing a predictively useful understanding of the relationship between the 
repetitive features of monomer structure and conformational properties at the polymer 
level.  
ii. One must endow the resulting foldamers with interesting chemical functions, by design, by 
randomization and screening (“evolution”), or by some combination of these two 
approaches.  
0 25 50 75 100 
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1998 
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iii. For technological utility, one must be able to produce a foldamer efficiently, which will 
generally include preparation of the constituent monomers in stereochemically pure form 
and optimization of heteropolymer synthesis. 
 
The propensity to fold of these new synthetic molecules is due to many internal or external 
parameters. Internal factors consist of the overall shape and rigidity of the molecule and its ability 
to establish attractive or repulsive intramolecular non-covalent interactions. These factors depend 
on monomer size and shape, linkage orientation, rotational restrictions, local intramolecular 
interactions, and interactions between monomers remote from each other in a sequence. 
Generally, a molecule that behaves as a foldamer has a certain degree of backbone rigidity that 
limits the entropic cost of adopting an organized conformation. External factors include solvent 
effects such as hydrophobic effects, aggregation (dimerization-induced folding), host-guest 
complexation (guest-induced folding), and contacts with interfaces (folding on surfaces). 
The folded secondary structures of foldamers are similar to those found in biopolymers (helices, 
linear strands, turns and sheets). The helix in particular is by far the most frequently characterized 
object. 
Nevertheless, foldamers that display folding motifs unknown or uncommon in biopolymers do 
exist. These include, for example, pillar-like architectures (stacks of aromatic rings, Figure 13),11 
knots (Figure 14)12 and spiral-like objects (‘tail-biters’, Figure 15).13 
 
 
                                               
11 Lokey, R. S.; Iverson, B. L. “Synthetic molecules that fold into a pleated secondary structure in solution” Nature, 
1995, 375, 303-305. 
12
 Brüggemann, J.; Bitter, S.; Müller, S.; Müller, W. M.; Müller, U.; Maier, N. M.; Lindner, W.; Vögtle, F. “Spontaneous 
knotting-from oOligoamide threads to trefoil knots” Angew. Chem., Int. Ed. 2007, 46, 254-259. 
13
 Hunter, C. A.; Spitaleri, A.; Tomas, S. “Tailbiter: a new amide foldamer” Chem. Commun. 2005, 29, 3691-3693. 
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Figure 13. Pillar-like architectures due to stacks of aromatic rings A and B of the molecule. 
 
 
Figure 14. Example of amide knot. 
 
 
Figure 15. Structure of tailbiter foldamer (a) and its three-dimensional structure, calculated using the folding-induced 
changes in chemical shift. 
 
In his work, William F. DeGrado divided foldamers into two general molecular classes, determined 
by the presence or absence of aromatic units within the monomer unit (Figure 16).14 
 
Figure 16. Examples of foldamer frameworks. 
                                               
14 Goodman, C. M.; Choi, S.; Shandler, S.; DeGrado, W. F. “Foldamers as versatile frameworks for the design and 
evolution of function” Nature Chemical Biology, 2007, 3, 252-262. 
20 
 
 
“Aliphatic” foldamers or, in general, foldamers synthesized using a biomimetic approach, have 
saturated carbon chains separating amide or urea groups. Example of this group include the β-, γ- 
and δ-, oligoureas, azapeptides, pyrrolinones, α-aminoxy-peptides and sugar-based peptides.  
The helices formed by foldamers are characterized by their handedness and the number of atoms 
within repeating hydrogen bonding rings of their structures. A second feature of the helix is the 
orientation of the amide groups; hydrogen bonding generally causes the carbonyl of successive 
amides to either point toward the N terminus or the C terminus, thereby giving rise to exposed 
amides at the ends of the helices. While in conventional peptides, the main conformations are 310- 
and α-helices, very different conformations are observed when additional methylene groups are 
inserted between the amides of the monomers. The second molecular class of foldamers makes 
use of aromatic spacers within the backbone. Examples of this group include oligo-phenylene-
ethynylenes, sequences of alternating aromatic electron donors and acceptors, aryl-oligomers in 
particular those based on aza-heterocycles (pyridines, pyrimidines, pyridazines, etc.), aromatic 
tertiary amide, imide or urea oligomers and aromatic oligoamides (Figure 17). 
The latter ones have been rapidly growing as an important class of foldamers due to a number of 
remarkable properties, including the high stability of their folded structures, the predictability of 
their folding modes, their propensity to crystallize (giving access to structural data at atomic 
resolution), and their relative ease of synthesis. There is no doubt that foldamer diversity will 
further increase even though designing, synthesizing, and structurally characterizing a new 
foldamer can all prove very challenging. 
 
 
Figure 17. a) Aza-aromatic oligomers. b) Tertiary aromatic ureas. c) Aromatic oligoamides.  
21 
 
Recently, several examples of hybrid foldamers have been reported, containing mixtures of - and 
β-, - and - or β- and -amino acids in alternating order.15 These foldamers allow the formation of 
new kind of helices, besides those that may be obtained only from -, β- or -peptides, as shown 
in Figure 18. 
 
 
Figure 18. Helices with 41 hydrogen-bond patterns in , ,  and hybrid peptides.  
 
The virtues of alternating longer sequences of - and β-amino acids, so called /-peptide 
foldamers, have been recognized only a few years ago. During this course, several new helix types 
have also been discovered. In the year 2004, two groups independently investigated the solution 
properties of /-peptides with a 1:1 backbone alternation.16 
Beside helical structures with hydrogen bonds pointing only into one direction, either backward or 
forward along the sequence, also mixed helices (β-helices) with hydrogen bonds alternately 
changing in forward and backward direction were found in these regular hybrid peptides.17  
                                               
15 Prema Vasudev, G.; Chatterjee, S.; Shamala N.; Balaram, P. “Structural chemistry of peptides containing backbone 
expanded amino acid residues: conformational features of , γ, and hybrid peptides” Chem. Rev. 2001, 111, 657-687. 
16 Hayen, A.; Schmitt, M. A.; Ngassa, F. N.; Thomasson K. A.; Gellman, S. H. “Two helical conformations from a single 
foldamer backbone: “Split Personality” in Short α/β-Peptides” Angew. Chem. Int. Ed. 2004, 43, 505-510. 
17
 Baruah, P. K.; Sreedevi, N. K.; Gonnade, R.; Ravindranathan, S.; Damodaran, K.; Hofmann, H.-J.; Sanjayan, G. J. 
“Enforcing periodic secondary structures in hybrid peptides:  a novel hybrid foldamer containing periodic γ-turn motifs” 
J. Org. Chem. 2007, 72, 636-639. 
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1.3 New pseudopeptide foldamers based on oxazolidinone ring  
 
Peptidomimetic modifications are frequently used as attractive methods to provide more 
conformationally constrained and thus more stable and bioactive peptides. Among 
peptidomimetic approaches, particularly attractive are pseudopeptides, or peptide bond 
surrogates in which peptide bonds have been replaced with other chemical groups. 
In the previous chapter, it was stressed the central role of proline in the conformational behaviour 
of peptides which contain it. From a synthetic point of you, the direct use of proline is not 
recommended because of its cis-trans isomerization problems. The possibility of controlling this 
isomerisation is very important in the design of peptidomimetics. As a consequence, many proline 
surrogates have been designed for the study and control of conformational transitions in peptides 
and proteins. For instance, many pseudoprolines (ψ-Pro) have been obtained by 
cyclocondensation of the amino acids cysteine, threonine or serine with aldehydes or ketones. 
In the last few years the design and synthesis of oligomers based on proline units, both in the 
presence and absence of stabilizing hydrogen bonds, have been extensively pursued.  
 
1.3.1 Conformational studies of oxazolidin-2-one derivatives 
 
Five-membered cycles that contain a nitrogen and a carboxy unit adjacent to one another in the 
ring may be assigned to the family of pseudoprolines. The research group of professor Claudia 
Tomasini demonstrated that the presence of pseudoproline units like L-pyroglutamic acid and 
trans-(4S,5R)-4-carboxy-5-methyl oxazolidin-2-one (L-Oxd) in more complex molecular 
architectures can lead to the formation of stable conformations, both in solution and in solid state 
(Figure 19). 
The acylation product of those pseudoprolines leads to a particular backbone, in which the 
nitrogen atom of the ring is adjacent to both an exocyclic and an endocyclic carbonyl group, 
forcing them to a strict trans conformation. This effect is due to the tendency of the two carbonyl 
groups to orient themselves apart from one another.  
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Figure 19. The L-Oxd is a pseudoproline. In the figure is also shown the preferential conformation of the N-acylated 
form. 
 
The particular behaviour of this kind of derivatives was confirmed with several techniques. 
An interesting outcome was obtained from the analysis of the 1H NMR spectrum of 
oligopseudopeptide Boc-L-Ala-L-Ala-pGlu-OBn. This compounds shows a signal centered at 5.6 
ppm (Figure 20), which corresponds to the α-hydrogen of protected alanine and is very deshielded 
compared with Boc-L-Ala-L-Pro-OBn (δ=4.46 ppm). 
This outcome should be ascribed to the presence of the carbonyl of the γ-lactam which strongly 
deshields Ha that is nearby the carbonyl, so that the peptide bond is in the trans conformation.
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Figure 20. The chemical shifts of Ha proton clusters in a region significantly downfield from that common to peptide Hb 
protons. 
 
The 1H NMR spectrum of the dimer Boc-L-Oxd-L-Oxd-OBn shows the same deshielding effect, as 
the chemical shift of the heterocycle A hydrogen Ha resonates at 5.49 ppm, while Hb resonates at 
4.59 ppm (Figure 21).19 
                                               
18 Villa, M.; Tomasini, C. “Pyroglutamic acid as a pseudoproline moiety: a facile method for its introduction into 
polypeptide chains” Tetr. Lett. 2001, 42, 5211-5214. 
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Figure 21. The doublet due to Ha proton is particularly deshielded if compared to the signal of Hb proton. 
 
Finally, the occurrence of a nonconventional, weak C-H···O=C hydrogen bond interaction was 
confirmed by X-ray diffraction for the Boc-(L-pGlu)2-OH dipeptide (Figure 22).
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Figure 22. X-ray diffraction structure of Boc-(L-pGlu)2-OH. 
 
A further confirmation of a preferred and ordered geometry was obtained by Circular Dichroism 
measurements (CD). 
                                                                                                                                                            
19 Lucarini, S.; Tomasini, C. “Synthesis of oligomers of trans-(4S,5R)-4-carboxybenzyl 5-methyl oxazolidin-2-one:  an 
approach to new foldamers” J. Org. Chem. 2001, 66, 727-732. 
20 Bernardi, F.; Garavelli, M.; Scatizzi, M.; Tomasini, C.; Trigari, V.; Crisma, M.; Formaggio, F.; Peggion, C. and Toniolo, C. 
“Pseudopeptide foldamers: the homo-oligomers of pyroglutamic acid” Chem. Eur. J. 2002, 8, 2516-2525. 
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CD is a valuable tool that can reveal important characteristics of the secondary structure of 
biological molecules like sugars, proteins, nucleic acids, peptides. 
CD spectroscopy measures differences in the absorption of left-handed polarized light versus 
right-handed polarized light which arise due to structural asymmetry. The absence of regular 
structure results in zero CD intensity, while an ordered structure results in a spectrum which can 
contain both positive and negative signals. 
Indeed, analyzing the ellipticity as a function of the wavelength, it is possible to build a 
mathematical model of the tridimensional geometry of the molecule, like helix or β-sheet. 
To understand the role of oxazolidinones moieties in the formation of stable structures, a lot of 
different oligomers where synthesized. The simplest ones are L-Oxd homo-oligomers (Figure 23). 
Solution conformation analysis were done using FTIR absorption, 1H NMR and CD techniques.21 
 
 
Figure 23. Chemical structure of the Boc-(L-Oxd)n-OBn species investigated. 
 
The CD spectra series (Figure 24) suggests conclusions similar to those observed for the L-pGlu 
series in a previews work, where Tomasini discovered the formation of a new type of helical 
structure, similar to that adopted by poly-(L-Pro)n with trans tertiary peptide bonds (type II). 
                                               
21
 Tomasini, C.; Trigari, V.; Lucarini, S.; Bernardi, F.; Garavelli, M.; Peggion, C.; Formaggio, F.; Toniolo, C. 
“Pseudopeptide Foldamers − The Homo-oligomers of benzyl (4S,5R)-5-Methyl-2-oxo-1,3-oxazolidine-4-carboxylate” 
Eur. J. Org. Chem. 2003, 259-267. 
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Figure 24. Normalized per-residue CD spectra (1 mm in MeOH) of Boc-(L-Oxd)n-OBn (n = 1-6). 
 
The simplest hybrid oligomers that can be prepared have the general formula Boc-(Gly-L-Oxd)n-
OBn (Gly = glycine) (Figure 25).22  
 
 
Figure 25. Chemical structure of the Boc-(Gly-L-Oxd)n-OBn species investigated. 
 
The regular increase in C=O···H-N hydrogen bonds from n = 1 to n = 4 suggested by the IR analysis 
was also detected on investigation of the DMSO-d6 dependence of the NH proton chemical shift.  
The per-residue CD signals change on going from n = 1 to n = 4 with a dramatic increase in 
absorbance, thus showing that an extra effect besides the chromophore absorption is present. 
This can be attributed to the formation of hydrogen bonds and, as a result, of a secondary 
structure.  
                                               
22 Luppi, G.; Soffrè, C.; Tomasini, C. “Stabilizing effects in oxazolidin-2-ones-containing pseudopeptides” Tetrahedron: 
Asymmetry, 2004, 15, 1645-1650. 
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To investigate the preferred conformations of oligomers of the Boc-(AA-Oxd)n-OBn series further, 
Gly was replaced with Ala, thus introducing a methyl group as a side chain.23 The relative 
stoichiometry of residues is crucial for the formation of well-ordered secondary structures. 
Oligomers of both the Boc-(L-Ala-L-Oxd)n-OBn (Ala = alanine) (Figure 26) and the Boc-(L-Ala-D-
Oxd)n-OBn (Figure 27) series were therefore synthesized, in order to check whether the Gly pro-S 
hydrogen or the pro-R hydrogen should be replaced. FT-IR and NMR techniques revealed that only 
the monomeric unit L-Ala-D-Oxd permits the formation of internal hydrogen bonds, confirming 
that only one side of the previous glycine face was actually involved in the helix formation. 
 
 
Figure 26. Chemical structure of the Boc-L-Ala-L-Oxd-OBn series. 
 
 
Figure 27. Chemical structure of the Boc-L-Ala-D-Oxd-OBn series. 
 
Further confirmation of helix formation in the longer oligomers of the Boc-(L-Ala-D-Oxd)n-OBn set 
was obtained by recording the CD spectra of all the free acid derivatives of two series in MeOH 
solution. The per-residue CD spectra of the Boc-(L-Ala-L-Oxd)n-OH set (not shown) do not exhibit 
any significant change from the monomers to the higher oligomers, thus showing that no 
configuration-based effects take place. 
The per-residue CD spectra of the Boc-(L-Ala-D-Oxd)n-OH set are shown in Figure 28. Ellipticity 
increases, associated with reversal of the Cotton effect, were observed for Boc-(L-Ala-D-Oxd)5-OH 
and, more dramatically, for Boc-(L-Ala-D-Oxd)6-OH, thus suggesting the formation of ordered 
secondary structures. To define their natures, the CD spectrum of Boc-(L-Ala-D-Oxd)6-OH, 
                                               
23 Tomasini, C.; Luppi, G.; Monari, M. “Oxazolidin-2-one-Containing Pseudopeptides That Fold into β-Bend Ribbon 
Spirals” J. Am. Chem. Soc. 2006, 128, 2410-2420. 
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recorded at different concentrations (not shown), does not show any change as the concentration 
decreases: this finding excludes formation of self-associated secondary structures. 
 
 
 
 Figure 28. Normalized per-residue CD spectra of Boc-(L-Ala-D-Oxd)n-OH (n = 1-6, 1 mm in MeOH) 
  
 
Figure 29. Conformation of Boc-(L-Ala-D-Oxd)6-OBn, with the three stabilizing effects shown: (a) the rigid -CO-N(CH)-
CO- moiety, (b) the C=O···H-C H-bonds and (c) the C=O···H-N H-bonds. 
 
Of the ordered peptide secondary structures that could be formed, the CD spectra of the α and 310 
helixes and the β pleated sheet conformations were considered. From a general inspection of the 
spectra shown in Figure 28, Boc-(L-Ala-D-Oxd)5-OH and Boc-(L-Ala-D-Oxd)6-OH clearly fold in the 
310 helix configuration. More precisely, a β bend ribbon spiral structure can be attributed to Boc-
(L-Ala-D-Oxd)5-OH and Boc-(L-Ala-D-Oxd)6-OH. It may be considered a subtype of the polypeptide 
310 helix, being stabilized by alternate intramolecular C=O···H-N H-bonds and having approximately 
the same folding of the peptide chain (Figure 29). 
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The last example of hybrid oligomers reported here is the Boc-(L-Phe-D-Oxd)n-OBn series. The 
structures of Boc-(L-Phe-D-Oxd)n-OBn (n = 2-5) (Figure 30) were investigated both in solution and 
in the solid state.24 
 
 
Figure 30. Chemical structure of the Boc-L-Phe-D-Oxd-OBn series. 
 
Again, information on the preferred conformations of the oligomers in solution was obtained by 
analysis of FTIR, 1H NMR and CD absorption spectra. All data suggest that at least four L-Phe-D-Oxd 
units are required to obtain a folded structure, as was also observed for the oligomers of the L-Ala-
D-Oxd series; in the higher oligomers, the tendency to form ordered secondary structures 
increases and seems to be fully manifested at the pentamer level. Unfortunately, CD spectroscopy 
did not provide conclusive results, due to the strong absorptions of the phenyl groups around 200 
nm. 
                                               
24 Angelici, G.; Falini, G.; Hofmann, H.-J.; Huster, D.; Monari, M.; Tomasini, C. “Nanofibers from oxazolidi-2-one 
containing hybrid foldamers: What is the Right Molecular Size?” Chem. Eur. J. 2009, 15, 8037-8048. 
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2 In-solution conformational studies  
2.1 Conformational studies of Phe-rich foldamers by VCD spectroscopy and ab-initio 
calculations  
In the previous chapters, the conformational analysis in the liquid phase of hybrid foldamers that 
contain the pseudoprolines group Oxd, was described. The carbonyl present into the cycle 
introduces a constrain into the chain that forces the pseudo-peptide bond always into the trans 
conformation, favoring the secondary structures formation, even in the presence of a relatively 
small number of residues.  
As mentioned in the previous chapter, the relative configuration of the Oxd and the alternated 
amino acid is very important, since the L-Ala-D-Oxd series tends to form β-bend ribbon spirals, 
while the L-Ala-L-Oxd series does not. In the present chapter, longer oligomers of the same series 
with general formula Boc-(L-Phe-L-Oxd)n-OR (where n = 2-5 and R = H or OBn), are described.  
The conformational analysis has been carried out by 1H NMR, IR, ECD (electronic circular 
dichroism), and VCD (vibrational circular dichroism) spectroscopy, accompanied by ab-initio 
calculations. In particular, the latter two techniques can be very useful in the determination of the 
preferred secondary structure of this class of foldamers. 
 
2.1.1 VCD Technique 
Spectroscopic techniques have been potential tools in the secondary structure analysis of proteins 
and peptides, both qualitatively and quantitatively. Electronic circular dichroism (ECD) and Fourier 
transform infrared (FTIR) spectroscopy were widely used in protein structural analysis under 
various conditions. Vibrational circular dichroism (VCD) spectroscopy is a relatively new technique 
for the study of conformational preference of proteins and peptides. It measures the differential 
absorbance of left and right circularly polarized light in the infrared region originating from 
molecular vibrations. VCD can provide important conformational information in cases where ECD 
is complicated by the overlap of backbone amide and side-chain aromatic chromophores. This 
feature is particularly relevant for the studies of peptides containing aromatic amino acid residues 
that contribute significantly to electronic absorption in the near-UV region (190-230 nm), which is 
generally considered to arise exclusively from the backbone amide contribution. The 
conformational preferences of proteins in aqueous solutions have been studied using VCD. These 
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previous studies have shown that the amide I vibrational bands give characteristic VCD spectra for 
 helix, -sheet, combination of  and , random coil, and -turn structures in solutions. 
The VCD method of analysis involves comparison of the experimentally measured VCD spectrum 
to the one calculated from ab-initio quantum chemistry. 
The block diagram for the optical layout of a FT-VCD spectrometer is given in Figure 1.  
 
 
Figure 31. Block diagram for the optical layout of a FT-VCD spectrometer. 
 
IR radiation from a glower source is directed through an interferometer that encodes each 
spectral point with a Fourier frequency. The radiation from the interferometer passes through an 
optical filter so that it is linearly polarized to define a single state of polarization. Then the IR beam 
passes through a photoelastic modulator (PEM) (that sine-wave modulates the polarization 
between LCP and RCP states in the frequency range of tens of kilohertz) and finally propagates 
through the sample, which imposes an intensity modulation on the beam at the PEM frequency of 
Fourier frequencies in the spectrum where there is VCD. A cooled infrared detector then converts 
the IR beam intensity to an electrical signal that is processed by the subsequent electronics. There 
are two electronic pathways. One is the usual pathway for the measurement of the IR spectrum, 
and the other pathway includes a lock-in amplifier tuned to the PEM frequency, which 
demodulates the spectral information at the frequency and leads to the VCD spectrum.  
In VCD analysis is important to assess the conformational flexibility and to determine which 
conformers are significantly populated under the experimental measurements conditions. To 
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identify low energy conformation, a conformational search can be carried out at the molecular 
mechanics level, with software such as HyperChem (Hypercube, Gainesville, FL), Spartan 
(Wavefunction, Irvine, CA), Macro-Model (Schrodinger, Portland, OR), Irsight II (Accelrys, San 
Diego CA) or Confort (Tripos, St. Louis, MO). 
For molecules with few conformers, it is often beneficial to calculate the optimized conformers 
and energies at a semiempirical level (PM3 or AM1) in order to identify the starting conformations 
for DFT calculations. 
For identification of dominant solution conformations, the observed IR and VCD spectra are 
compared with overlays of the calculated spectra for a group of low-energy conformers. Based on 
the calculated relative energies for conformers (usually within 1 kcal/mol above the lowest energy 
conformers), the fractional Boltzmann populations at the measurement temperature is calculated: 
 
  
  
              
   
 
   
N0 = population of the lowest energy conformer 
Ni = population of conformer i 
 
Composite IR and VCD spectra are generated by weighting with Boltzmann populations and are 
afterwards compared with their experimental counterparts. Such comparison allows identification 
of the dominant conformations in solution, besides the absolute configuration. This is one of the 
major advantages of the VCD technique over X-ray analysis, the latter providing only the lattice 
conformation. 
When large deviations are found in comparing composite calculated spectra with experimental 
spectra, the presence of additional conformations and/or unanticipated solvent effects should be 
explored. Such events are usually met when molecules prone to hydrogen bonding or other strong 
intermolecular associations are investigated. 
 
33 
 
2.1.2 Synthesis  
Boc-L-Phe-L-Oxd-OBn 1 can be prepared in high yield by addition of Boc-L-Phe-OH to L-Oxd-OBn in 
the presence of HBTU and TEA in dry acetonitrile (Scheme 1). The L-Oxd-OBn moiety can easily be 
synthesized in multigram scale starting from L-Thr.25 
The oligomer series Boc-(L-Phe-L-Oxd)n-OBn (n = 2, 3, 4, 6) 4-10 have been synthesized in solution. 
Boc-(L-Phe-L-Oxd)-OH 2 has been obtained by selective deprotection of the C-terminal benzyl 
ester with H2 in methanol in the presence of Pd/C (5%), and H-L-Phe-L-Oxd-OBn·CF3CO2H 3 was 
prepared by cleavage of the N-terminal Boc moiety with anhydrous TFA in dichloromethane 
(Scheme 1). 
Then, 2 and 3 were coupled using HBTU and TEA in dry acetonitrile in an inert atmosphere 
providing 4 in satisfactory yield. By deprotection of the carbobenzoxy group with H2 in methanol in 
the presence of Pd/C (5%), the corresponding acid 5 was prepared. Repetition of these two steps 
produces Boc-(L-Phe-L-Oxd)3-OBn 6 in good yield. The longer oligomers Boc-(L-Phe-L-Oxd)4-OBn 8 
and Boc-(L-Phe-L-Oxd)6-OBn 10 have been obtained by coupling Boc-(L-Phe-L-Oxd)2-OH 5 and Boc-
(L-Phe-L-Oxd)4-OH 9, respectively, with H-(L-Phe-L-Oxd)2-OBn·CF3CO2H 7 using HBTU and TEA in 
dry acetonitrile. 
All the deprotection steps were performed with excellent yields, while the coupling step yields 
ranged between 68 and 84%. The purification by flash chromatography of the longer oligomers 
proved to be difficult due to the low solubility of Boc-(L-Phe-L-Oxd)3-OBn 6, Boc-(L-Phe-L-Oxd)4-
OBn 8, and Boc-(L-Phe-L-Oxd)6-OBn 10 in any solvent, as all the products were blocked in the silica 
gel and the yields dramatically decreased. This obstacle was overcome by performing the 
purification with the help of an ultrasound bath. The reaction crude was dissolved in ethyl acetate 
and washed with water to eliminate the water-soluble byproduct (HOBt in part, unreacted amines 
and acids, etc.), and then it was concentrated and the solvent replaced with cyclohexane. This 
mixture was sonicated so that the byproduct, tetramethylurea, and the remaining part of HOBt 
dissolved in the apolar solvent, and the desired product could be recovered pure after filtration. 
Following this procedure, the oligomers 6, 8, and 10 were obtained pure in satisfactory yields. 
 
                                               
25
 Tomasini, C.; Trigari, V.; Lucarini, S.; Bernardi, F.; Garavelli, M.; Peggion, C.; Formaggio, F.; Toniolo, C. 
“Pseudopeptide Foldamers. The Homo-oligomers of the Benzyl (4S,5R)-5-Methyl-2-oxo-1,3-oxazolidine-4-carboxylate” 
Eur. J. Org. Chem. 2003, 259-267. 
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Scheme 1. (i) HBTU (1.1 equiv), TEA (2 equiv), dry CH3CN, r. t. = 1 h; (ii) H2, Pd/C (10%), MeOH, r. t. = 16 h; (iii) TFA (18 
equiv), dry CH2CI2, r. t. = 4 h; (iv) HBTU (1.1 equiv), TEA (3 equiv), dry CH3CN, r. t. = 1 h. 
 
2.1.3 Conformational Analysis in solution  
Information on the preferred conformation of the oligomers in solution was obtained by the 
analysis of FT-IR, 1H NMR, ECD, and VCD absorption spectra and by DFT (density functional theory) 
quantum chemical calculations on Boc-L-Phe-L-Oxd-OBn. 
For a conformational analysis in solution, IR-spectroscopy is very useful because the analysis of the 
N-H stretching regions helps one to detect if intramolecular N-H···O=C hydrogen bonds are 
formed, since nonhydrogen-bonded amide NH bonds exhibit a stretching signal above 3400 cm-1, 
while hydrogen-bonded amide NH bonds26 produce a stretching band below 3400 cm-1. 
The FT-IR spectra were recorded for 3 mM solutions in both methylene chloride (aprotic polar 
solvent) and carbon tetrachloride (apolar solvent). This low concentration was chosen in order to 
avoid possible self-aggregation and due to the low solubility of the longer oligomers 6, 8, and 10.  
                                               
26 Yang, J.; Gellman, S. H. “Energetic superiority of two-center hydrogen bonding in a model system” J. Am. Chem. Soc. 
1998, 120, 9090-9091. 
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Figure 32 shows the FT-IR absorption spectra of the oligomers 1, 4, 6, 8, and 10 in methylene 
chloride and carbon tetrachloride. 
 
 
Figure 32. (a) N-H stretching regions of the IR absorption spectra for 3 mM samples of oligomers 1, 4, 6, 8, and 10 in 
CH2Cl2 at room temperature. (b) N-H stretching regions of the IR absorption spectra for 3 mM samples of oligomers 1, 
4, 6, 8, and 10 in CCl4 at room temperature. 
 
For all compounds in methylene chloride, a strong band above 3400 cm -1 was recorded and 
indicates that no hydrogen bond is formed (Figure 32a). A shoulder centered below 3400 cm-1 
(about 3340 cm-1) appears for 4, 6, 8, and 10: it becomes stronger with increasing foldamer chain 
length but never becomes the main stretching band. The formation of this shoulder suggests that 
an equilibrium takes place among different conformations. In an apolar solvent, like carbon 
tetrachloride, the results are quite different: while for compound 1, only one band centered at 
3446 cm-1 is observed, for longer oligomers, a broad band centered at about 3300 cm-1 appears 
(Figure 32b). This effect may be due to equilibrium between structures, or it simply could be 
ascribed to the formation of intermolecular hydrogen bonds due to the self-aggregation of these 
compounds in an apolar solvents. 
Additional information on the folding propensity of these compounds in solution were obtained 
my means of 1H NMR experiments in solution. The occurrence of intramolecular C=O···H-N 
hydrogen bonds was checked also by investigating the dependence of the NH proton chemical 
shifts on an increasing percentage (up to 10%) of DMSO-d6 in a 3 mM CDCl3 solution. DMSO is a 
strong hydrogen-bond acceptor, and if DMSO is bound to a free NH proton, a considerable 
downfield shift of the proton signal can be expected.27 
                                               
27 Kopple, K. D.; Ohnishi, M.; Go, A. “Conformations of cyclic peptides. IV. Nuclear magnetic resonance studies of cyclo-
pentaglycyl-L-leucyl and cyclo-diglycyl-L-histidyldiglycyl-L-tyrosyl” Biochemistry, 1969, 8, 4087-4095. 
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The Δδ values (difference of NH proton chemical shifts for the spectra recorded in pure CDCl3 and 
in 9:1 CDCl3/DMSO-d6) for NH hydrogens of oligomers Boc-(L-Phe-L-Oxd)n-OBn 6, 8, and 10 are 
summarized in Table 1. All the hydrogen amides have Δδ values above 1.8 ppm: these values are 
very high and account for non-hydrogen-bonded NH amide protons. In any case, it is worth 
mentioning that the NH-Boc hydrogens have small Δδ values that become smaller as the foldamer 
becomes longer.28 
 
Table 1. Δδ (ppm) for NH Titration for Oligomers Boc-(L-Phe-L-Oxd)n-OBn with n = 3, 4, and 6. 
Compound NH-Boc NH1 NH2 NH3 NH4 NH5 
6 0.19 1.98 2.08 
   
8 0.10 1.98 2.05 2.07 
  
10 0.08 1.85 1.99 1.96 1.97 2.16 
 
2.1.4 Circular dichroism techniques 
To get more information about the preferred conformations adopted by those molecules, circular 
dichroism techniques have been used. 
ECD measurements were recorded for 1 mM methanol solutions at room temperature for all 
compounds. The overlap of the spectra of 1, 4, 6, 8, and 10, normalized per residue, is reported in 
Figure 33 and exhibits, for all foldamers, a positive band centered at 195 nm, due to either the 
peptide transition or the strong B transitions of Phe that are usually located around 188 nm. 
 
 
                                               
28 Stevens, E. S.; Sugawara, N.; Bonora, G. M.; Toniolo, C. “Conformational analysis of linear peptides. 3. Temperature 
dependence of NH chemical shifts in chloroform” J. Am. Chem. Soc. 1980, 102, 7048-7050. 
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Figure 33. Normalized per-residue ECD spectra of the Boc-(L-Phe-L-Oxd)n-OBn (n = 1-6) series in MeOH solution (1 
mM). 
 
The ECD spectra of compound 1 display a negative signal at ca. 215 nm and a strong positive band 
at 195 nm, while at 190 nm, a negative ellipticity value is shown. In addition, a broad positive 
unfeatured band between 270 and 220 nm (crossover points) is displayed and may be attributed 
to the aromatic contribution of the Phe residue, a strongly absorbing chromophore. Some spectral 
features of longer oligomers are probably due to a mixture of conformers present in solution. It is 
clear from Figure 33 that the negative feature at 215 nm in 1 becomes weaker and blue shifted 
with increasing chain length (in 10 it falls at 205 nm). A similar blue shift is shown by the positive 
broad band from 238.5 nm in 1 to 234.0 nm in 10. These spectral features seem to rule out the 
possibility of a self-assembly of the oligomer, driven by the stacking interaction of aromatic units, 
while a PPII conformation could be taken into account supported by the fact that the broad band 
due to the aromatic chromophore contributions (with its maximum at 234 nm) could hide the 
characteristic positive peak around 220 nm. 
In order to gain further information regarding the preferred conformations of these systems, we 
also recorded VCD spectra in the mid-IR region.  
As explained above, aromatic ECD chromophores interfere with the signals characteristic of the 
amino groups, which are usually associated with backbone conformations of peptides and 
proteins. 
VCD measurements were recorded at room temperature for 20 mM solutions in carbon 
tetrachloride for 1; for longer oligomers the solubility in this solvent is too low to obtain VCD 
spectra. For this reason all Boc-(L-Phe-L-Oxd)n-OBn compounds (n = 1, 2, 3, 4, 6) were considered 
in 20 mM CD3OD solutions. The concentrations needed in VCD spectroscopy are actually quite 
large, and this should be kept in mind when comparing with the previous analysis based on the 
ECD and IR of dilute solutions. 
A qualitative comparison of the VCD spectra recorded in methanol, with help from the literature 
data on peptides, can be carried out. In Figure 34 we report the IR and VCD spectra for all 
oligomers in the L form. To provide evidence for the differences in the behavior of different-sized 
foldamers, we normalized IR and VCD spectra, dividing ε and Δε by n, for each Boc-(L-Phe-L-Oxd)n-
OBn considered. We distinguish the two regions: 900-1600 cm-1 on the right side and 1600-1800 
cm-1 on the left side (the latter contains the carbonyl stretching modes coupled with the NH in-
plane bending modes, defining the amide I modes, which are so often used in the study of 
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peptides and proteins).29 Regarding the amide I bands, the negative feature at 1675 cm-1, 
dominating over the positive component at higher frequency, may be suggestive of β structures 
for compounds 4, 6, 8, and 10. However, in usual amino-acidic peptides, this band appears at 
wavenumbers lower than 1650 cm-1; the copresence of a positive component at higher energy is 
compatible with PPII-type conformations, which in the case of peptides present precisely a 
couplet. The fact that observed wavenumbers do not correspond to the values usually observed 
for peptides can be attributed to the Oxd unit. 
 
 
Figure 34. IR and VCD spectra of the Boc-(L-Phe-L-Oxd)n-OBn (n = 1, 2, 3, 4, 6) series in methanol-d4. The ε and Δε are 
presented in residue units (see text). 
 
Both IR and VCD spectra of compound 1 are somewhat different from those of the longer 
foldamers, in agreement with ECD findings. 
To gain further information on these systems and to verify the latter observation, we recorded 
VCD spectra also in CCl4 for compound 1, which can be dissolved in sufficient amount. 
The VCD spectra of the two enantiomers are reported in the bottom part of Figure 35, while in the 
top part we provide the corresponding IR spectra; still we distinguish the two regions 1600-900 
and 1600-1800 cm-1. 
                                               
29 Cantor, C. R.; Schimmel, P. R. “Biophysical Chemistry” W. H. Freeman and Co.: San Francisco, 1980. 
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Figure 35. IR (top) and VCD (bottom) spectra of Boc-L-Phe-L-Oxd-OBn 1 (pink trace) and of the enantiomer Boc-D-Phe-
D-Oxd-OBn (blue trace) in CCl4 (20 mM solution). Numbers are introduced to facilitate correspondence between IR 
and VCD. 
The shape of the IR spectrum presents differences with respect to the one in methanol; in 
particular the band at 1690 cm-1 is not present. This suggests that, as expected, the preferential 
conformations are strongly dependent on the solvent nature. 
2.1.5 DFT Calculations  
In order to understand the preferred conformation adopted by monomer 1 in an apolar solvent, 
DFT calculations have been performed to simulate its VCD spectrum. The data from CCl4 can be 
considered representative of the isolated molecule, i.e., interactions with solvent molecules are 
expected to be small. For this reason, such data are the easiest ones to simulate and calculations 
in vacuo can be considered a good approximation.30 We performed DFT calculations on compound 
1 by first optimizing geometries and then by calculating vibrational frequencies, normal modes, 
and infrared and VCD intensities (dipole and rotational strengths), allowing us to finally simulate 
spectra for due comparison with experimental data (based on the assumption of Lorentzian 
bandshapes with a 12 cm-1 width). The relevant conformational degrees of freedom for compound 
1 are shown in Figure 32. The conformational search has been conducted at the PM3 level and at 
the B3LYP/6-31+G** level. 
 
                                               
30 Stephens, P. J.; Devlin, F. J. “Determination of the structure of chiral molecules using ab initio vibrational circular 
dichroism spectroscopy” Chirality, 2000, 12, 172-179. 
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Figure 36. Atom numbers and definition of dihedral angles for compound 1. 
 
In Figure 37 we show only the comparison between the Boltzmann weighted averages of the 
calculated spectra and the experimental data. The most populated conformers exhibit VCD and IR 
spectra resembling the experimental ones; this is important since it means that the calculated 
geometries and populations adequately represent the situation in CCl4 solution. 
With those data we may conclude that the most-populated conformer exhibits values for the 1 
and ψ1 angles typical of a PPII helix
31 (the PPII and  structures have similar ψ but different  
values).  
The former band at 1710 cm-1 can be attributed to the amide I mode, which is normally taken as a 
marker of peptide secondary structure; it has the aspect of a strong negative band at lower 
frequencies followed by a positive feature at higher frequencies which can be ascribed to a PPII 
structure. We notice, however, that the frequency is much higher than the standard amide I 
frequency (ca. 1650 cm-1); this may be due to both the short foldamer length and the presence of 
the non-amino-acidic group, Oxd. In conclusion, considering the overall spectrum, we maintain 
that the observed VCD signals are compatible with the lower-energy conformers whose backbone 
angles are consistent with a PPII or a  geometry, but different from higher-energy conformers 
with 1 and ψ1 angles appropriate for  or 310 helices. We reiterate, though, that the description 
given is just indicative of the backbone dihedral angles assumed by Boc-l-Phe-l-Oxd-OBn 1, which 
is too short to show a real peptide secondary structure. 
                                               
31
 Eker, F.; Gribenow, K.; Cao, X.; Schweitzer-Stenner, R. “Preferred peptide backbone conformations in the unfolded 
state revealed by the structure analysis of alanine-based (AXA) tripeptides in aqueous solution” Proc. Natl. Acad. Sci. 
U.S.A. 2004, 101, 10054-10059. 
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Figure 37. Comparison of experimental IR (top) and VCD (bottom) spectra of 1 with the corresponding Boltzmann 
average calculated spectra. 
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2.2 Cyclopeptides 
Cyclopeptides can act as antibiotics, regulators of membrane ion transport, and templates for 
protein design.32 In recent years, new reports of nanotube formation from cyclopeptides have 
added another dimension to their utility as new biomaterials. The incorporation of chosen, non-
amino acids into cyclopeptides is a promising approach to designs capable of performing specific 
tasks.33 
Although such hybrid cyclopeptides are common in the microbial world, some groups of synthetic 
organic chemists have only recently began to explore such designs for creating architecturally 
beautiful and functionally useful macrocyclic hybrid peptides.34 
Conformational studies on cyclopeptides as cyclo-(L-Pro-Gly)3 and cyclo-(L-Pro-Gly)4
35 shows that 
they are very flexible molecules: in polar solvents cyclo-(L-Pro-Gly)3, adopts an asymmetric 
conformation which contains one cis Gly-Pro peptide bond, while in the nonpolar solvents, the 
conformer is C3 symmetric and has all peptide bonds trans. 
This effect should be avoided using oxazolidin-2-one rings, because the presence of the endocyclic 
carbonyls force it exclusively in the trans conformation (see the previous chapter).  
The group of Tomasini has recently reported the synthesis of six cyclopseudopeptides all having 
general formula cyclo-(L-Xaa-D-Oxd)n (with n = 3 or 4).
36 In these compounds, the CHα proton 
chemical shift of the nearby amino acid is less deshielded with a chemical shift below 5 ppm, 
probably because of the cycle constraint, also confirmed by the low cyclization yields.37 
In the present chapter, a medium-sized ring containing four units, all formed by an α-amino acid 
and a Oxd group in the same configuration (L or D) is described. In the final sequence, the four LL 
                                               
32
 Darshan, R. “Designer hybrid cyclopeptides for membrane ion transport and tubular structures” Acc. Chem. Res. 
2001, 34, 919-930. 
33
 Brea, R. J. Reiriz, C. Granja, J. R. “Towards functional bionanomaterials based on self-assembling cyclic peptide 
nanotubes” Chem. Soc. Rev. 2010, 39, 1448-1456. 
34 Yoo, B.; Shin, S. B.; Y. Huang, M. L.; Kirshenbaum, K. “Peptoid Macrocycles: Making the Rounds with Peptidomimetic 
Oligomers” Chem. Eur. J. 2010, 16, 5528-5537. 
35 a) Deber, C. M.; Blout E. R. “Cyclic peptides. Amino acid-cyclic peptides complexes” J. Am. Chem. Soc. 1974, 96, 7566-
7568; b) Madison, V.; Deber, C.M.; Blout, E. R. “Cyclic peptides. 17. Metal and amino acid complexes of cyclo(pro-gly)4 
and analogues studied by nuclear magnetic resonance and circular dichroism” J. Am. Chem. Soc. 1977, 99, 4788-4798; 
c) Madison, V.; Atreyi, M.; Deber, C. M.; Blout, E. R. “Cyclic peptides. IX. Conformations of a synthetic ion-binding cyclic 
peptide, cyclo-(pro-gly)3, from circular dichroism and 1H and 13C nuclear magnetic resonance” J. Am. Chem. Soc. 
1974, 96, 6725-6734. 
36 Angelici, G.; Tresanchez Carrera, R.; Luppi, G.; Tomasini, C. “The Design and Synthesis of Dansyl-Containing Cyclic 
Pseudopeptides” Eur. J. Org. Chem. 2008, 3552-3558. 
37 a) Tomasini, C.; Luppi, G.; Monari, M. “Oxazolidin-2-ones-containing pseudopeptides that fold into β-bend ribbon 
spirals” J. Am. Chem. Soc., 2006, 128, 2410-2420; b) Bernardi, F.; Garavelli, M.; Statizzi, M.; Tomasini, C.; Trigari, V.; 
Crisma, M.; Formaggio, F.; Peggion, C.; Toniolo, C. “Pseudopeptide foldamers. The homo-oligomers of pyroglutamic 
acid” Chem. Eur. J., 2002, 8, 2516-2525. 
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or DD units are alternated so that, after cyclization, cyclo-(L-Xaa-L-Oxd-D-Xaa-D-Oxd-L-Xaa-L-Oxd-
D-Xaa-D-Oxd) is formed (Figure 38).  
 
 
Figure 38. General structure of the compound 11, a 24-membered ring containing the alternated L-Xaa-L-Oxd and D-
Xaa-D-Oxd units. 
 
2.2.1 Synthesis 
Compound 11 (Figure 38) has been synthesized in the liquid phase and in a few steps, all obtained 
with satisfactory yields (Scheme 2). First of all, the four units shown in Figure 39 have been 
synthesized in solution by reaction of a Boc-Xaa-OH with H-Oxd-OBn, in the presence of HBTU and 
an excess of DBU. They all have the general formula Boc-Xaa-Oxd-OBn, and contain four different 
amino acids [Val, Ala, Asp(OcHex), Gly] to have information on the cycle preferred conformation. 
The four compounds Boc-L-Val-L-Oxd-OBn 12, Boc-D-Ala-D-Oxd-OBn 13, Boc-L-Asp(OcHex)-L-Oxd-
OBn 14 and Boc-Gly-D-Oxd-OBn 15 (Figure 39) have all been obtained in high yield, after 
purification by silica gel chromatography. 
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Figure 39. Building blocks utilized in this work. 
 
 
 
 
 
Scheme 2. Reagents and conditions: (i) H2, Pd/C (10%), MeOH, r.t., 2 h; (ii) TFA (18 equiv.), dry CH2Cl2, r.t., 3 h; (iii) 
HBTU (1 equiv.), DBU (2 equiv.), dry CH3CN, r.t., 3 h; (iv) HATU (1 equiv.), TEA (3 equiv.), dry CH3CN, r.t., 45 min. 
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The synthesis of the open chain Boc-L-Val-L-Oxd-D-Ala-D-Oxd-L-Asp(OcHex)-L-Oxd-Gly-D-Oxd-OBn 
20 was obtained in three steps, by coupling the Boc-Xaa-Oxd-OBn units and alternating the L and 
the D moieties (Scheme 2). In any case one moiety was treated with trifluoroacetic acid in 
dichloromethane to remove the Boc moiety and the other one with H2 and Pd/C to obtain the free 
carboxy unit, then the two compounds were used without any purification and coupled in the 
presence of HBTU and triethylamine (TEA). Following this protocol, we prepared the tetramer 16, 
then the hexamer 18 and finally the octamer 20. In any case a flash chromatography purification 
was required after each coupling step. The yields were generally good, ranging between 75% and 
80%. 
The cyclization step proved to be more difficult, because a large ring with 24 atoms was prepared. 
Therefore, first of all we removed the protective benzyl group by reaction with H2 in the presence 
of Pd/C to obtain the free acid 21 in quantitative yield and then the Boc moiety by reaction with 
trifluoroacetic acid to prepare the corresponding amine as its triflouroacetic salt. This compound 
was directly cyclised in acetonitrile in low concentration (1 mM) to promote the ring formation. By 
reaction with HATU and an excess of TEA, the desired cycle 11 was prepared. Because it is very 
polar and water soluble, it could not be purified by silica gel chromatography, so it was first 
washed with little amounts of acetonitrile, then purified with HPLC (H2O/acetonitrile 
80: 20 → 70:30 as eluant) and obtained pure in 62% yield from 20. 
 
2.2.2 Conformational Analysis in solution  
Information on the preferred conformation of the oligomers in solution was obtained by the 
analysis of FT-IR and 1H NMR. 
The infrared (IR) spectrum of cycle 11 suggests that no hydrogen bond is formed. The preferential 
conformation of this very flexible ring was studied by 1H NMR analysis, with the main target of 
checking if the NH hydrogens are close to one another or if a large hollow is retained after 
cyclization. All the NMR spectra were recorded in DMSO-d6, because of its low solubility in CDCl3. 
First, 1 H NMR and gCOSY spectra have been recorded to assign all the chemical shifts, mainly to 
the CHα and to the NH hydrogens, to check if the rigid trans conformation of the imido group is 
retained (Figure 40 and Table 2), is in contrast with the results obtained for the cyclo-(L-Xaa- D-
Oxd)n previously reported.
36  
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Figure 40. Enlargement of a gCOSY 1 H NMR spectrum of 11, showing the coupling between NH and the vicinal CHα of 
the four amino acids. 
 
Table 2. Chemical shift of the NH and CHα hydrogens of 11, compared with the CHα hydrogen of 12,12,14,15 
Amino Acid δ (NH) δ (CH) δ (CH)-12-15 
L-Val 8.95 5.84 5.46 
D-Ala 9.09 5.59 5.35 
L-Asp(OcHex) 9.21 5.85 5.76 
Gly 9.30 4.50 4.74 
aThe spectrum is recorded in DMSO-d6. 
bThese chemical shifts are referred to the spectra of the precursors 12, 13, 14, 15 and are recorded in CDCl3. 
 
The chemical shifts of the four CHα hydrogens are very deshielded compared with the normal 
chemical shifts of an α-amino acid, and retain nearly the same position that they have in the four 
building blocks 12, 13, 14, 15, that are totally free of any constraint. This outcome is a 
confirmation that the local constraint typical of the 4-carboxy-oxazolidin-2-ones is a strong effect, 
present also in medium-sized rings. 
To have information on the preferential conformation of the cycle 11, we recorded a NOESY 2D 
spectrum on a 10 mM of it in DMSO-d6.  
In Figure 41 it is summarized the significative NOE enhancements of 11 in DMSO-d6. To have a 
confirmation that these enhancements are due to the formation of the cycle, it was also recorded 
the same experiment on the open chain 20 to make a comparison between the two results.  
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The signals that the two compounds share are presented in blue, while the interactions that exist 
only in the cycle and not in the open chain are reported in red.  
From these experiments, it’s possible to gather that the open chain presumably lies in an open 
form, while the cycle 11 does not. 
 
 
Figure 41. NOE enhancements as gathered from the NOESY 2D spectrum of 20 (left) (10 mM solution in DMSO-d6, 
mixing time 900 ms) and 11 (right) (10 mM solution in DMSO-d6, mixing time 700 ms). 
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3 Supramolecolar materials 
 
3.1 Introduction  
Traditionally objects and devices have been made through a “top-down” approach where an item 
is carved, or moulded out of a larger bulk material. Nanomaterials require specialized techniques 
such as electron-beam and atomic force microscopy based lithography. A “bottom-up” approach 
provides an alternative route to the development of nanoscale objects and devices. An obvious 
source of inspiration for the design of nanoscale materials from the bottom up is provided by 
Nature. Evolution has produced a range of self-assembling nanoscale systems based on lipids, 
nucleic acids and amino acids (see the first chapter). In these systems, disordered mixtures of 
molecular building blocks spontaneously arrange themselves to form highly organized structures 
with well defined properties.38  
We know that there is a relationship between amino acid sequence and structure. In peptide 
based nanomaterials, the structure formed by a single peptide can interact with another 
complementary peptide via non-covalent interactions: ionic, hydrophobic, hydrogen bonding and 
π-stacking. When a large number of these building blocks are held together, supramolecular 
structures can be formed.  
Of the enormous number of possible peptide sequences, only comparatively few are encountered 
in biological systems. The challenge is to find the rules that link peptide sequences to structures. 
Researchers have made significant progress in this area and it now becomes possible to design 
structures that have specific properties to fulfill a specific purpose. 
There are many potential applications of self-assembled peptide systems, since they represent 
attractive natural building blocks for the design of new nanostructures and nanomaterials, such as, 
wires, layers, gels, scaffolds, templates and liquid crystal.  
Moreover, there is an interest in growing cells in a more ‘‘natural’’ environment. To do this, an 
artificial extracellular matrix (ECM) is needed. In their natural environment (i.e. within tissues), 
cells grow through a matrix of proteins and glycoproteins, the most common being collagen. A 
number of peptide based fibrous networks have been developed to allow cell growth in a 3D 
environment similar to an ECM. 
                                               
38
 Ulijn, R. V.; Smith, A. M. “Designing peptide based nanomaterials” Chem. Soc. Rev., 2008, 37, 664-67. 
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Aggeli et al.39 presented a generic statistical mechanical model for the self assembly of chiral rod-
like units, such as β-sheet-forming peptides, into helical tapes, which with increasing 
concentration associate into twisted ribbons (double tapes), fibrils (twisted stacks of ribbons), and 
fibers (entwined fibrils). 
Besides the use of β-sheets as a basis for fibrous structures, also -helices may be used as 
components of coiled-coils for the purposes of self-assembly, as described first by Pauling, Corey 
and Crick.40 
In this context, the self-assembly of small peptides made of only 2-3 amino acids has been recently 
studied by Banerjee and co-workers, who demonstrated that one can obtain stable β-sheet or 
helix-like structures by interaction of small peptides that are held together by 2-3 hydrogen 
bonds.41  
In a remarkable work, Tomasini and coworkers reported the formation of a fibrous supramolecular 
material based on the molecule Boc-L-Phe-D-Oxd-OBn 22.42  
This material was obtained as a fiber-like white solid after slow solvent evaporation of a solution 
of Boc-L-Phe-D-Oxd-OBn (20-25 mM) in a mixture (1:1) of cyclohexane/ethyl acetate (Figure 42b). 
The molecule also shows good solubility in polar solvents such as acetonitrile, methanol, diethyl 
ether and ethyl acetate, but is not soluble in water. It assembles to form a fiber-like material 
under a wide variety of solution conditions. This material shows strong birefringence and has 
defined edges. It is made of bundles of crystalline-shaped filaments clustered and aligned along 
the main bundle direction (Figure 42c).  
 
                                               
39 Aggeli, A.; Nyrkova, I. A.; Bell, M.; Harding, R.; Carrick, L.; McLeish, T. C. B.; Semenov, A. N.; Boden, N. “Hierarchical 
self-assembly of chiral rod-like molecules as a model for peptide b-sheet tapes, ribbons, fibrils, and fibers” PNAS, 2001, 
98, 11857-11862. 
40
 Pauling, L.; Corey, R. B. “Structure of the nucleic acids” Nature, 1953, 171, 59-61. 
41 a) Samit, G.; Drew, M. G. B.; Banerjee, A. “Dipeptide nanotubes, with N-terminally located ω-amino acid residues, 
that are stable proteolytically, thermally, and over a wide range of pH” Chem. Mater. 2008, 20, 2282-2290; b) Bose, P. 
P.; Das, A. K.; Hedge, R. P.; Shamala, N.; Banerjee, A. “pH-sensitive nanostructural transformation of a synthetic self-
assembling water-soluble tripeptide: nanotube to nanovesicle” Chem. Mater. 2007, 19, 6150-6157. 
42 Angelici, G.; Falini, G.; Hofmann, H.-J.; Huster, D.; Monari, M.; Tomasini, C. “A fiberlike peptide material stabilized by 
single intermolecular hydrogen bonds” Angew. Chem. Int. Ed., 2008, 47, 8075-8078. 
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Figure 42. (a) Chemical structure of compound 22. (b) Boc-L-Phe-D-Oxd-OBn after slow evaporation of a mixture 
cyclohexane/ethyl acetate (1:1). (b) SEM image of filament bundles of Boc-L-Phe-D-Oxd-OBn. Scale bar: 20 μm.  
 
Interestingly, the thicknesses and the widths of the mature filaments are almost constant, 
regardless of the solvent conditions for assembly, whereas their lengths vary widely even under a 
single set of experimental conditions. The material is stable. Its overall shape was conserved in the 
precipitation media for several months and even after it had been air-dried. Only strong thermal 
treatment, such as by an electron beam, provoked the disintegration of the material. 
The solid-state structure of Boc-L-Phe-D-Oxd-OBn can be considered a borderline case of a parallel 
β sheet structure; indeed, all the examples reported in the literature show fiber-forming peptides 
that are stabilized in the solid state by at least two N-H···O=C hydrogen bonds. In contrast, this 
fiber-like material is stabilized only by single hydrogen bonds between dipeptide units. 
 
3.2 Imidazolidinones Vs Oxazolidinones 
 
As it was demonstrated that compound 21 forms fibers with the monomers arranged in infinite 
chains connected only by a single hydrogen bond, we were tempted to look for other molecules 
with such unusual properties. 
For this purpose, it was synthesized the pseudodipeptide Boc-L-Phe-D-Imz-OBn 23 (Imz = 
imidazolidin-2-one-4-carboxylate) and investigated its structure in the solid state. This compound 
is similar to Boc-L-Phe-D-Oxd-OBn but contains an additional NH group in the heterocyclic ring 
oriented nearly orthogonal to the pre-existing one (Figure 43). The presence of two NH hydrogen 
bonds that are not oriented along the same axis should favor the formation of a two-dimensional 
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arrangement. This effect should drive the formation of layers instead of fibers, that were obtained 
with Boc-L-Phe-D-Oxd-OBn, which can form only one hydrogen bond. 
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Figure 43. Schematic structural comparison of Boc-L-Phe-D-Oxd-OBn and Boc-L-Phe-D-Imz-OBn (red and blue arrows 
show the hydrogen bond directions). 
 
The dipeptide Boc-L-Phe-D-Imz-OBn 23 was prepared in a single step starting from the readily 
available Boc-L-Phe-D-Asn-OBn and utilizing a modified methodology for the Hofmann 
rearrangement that was recently described by Tomasini.43 This method was necessary because the 
preparation of an imidazolidin-2-one-4-carboxylate could not be performed by reaction of 1,2-
diaminopropanoic acid (DAP) with triphosgene, due to the low availability of DAP and the poor 
reaction yield (Scheme 3). 
 
 
Scheme 3. Synthesis of Boc-L-Phe-D-Imz-OBn 23 
 
                                               
43
 Angelici, G.; Contaldi, S.; Green, S. L.; Tomasini, C “Synthesis of imidazolidin-2-one-4-carboxylate and of (tetrahydro) 
pyrimidin-2-one-5-carboxylate via an efficient modification of the Hofmann rearrangement” Org. Biomol. Chem. 2008, 
6, 1849-1852. 
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The rearrangement is a very general reaction and can be applied both to protected asparagine and 
to asparagine-containing protected polypeptides. It is promoted by the readily available PhI(OAc)2 
in the presence of DBU and provides the desired heterocycle in high yield (Figure 44). 
 
 
 
Figure 44. Suggested mechanism of the modified Hofmann rearrangement for the synthesis of 4-substituted 
imidazolidin-2-one. 
 
After preparation and purification with conventional methods, Boc-L-Phe-D-Asn-OBn was treated 
with PhI(OAc)2 and DBU in tetrahydrofuran for 1 h to furnish the desired compound 23 in 65% 
yield after flash chromatography.  
The conformation of compound 23 was analyzed in solution and in the solid state. A first analysis 
was performed, comparing the IR spectrum of a 3 mM solution of 23 in dichloromethane with the 
spectrum of a 1% mixture of 1 in KBr. The spectral regions concerning the NH and CO stretching 
bands are reported in Figure 45. 
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Figure 45. FT-IR absorption spectra (a) in the N-H stretching region (3600-3200 cm
-1
) and (b) in the C=O stretching 
region (1850-1600 cm
-1
) for 3 mM samples of 23 in pure CH2Cl2 (black line) and as a 1% solid mixture with KBr (red 
line) at room temperature. 
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While hydrogen bonding is clearly present in the solid state as shown by two peaks (3391 and 
3371 cm-1) belonging to a broadband, no hydrogen bonding is present in the diluted solution (3444 
cm-1), and thus intramolecular NH hydrogen bonds are absent. A strong variation of the spectrum 
in the CO region confirms this result. 
Several attempts were made to obtain macroscopic ordered structures in the solid state by slow 
evaporation of solutions of 23 in different solvents. The formation of crystal aggregates of 23 was 
observed by slow evaporation of a 1:1 mixture of cyclohexane/ethyl acetate, which was used for 
the evaporation of Boc-L-Phe-D-Oxd-OBn. 
In contrast, slow evaporation from protonated solvents such as methanol, ethanol, and 
isopropanol provided crystals, which were useful for single crystal X-ray diffraction studies. 
Interestingly, the nature of the alcohol has an influence on the preferential elongation and 
macroscopic side-aggregation of the crystals (Figure 46), which show a common tendency to 
aggregate laterally along their main axis (Figure 46a,c,e). In the aggregates of 23a, the lateral 
association extends over several hundred micrometers. Their image under the optical microscope 
with cross polars shows them preferentially iso-oriented (insets in Figure 46a). The degree of order 
in crystal association continuously decreased when ethanol and isopropanol were used as 
solvents, as shown by the reduced birefringence of crystals 23b and 23c (insets in Figure 46c,e). 
Crystals suitable for single crystal X-ray diffraction were obtained from isopropanol solutions in a 
crystallization trial using seed crystals from the homogeneous precipitation in the same solvent 
(Figure 46f). The observation of crystals by SEM (Figure 46b,d,f) shows that each crystal is made of 
several layers which are cast on the top of each other. This superstructure organization is also 
present in the single crystals obtained from isopropanol by seeding (inset of Figure 46f). Thus, in 
all these crystals a plywood structure is present, with a varying degree of order as a function of the 
precipitation conditions. 
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Figure 46. Optical micrographs of crystals of 23 precipitated by slow evaporation from solutions of 23 in (a) 23g from 
methanol, (c) 23b from ethanol, and (e) 23c from isopropanol. The top insets in (a, c, e) show the same images under 
cross polars. The bottom inset (c) shows an aggregate of plate-like crystals precipitated from an ethanol solution. In 
the left insets in (f) optical micrographs of a crystal of 23c are shown obtained in a seeding crystallization trial from an 
isopropanol solution. Scanning electron microscopy images of crystals of 23a, 23b, and 23c are shown in (b), (d), and 
(f), respectively. The plywood structure is evident for 23a (b) and 23b (d). The insets in (b) and (d), and that on the 
right in (f), show that all crystals are made of several layers. 
 
The formation of these plate-like crystals only by slow evaporation of the protonated solvents 
suggests the idea that the solvents may play an active role in crystal formation.44 The obtained 
single crystals were analyzed by X-ray diffraction (XRD) and thermal analysis. Crystals of 23 grown 
from methanol and ethanol, respectively, show the formation of methanol (23a) and ethanol 
solvates (23b). In addition to the solvent, two independent molecules of 23 are present in the unit 
cell (Figure 47). 
                                               
44 Guha, S.; Drew, M. G. B.; Banerjee, A. “Solvent-induced dynamic single-crystal-to-single-crystal transformation of a 
synthetic peptide-based cyclic compound” Cryst.Eng.Comm. 2009, 11, 756-762. 
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Figure 47. View of the content of the unit cell of 23 crystallized with (a) methanol (structure 23a) and (b) ethanol 
(structure 23b). 
 
The two peptide molecules in structure 23a have approximately the same backbone conformation 
(Figure 47). The two conformers differ only in the orientation of the benzyl ring of the OBn moiety. 
In the unit cell, each conformer belongs to a separate infinite chain of peptide molecules, which 
are arranged in parallel orientation. Two consecutive residues in the chains are connected by only 
one NH···O=C hydrogen bond between the amidic NH proton of the L-Phe residue of the one 
peptide molecule and the carbonyl function of the Boc group of the other one. 
The infinite chains are arranged in an antiparallel orientation along the a axis (Figure 48a). The 
phenyl rings are in a displaced stacked arrangement, but the offset of the phenyls prevents π-π 
stacking. The conformation of the monomers and the arrangement of the chains is in close 
correspondence to that found in Boc-L-Phe-D-Oxd-OBn (22). The presence of the NH unit in D-Imz, 
replacing the oxygen atom in the D-Oxd ring, allows the formation of further hydrogen bonds. This 
possibility leads to an interconnection of two peptide chains via the bifurcated NH bond involving 
the Imz NH group of a peptide molecule of one chain and two carbonyls of the other chain. One 
carbonyl group comes from an L-Phe residue, and the other from the D-Imz constituent of the 
other chain. Although the NH···OC distances are larger (2.35 and 2.52 Å) than those found in 
typical hydrogen bonds, the general electrostatic effect in this arrangement favors the 
interconnection. In comparison to the D-Oxd crystals, the packing is more complex because of the 
presence of one methanol molecule that acts as a linker between the two chains establishing two 
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H-bonds using both the oxygen and hydrogen atoms (O13-H80···O8, O13···H1-N1) of the solvent 
molecule (Figure 48b). 
 
 
Figure 48. (a) View down the c axis showing the chains of the two different conformers running along the a axis; (b) 
view down the a axis showing the H-bond interactions among chains of the two different conformers of 23. Dark 
dotted lines indicate hydrogen bonds; color code: C gray (in one conformer) and green (in the second conformer), O 
red, N blue. 
 
The single crystal X-ray diffraction study carried out on crystals of 23 grown from ethanol shows 
the formation of an ethanol solvate 23b isostructural with the methanol solvate 23a. And, 
therefore, the crystal packing is almost identical to that described for 23a and needs no further 
comments. 
A crystal suitable for single crystal X-ray diffraction studies could also be obtained from 
isopropanol. In this case, no solvent molecules are involved in the crystal structure of 23c, 
probably due to the larger size of the isopropanol molecule, that can no longer be accommodated 
in the cavity between two molecules of 23. In the crystal packing of 23c, two different types of 
intermolecular hydrogen bonds are present (Figure 49). One hydrogen bond connects the amidic 
NH hydrogen of the L-Phe unit with the carbonyl oxygen of the CO group of the D-Imz moiety 
belonging to another peptide molecule. The other involves the NH proton of the D-Imz ring and 
the carbonyl oxygen of a Boc group of another peptide molecule. These weak interactions 
generate also a 2D-network parallel to the ab plane, which is different from that observed in the 
packing of 23g and 23b, respectively. Quantum chemical calculations on the two different crystal 
packings with six peptide molecules but without solvent molecules show a slight preference for 
the packing of 23c by 8.3 kJ/mol at the HF/6-31G* level of ab-initio MO theory. By interaction with 
an additional solvent molecule, the methanol/ethanol solvate packings can obviously compensate 
for this disadvantage. 
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Figure 49. (a) View down the c axis and (b) view down the a axis of the crystal packing of 23c (hydrogen atoms omitted 
for clarity). 
 
In order to investigate the effect of temperature on the structure of the plate-like crystals of 23a, 
23b, and 23c, calorimetric and X-ray powder diffraction analyses were carried out (Figure 50). The 
heating profile of single crystals of 23a (Figure 50a) shows a broad endothermic peak at 46 °C 
followed by two sharp endothermic peaks, a strong one at 89 °C and a weak one at 141 °C. For a 
better understanding, the structural reorganization of 23a associated with the thermal treatment 
was followed by X-ray powder diffraction (Figure 50b). The experimental X-ray diffraction pattern 
of 23a collected at room temperature (Figure 50b, polymorph 23a-I) shows all the peaks present in 
the diffraction pattern calculated from the single crystal structure of 23a (Figure 50b, polymorph 
23a-C) and some additional peaks belonging to the diffraction pattern of 23a after the thermal 
treatment just above the temperature first endothermic peak (Figure 50b, polymorph 23a-II). The 
23a material TGA profile analysis indicates a weight loss of 3.8 % in the temperature range 
between 23 and 68 °C. Thus, the first endothermic peak could be associated with the loss of 
methanol molecules from the crystal lattice (stoichiometric content of 3.3% w/w). These 
observations suggest that the material precipitating at room temperature is a mixture of crystals 
containing solvent and solvent-free crystals. No differences in the morphology of these two 
species of crystals have been observed. Above a temperature of 100 °C after the strong 
endothermic peak at 89 °C, the polymorph of 23a-III is formed, which melts at a temperature of 
141 °C giving an amorphous material (Figure 50b, polymorph 23a-IV). The heating profile of single 
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crystals of 23b (Figure 50c) shows two overlapping endothermic peaks at 95 and 109 °C followed 
by a very weak one at 144 °C. 
 
 
Figure 50. Differential scanning calorimetry profiles of crystals of 23 precipitated from a solution of (a) methanol (23a), 
(c) ethanol (23b), and (e) isopropanol (23c). (b) X-ray powder diffraction patterns of single crystals of 23a after thermal 
treatment up to the temperature I-IV. (d) X-ray powder diffraction patterns of single crystals of 23b after thermal 
treatment up to the temperature I-III. (f) X-ray powder diffraction patterns of single crystals of 23c after thermal 
treatment up to the temperature I and II. In panels b, d, and f, the calculated powder diffraction pattern from the 
single crystal structure (c) is reported for comparison with I. In panel b, the asterisks in I indicate the diffraction peaks, 
which belong to the desolvated form II. 
 
Also in this case the structural reorganization of 23b associated with the thermal treatment was 
followed by X-ray powder diffraction (Figure 50d). The experimental X-ray diffraction pattern of 
23b-I collected at room temperature shows all the peaks present in the diffraction pattern 
calculated from the single crystal structure of 23b-c. This indicates that the material precipitating 
at room temperature is a pure phase. At a temperature of 97 °C after the endothermic peak at 95 
°C, a second polymorph of 23b-II is formed. This polymorph melts at a temperature of 109 °C 
giving the amorphous material 23b-III. The material 23b TGA profile indicates a weight loss of 5.8% 
in the range of temperature between 65 and 120 °C. This value is close to the stoichiometric 
content of solvent in 23b (5.8% w/w). 
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Finally, single crystals of 23c (Figure 50e) show a heating profile, in which only one strong 
endothermic peak at 150 °C is present. The material 23c is a pure phase, as shown by the 
correspondence among all the peaks present in the experimental X-ray powder diffraction pattern 
(Figure 50f, 23c-I) and the one calculated from the single crystal structure (23c-C). Moreover, this 
compound melts at 150 °C, giving the amorphous material 23c-II. This material does not host 
solvent in its crystal lattice, as confirmed by the absence of peaks in the first derivative of the TGA 
profile below the decomposition temperature. All these materials start to decompose at 
temperatures above 180 °C. 
 
3.3 L-Phe-D-Oxd: a “privileged scaffold”  
 
To understand the importance of the L-Phe-D-Oxd scaffold to build new architectures and, in 
particular, the role of the D-Oxd group, we decided to explore how it behaved when it was 
included in more complex structures and if the term “privileged scaffold” could be used to define 
it. This term was first proposed by Evans et al. to describe selected structural types that bind to 
multiple, unrelated classes of protein receptors as high-affinity ligands.45 These privileged 
structures are typically rigid, polycyclic heteroatomic systems capable of orienting a variety of 
substituent patterns in a well-defined three-dimensional space.46 
 
3.3.1 Different behaviour of two epimers 
In this paragraph, the self-assembly of two epimers, Boc-L-Phe-D-Oxd-(S)-β3-hPhg-OBn (24) and 
Boc-L-Phe-D-Oxd-(R)-β3-hPhg-OBn (25), is described. Both of these molecules contain the scaffold 
L-Phe-D-Oxd, but differ for the introduction of the two enantiomers of β3-homophenylglycine. The 
reversal of the stereogenic center contained in this moiety is crucial on the preferred molecular 
conformation and, as a result, on the crystal morphology. 
Compounds 24 and 25 are easily prepared by coupling of the already described Boc-L-Phe-D-Oxd-
OH moieties with (R)-β3-hPhg-OBn or (S)-β3-hPhg-OBn, respectively, in high yield by standard 
                                               
45
 Evans, B. E.; Rittle, K. E.; Bock, M. G.; DiPardo, R. M.; Freidinger, R. M.; Whitter, W. L.; Lundell, G. F.; Veber, D. F.; 
Anderson, P. S.; Chang, R. S. L.; Lotti, V. J.; Cerino, D. J.; Chen, T. B.; Kling, P. J.; Kunkel, K. A.; Springer, J. P.; Hirshfield, 
J. “Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists” J. Med. 
Chem. 1988, 31, 2235-2246. 
46
 Nicolaou, K. C.; Pfefferkorn, J. A.; Roecker, A. J.; Cao, G.-Q.; Barluenga, S.; Mitchell, H. J. “Natural product-like 
combinatorial libraries based on privileged structures. 1. General principles and solid-phase synthesis of benzopyrans” 
J. Am. Chem. Soc. 2000, 122, 9939-9953. 
60 
 
methods in solution. The coupling steps are reported in Scheme 4. The compounds were obtained 
pure as white solids after purification by flash chromatography (cyclohexane/ethyl acetate 8/2 as 
eluants). 
 
 
Scheme 4. (i) CF3COO
- +H3N-(S)-β
3-hPhg-OBn (1 equiv), HBTU (1.1 equiv), TEA (3 equiv), dry CH3CN, 40 min, r.t.; (ii) 
CF3COO
- +H3N-(R)-β
3-hPhg-OBn (1 equiv), HBTU (1.1 equiv), TEA (3 equiv), dry CH3CN, 40 min, r.t. 
 
The preferential conformation assumed by the two compounds was analyzed by FT-IR 
spectroscopy in diluted solution (3 mM) Figure 51. It is possible to recognize the presence of a 
chelate NH hydrogen bond for the compound 25, as demonstrated by the peaks centered at 3350 
and 1670 cm-1, while 24 does not. This outcome suggests that only 25 forms a -turn structure. 
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Figure 51. FT-IR absorption spectra in the N-H (left) and C=O (right) stretching regions for 3 mM concentration 
samples of oligomers 24 and 25 in pure CH2Cl2 at room temperature. 
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This outcome is confirmed by solution NMR spectroscopy, where we investigated the DMSO-d6 
dependence of the NH proton chemical shifts. DMSO is a strong hydrogen bond acceptor and, if 
bound to a free NH proton, a considerable downfield shift of the proton signal can be expected. 
Both compounds have two NH groups, belonging to a carbamate group and an amide group, 
respectively. While the chelation of the carbamate NH is uncertain for both compounds, it is 
possible to notice that the Phe-NH group is poorly chelated for 24 and much more chelated for 25, 
thus confirming the outcome of the FT-IR spectra. 
The FT-IR spectra of 24 and 25 in the solid state are very similar and show that all the NH 
hydrogens are hydrogen bonded, as all the stretching signals are below 3400 cm-1 (Figure 52). 
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Figure 52. FT-IR absorption spectra in the N-H (left) and C=O (right) stretching regions for a 1% solid mixture with KBr 
of oligomers 24 and 25 at room temperature. 
 
From the analysis of the two compounds in solution and in the solid state, it is only possible to say 
that both compounds tend to aggregate in the solid state, without any information about how 
they do it. For this purpose, an analysis of the two compounds was carried out by means of 
microscopy and X-ray diffraction. 
A wide morphological variety of samples based on compounds 24 and 25 obtained by evaporation 
from different solvents were analyzed by optical and electronic microscopy. 
The samples were precipitated by overnight evaporation of aliquots (20.0 mg each) from several 
solvents (methanol, ethanol, acetonitrile, cyclohexane/ethyl acetate, 1:1 mixture, or diethyl ether, 
1.0 mL each). A fast precipitation was also achieved by rotary evaporation. The obtained solids 
showed different morphologies depending on the kind of solvent and the solvent evaporation 
rate. In any case, the precipitation of 24 provoked the formation of a solid material made of 
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filamentous aggregates, in which the crystals showed a preferential direction of growth and had a 
strong tendency to aggregate laterally. This material always showed birefringence suggesting a 
high crystallinity (Figure 53a,c). Only when 24 was exsiccated by means of a rotary evaporator a 
powder-like material was obtained. Crystals of 24 suitable for a single crystal X-ray diffraction 
investigation were obtained only from methanol evaporation. An image of these crystals by 
scanning electron microscopy is reported in Figure 53c. They appear elongated in one direction 
with a hexagonal cross-section. Their length varied from one crystal to another in the range of 
several hundred of micrometers, while their thickness was almost constant around 20 μm. On the  
contrary, compound 25 did not always precipitate forming a filamentous structure (data not 
shown). It precipitated as a mixture of powder and small (around 1 μm) elongated crystal 
aggregates from acetonitrile, cyclohexane/ethyl acetate, or diethyl ether, while by evaporation 
from protonated solvents, methanol or ethanol, elongated single crystals were obtained (Figure 
53b,d). Of these, only the ones precipitated from ethanol were suitable for single crystal X-ray 
diffraction studies (see later). These crystals were also observed by scanning electron microscopy 
that showed an irregular morphology in which plate-like shapes are visible. 
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Figure 53. (a) Optical micrographs of 24 precipitated from cyclohexane/ethyl acetate. The elongated growth of the 
crystal is observable together with their high lateral aggregation. (c) Single crystals of 24 precipitated from ethanol, 
they are birefringent and have a hexagonal cross-section. (b, d) Crystals of 25 precipitated from ethanol observed by 
means of an optical and an electron microscope, respectively. 
 
The crystals of 24 and 25 that precipitated from different solvents were analyzed by X-ray powder 
diffraction. Compound 24 gave only one kind of crystals, irrespective of the solvent used 
(methanol, ethanol, acetonitrile, cyclohexane/ethyl acetate, or diethyl ether) in the crystallization 
trials. Interestingly, the same kind of crystals precipitated even when the process was carried out 
in very harsh conditions, such as rotary evaporator (Figure 54a). This tendency to precipitate in a 
unique conformation may indicate a high stability of this form, which may be already present in 
solution, before the precipitation process starts. Compound 25 showed a different behavior with 
respect to compound 24. It precipitated as a crystalline polymorph from methanol or acetonitrile, 
as a different polymorph from ethanol, and as a third polymorph from cyclohexane/ethyl acetate 
or diethyl ether (Figure 54b). The exsiccation of 25 using a rotary evaporator provoked the 
formation of a low crystallinity material, which could be a new polymorph or a mixture of 
polymorphs already precipitated from other solvents. It is conceivable to consider that the 
precipitation of this latter polymorph is strongly affected by the polarity and protonation of the 
solvent, as well as by the rate of crystallization. It is also interesting to note that the material 
precipitated from ethanol contained traces of the polymorphs obtained after precipitation from 
methanol or acetonitrile (Figure 55b). 
 
Figure 54. (Left) X-ray powder diffraction patterns of 24 precipitated from different solvents and exsiccated using a 
rotary evaporator. The calculated diffraction pattern from the structure of 24 obtained from crystals precipitated from 
methanol is shown as well. (Right) X-ray powder diffraction patterns of 25 precipitated from different solvents and 
exsiccated using a rotary evaporator. The calculated diffraction pattern from the structure of 25 obtained from 
crystals precipitated from ethanol is shown as well. Rotar indicate a material exsiccated by means of a rotary 
evaporator; MeOH, EtOH, MeCN, cHex/AcOEt, and Et2O indicate a material precipitated from methanol, ethanol, 
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acetonitrile, cyclohexane/ethyl acetate, and diethyl ether respectively; calc indicates the calculated diffraction 
pattern. 
 
Crystals suitable for an X-ray diffraction study were grown only by slow evaporation of a solution 
of 24 in methanol and of 25 in ethanol, both at room temperature. Any effort to grow from 
methanol crystals of 25, suitable for X-ray studies, was unsuccessful. 
The X-ray molecular structures of 24 and 25 are reported together in Figure 55, panels a and b, 
respectively, and relevant torsion angles for both are listed in Table 2. The two molecules are 
epimers and differ only for the configuration of the stereogenic center C6 which is S in 24 and R in 
25. As a consequence of this different stereogenic center, 25 has a higher degree of folding than 
24 (closer contact O8···H15A 3.05 Å), but no classical intramolecular hydrogen bond is observed in 
both epimers, in contrast with the behavior of 25 in solution. 
 
 
Figure 55. X-ray molecular structures of the two epimers 24 (a) and 25 (b). 
 
Each molecule of 24 is engaged in four intermolecular N-H···O=C hydrogen bonds of two types 
with the adjacent neighbors. Two interactions connect the amidic hydrogens of the side chain 
bearing the Boc group and the carbonylic oxygens of the amidic unit of the other side arm [N2-
H2N···O3′, symm. op.: (I) -x + y, -x, z + 1/3; O3···H2N′′-N2′′, symm. op.: (II) -y, x - y, -1/3 + z], while 
the ones of the second type involve the amidic hydrogen H3N and the carbonylic oxygen of the D-
Oxd ring [N3-H3N···O1′, O1···H3N′′-N3′′]. The crystal packing of 24 (Figure 56) therefore consists of 
parallel chains with a helical arrangement (Figure 57) running along the c axis. The formation of a 
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ternary helix in the solid state is in agreement with the SEM analysis as the crystals of 24 from 
methanol appear elongated in one direction with a hexagonal cross-section (Figure 53c). 
 
 
Figure 56. View down the b axis of the crystal packing of 24 showing the N-H···O=C H bonds. Only the hydrogen atoms 
involved in H bonding are shown. 
 
 
Figure 57. Space filling model showing the helical arrangement of one of the chains of 24: (a) top view, (b) view along 
the c axis. The molecules are represented in different colors for clarity. The hydrogen atoms involved in N-H···CO 
hydrogen bonds are represented as white cups. 
 
A closer inspection of the crystal packing of 24 reveals the presence of weaker intermolecular non 
classical H bonds beside the already mentioned N-H···CO hydrogen bonds generating the 1-D 
network. In particular, two of these H bonds are established between the carbonylic oxygen O1 
and the acidic proton of the D-Oxd ring of an adjacent molecule. Other two weak H bonds are 
observed between the endocyclic oxygen of the D-Oxd ring and one proton of a phenyl ring. All 
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these intermolecular interactions further stabilize the 1-D network, being oriented almost parallel 
to the stronger N-H···OC hydrogen bonds. 
A completely different packing is observed for epimer 25 (Figure 58) which maintains one 
intermolecular NH···OC hydrogen bond between equivalent amidic groups as observed in Boc-L-
Phe-D-Oxd-OBn (22). In addition, a second weaker hydrogen bond is observed between the amidic 
hydrogen of the other amide group and the uncoordinated carboxylic oxygen bearing the Bn 
group. As a result, epimer 25 is engaged in four interactions that are weak in comparison with 
those found in Boc-L-Phe-D-Oxd-OBn (22), but the hydrogen bonding pattern in the crystal lattice 
shows the formation of infinite 1-D H-bonded polymer of tape running along the a axis. 
 
 
Figure 58. View down the c axis of the crystal packing of 25 showing the N-H···CO hydrogen bonds. Only the hydrogen 
atoms involved in N-H···CO hydrogen bonding are shown. 
 
The supramolecular assembly of 25 is completed by other hydrogen bonding interactions. In detail 
the 1-D supramolecular polymer of 25 is further stabilized by CH/π bonding between the acidic 
hydrogen (H6) of one molecule and one phenyl ring of the neighbors. As a difference with the 
crystal packing of 24, there are also weak interchain H bonds involving the endocyclic oxygen O2 
of the D-Oxd ring and an aromatic hydrogen H19. 
To further investigate the effect of the absolute configuration variation of the β3-hPhg moiety on 
the properties of 24 and 25 in the solid state, single crystals of 24 and 25, obtained respectively, 
from methanol and ethanol, were also analyzed in their thermal properties by differential 
scanning calorimetry and thermogravimetry. Compound 24 undergoes an endothermic transition 
at a temperature of 170 °C, where it fuses converting to an amorphous material. After this first 
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thermal event, 24 shows a successive broad endothermic peak having a temperature of onset at 
about 206 °C and maximum at about 222 °C (Figure 59). At 206 °C 24 starts to decompose, as 
shown by thermogravimetric analysis (TGA). Compound 25 shows a differential scanning 
calorimetry (DSC) profile similar to that of 24. First an endothermic peak appears at 167 °C, which 
is associated with a transition from the crystalline to an amorphous state (Figure 9), and then a 
broad endothermic peak follows with an onset and maximum temperature of about 218 and 240 
°C, respectively. 
 
Figure 59. (Left) Differential scanning calorimetry profiles from single crystals of 24 and 25. (Right) X-ray powder 
diffraction patterns corresponding to different regions in the thermal profiles of 24 and 25. 
 
1850 1800 1750 1700 1650 1600
0,0
0,1
0,2
0,3
0,4
0,5
0,6
0,7
1787
A
b
s
o
rb
a
n
c
e
 (
%
)
 (cm
-1
)
 1 3 mM in CH
2
Cl
2
 1 1% in KBr
 1 1% in KBr after heating at 180 °C
 2 3 mM in CH
2
Cl
2
 2 1% in KBr
 2 1% in KBr after heating at 180 °C
 
Figure 60. FT-IR absorption spectra in the C=O (right) stretching regions for oligomers 24 and 25 under different 
conditions. Black line: 24 in 3 mM solution in CH2Cl2; magenta line: 24 in 1% mixture with KBr; blue line: 24 crystallized 
from methanol, after heating at 180 °C (polymorph 24-II); red line: 25 in 3 mM solution of CH2Cl2; yellow line: 25 in 1% 
mixture with KBr; green line: 25 crystallized from ethanol, after heating at 180 °C (polymorph 25-II). 
 
The 24-II FT-IR spectrum in the C=O bands region presents a band at 1787 cm-1 and a broadband 
centered at about 1700 cm-1. A similar FT-IR spectral region is observed when 24 is present in a 
68 
 
dilute solution of CH2Cl2 (Figure 60). This suggests that, as a consequence of the thermal 
treatment, after the first endothermic peak, compound 24 goes in an amorphous state, in which it 
assumes conformations similar to those in solution. In contrast, the IR analysis of a sample of 25 
after thermal treatment does not show any peak at 1780 cm-1; thus, its amorphous state somehow 
still retains an ordered structure. 
 
3.3.2 One more Phe … 
 
Since the emergence of Phe-Phe as a self-assembling building block, many studies have been 
made to organize the FF-based building blocks into various functional nanostructures such as 
nanotubes (Figure 61), spherical vesicles, nanofibrils, nanowires and ordered molecular chains.47 
 
 
 
Figure 61. A proposed schematic illustration of formation of Phe-Phe-based nanotubes. 
 
Thus, we prepared the tripeptide Boc-L-Phe-L-Phe-D-Oxd-OBn (26) to determine its properties in 
the solid state (Figure 62). 
 
 
 
Figure 62. Chemical structure of Boc-L-Phe-L-Phe-D-Oxd-OBn. 
 
                                               
47 Yan, X.; Zhu, P.; Li, J. "Self-assembly and application of diphenylalanine-based nanostructures” Chem. Soc. Rev. 2010, 
39, 1877-1890. 
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The 1H NMR spectrum of 26 shows the presence of a single conformer, that tends to aggregate 
into crystalline fibre-like materials, due to its rigid conformation. In Figure 63, optical microscopy 
(OM) and SEM images of 26 are reported. 
 
 
Figure 63. a) OM and b) SEM images of 26. 
 
It is possible to observe that 26 forms elongated crystals (up to a few millimeters) locally iso-
oriented. Each single crystal (about 20 mm thick) has a well-defined crystalline habit and shows 
faces that are probably parallel to the crystallographic a axis. The pseudo-hexagonal cross-section 
is also shown. 
The conformational analysis of 26 in the solid state was further elucidated by a single-crystal X-ray 
diffraction study. 
The molecular conformation of 26 is shown in Figure 64a and relevant torsion angles are reported 
in Table 3. The backbone torsion angles for the two L-Phe units correspond approximately to those 
in peptide β strands. In the crystal packing of 26 (Figure 64b) each molecule is connected through 
four intermolecular NH···OC hydrogen bonds [N2H2N···O6′ 2.204 Å, N2···O6′ 3.005(4) Å, N2-
H2N···O6′ 163°, symmetry code (I): x-1,y,z; N3H3N···O7″ 2.137 Å, N3···O7″ 2.941 Å, N3-H3N···O7″ 
168°, symmetry code (II): x + 1,y,z] to two neighbours, thus generating an infinite parallel β-sheet 
structure running along the crystallographic a axis. Interestingly, this arrangement is similar to that 
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observed in Boc-L-Phe-D-Oxd-OBn, in which one unit is connected to the adjacent ones through 
single NH···OC hydrogen bonds.48 
 
 
Figure 64. a) X-ray molecular structure and b) crystal packing of 26. 
 
Table 3. Selected backbone torsional angles [°] for 26. 
L-Phe1 C31-N3-C23-C22 φ1 -127.3(3) 
 N3-C23-C22-N2 ψ1 109.5(3) 
L-Phe2 C22-N2-C14-C13 φ2 -126.4(3) 
 N2-C14-C13-N1 ψ2 147.9(3) 
Oxd C13-N1-C9-C8 φ3 56.2(4) 
 N1-C9-C8-O1 ψ3 32.4(4) 
 
We could also confirm that Oxd moiety was essential for the properties of the supramolecular 
material. Compounds 19 and 20 were synthesized replacing the D-Oxd moiety with a D-Pro (D-Pro 
= D-proline) moiety in compounds 22 and 26 (Figure 65). 
 
                                               
48
 Guha, S.; Drew, M. G. B.; Banerjee, A. “Construction of supramolecular helices and breaking the helicity by forming 
supramolecular β-Sheet structures using suitable self-assembling pseudopeptide building blocks” Cryst. Growth. Des. 
2010, 10, 47164721. 
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Figure 65. Molecules 27 and 28 where synthesized as they are the same backbone of 22 and 26, but with a proline 
heterocycle instead of an oxazolidinone one.  
 
In contrast with their Oxd analogues, compounds 27 and 28 do not show any propensity to form 
fibre-like materials because they hardly become solids: 27 is a liquid and 28 is an amorphous solid, 
as shown by its powder X-ray diffraction (not reported).  
 
3.4 Gel 
 
In daily life most people encounter systems based on gelating agents, often without realizing it. 
From a scientific perspective a definitive definition of a gel is still lacking, mainly due to the 
chemical diversity encountered in gelation science. The gel state has been recognized already for 
over 150 years. In 1861 Thomas Graham gave the following description: “While the rigidity of the 
crystalline structure shuts out external expressions, the softness of the gelatinous colloid partakes 
of fluidity and enables the colloid to become a medium for liquid diffusion, like water itself”.49 In 
the following years more rigorous definitions were proposed which attempted to link the 
microscopic and macroscopic properties of a gel.50 Based on these definitions a substance is a gel 
if it (i) has a continuous microscopic structure with macroscopic dimensions that is permanent on 
the time scale of analytical experiments and (ii) is solid-like in its rheological behaviour despite 
                                               
49 Graham, T. “Liquid Diffusion Applied to Analysis” Phil. Trans. Roy. Soc. 1861, 151, 183-224. 
50
 a) Flory, J.P. “Theoretical aspects of photoemission, photodesorption and photochemistry of adsorbates” Faraday 
Discuss. Chem. Soc. 1974, 57, 7-18; b) Gelbart, W.M.; Ben-Shaul, A. “Micelles, membranes, microemulsions and 
monolayers” J. Phys. Chem. 1996, 100, 13169-13189. 
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being mostly liquid.51 Nevertheless, for screening programs the succinct definition of Jordon Lloyd 
is still useful: if it looks like a gel it must be a gel.52 
In general, a gel is the result of the self-assembly process of compounds which are capable of 
forming a 3D-network. Due to the formation of this network the solvent is not able to flow and the 
solvent, which is liquid at high temperatures, is solidified at room temperature. 
Gels can be divided in two separate classes, chemical and physical gels. The chemical gels are 
classified as gels in which the aggregation is driven by the formation of covalent cross-links 
between the compounds and this aggregation leads to the formation of a thermally irreversible 
network.53 Examples of these systems include cross-linked polymeric systems, which can be used 
for triggered drug release54 or inorganic oxides.55 Physical gels systems are formed by non-
covalent interactions and, hence, the gel formation is thermally reversible, which makes this type 
of gelators an excellent subject for studies into supra-molecular chemistry. 
Compounds able to form physical gels include clays, polymers, proteins, colloids and certain small 
organic compounds. Compounds of this latter group are called low molecular weight gelators 
(LMWGs). LMWGs are gelators consisting of organic compounds with a molecular weight of less 
than 2000 Da which show gelation behaviour in organic solvents (organogelators) and sometimes 
in water and/or alcoholic solvent (hydrogelators). 
It has been demonstrated that anisotropy in intermolecular interactions leading to self-assembly 
of gelator molecules is necessary for the formation of a gel fiber.56 Intermolecular interactions 
between gelator molecules can include London dispersion forces, ionic-ionic, dipole-dipole, 
hydrogen bonding, Van der Waals and π-π stacking interactions and in the majority of gel systems 
reported the combination of these forces are responsible for gelation. It has been demonstrated 
that there is a delicate balance between gelator structure, intermolecular interactions and 
gelation properties. 
 
                                               
51 Weiss, R.G.; Terech, P. “Molecular gels: materials with self-assembled fibrillar networks” Springer 2006, Dordrecht. 
ISBN 1-4020-3352-4. 
52 Jordan Lloyd, D. “In Colloid Chemistry by Alexander, J.” 1926, vol 1, 767-782, The Chemical Catalog Co, New York. 
53
 Gesser, H.D.; Goswami, P.C. “Aerogels and related porous materials” Chem. Rev. 1989, 89, 765-788. 
54 Daganli, R. “Intelligent gels” Chem. & Eng. News, 1997, 23, 26-37. 
55 Boury, B.; Corriu, R.J.P.; Le Strat, V.; Delord, P.; Nobili, M. “Hydrolysis/polycondensation in the solid state: access to 
crystalline silica-based hybrid materials” Angew. Chem., Int. Ed. 1999, 38, 3172-3175. 
56
 a) Van Esch, J.H.; Feringa, B.L. “New functional materials based on self-assembling organogels: from serendipity 
towards design” Angew. Chem., Int. Ed. Engl. 2000, 39, 2263-2266; b) Estroff, L.; Hamilton, A.D. “Water gelation by 
small organic molecules” Chem. Rev. 2004, 104, 1201-1217. 
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3.4.1 From Boc-L-Phe-D-Oxd-OBn to new LMWGs 
 
It was stated that the L-Phe-D-Oxd moiety can be defined a “privileged scaffold” because of its 
strong tendency to adopt well-organized 3D structure. For this reason, in this chapter it is 
described how the L-Phe-D-Oxd group it is included in more complex structures to behave as 
LMWGs, since an intermolecular interaction of suitable strength was required for the formation of 
a gel. 
In this chapter, two long-chain derivatives of Boc-L-Phe-D-Oxd-OBn 22 were synthesized to 
determine the properties of these new compounds as LMWGs. After several attempts, compounds 
29 and 30 were synthesized, which were two derivatives of azelaic acid, a dicarboxylic, medium-
sized aliphatic acid. Interestingly, no derivative of monocarboxylic acids, such as hexanoic or 
undecanoic acids, form any kind of gel. 
Compounds 29 and 30 may be defined as synthetic bolaamphiphiles.57 In general, these 
compounds reproduce the unusual architecture of monolayered membranes found in 
archaebacteria. 
Compound 22 was deprotected with TFA in dichloromethane to obtain the corresponding 
trifluoroacetate salt in quantitative yield; this was coupled with azelaic acid, using HBTU and 
triethylamine (Scheme 5). Compounds 29 was obtained pure after flash chromatography in high 
yields. Then, it was deprotected by hydrogenolysis to give the free carboxy termini 30 in 
quantitative yield. 
 
                                               
57 Shimizu, T. “Bottom-up synthesis and structural properties of self-assembled high-axial-ratio nanostructures” 
Macromol. Rapid Commun., 2002, 23, 311-331. 
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Scheme 5. Preparation of compounds 29 and 30. 
 
Then, the propensity of these two compounds to form gels was determined. The general method 
adopted to form gels was to place one compound (29 or 30) in a small test tube (8 mm in 
diameter) and dissolve it in pure solvent (distilled water was used) or in a solvent mixture (Table 4) 
to obtain a 10 mM solution. Because ultrasound influences the aggregation properties of the 
molecules in the solvents,58 the tube was sonicated for 20 min at room temperature, then it was 
left to stand for 2 h before gel formation was monitored. When a mixture of solvents was used, 
the solvent that the gelling compound was more soluble in was introduced first (i.e., 
dichloromethane was introduced first in entry 1 and methanol was introduced first in entry 5 in 
Table 4). 
 
Table 4. Gelation properties of compounds 29a-d and 30a-d in selected solvents (concentration: 10 mM). 
Entry Solvent Compd. After sonication[a] After 2 h[a] 
                                               
58 Isozaki, K.; Takaya, H.; Naota, T. “Ultrasound-induced gelation of organic fluids with metalated peptides” Angew. 
Chem. Int. Ed. 2007, 46, 2855-2857. 
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1 CH2Cl2/AcOEt 1:1 29 SP G 
2 CH2Cl2 29 S PG 
3 AcOEt 29 SP PG 
4 MeOH 30 SP SP 
5 H2O 30 SP PG 
6 MeOH/H2O 1:1 30 G G 
[a] SP = suspension; G = gel; PG = partial gel; S = solution 
 
The most common diagnostic test of gelation is tube inversion. In this test, a sample tube 
containing the mixture of compound and solvent was inverted to ascertain if the sample would 
flow under its own weight. A gel was assumed to be a sample that had a yield stress that 
prevented it from flowing down the tube. A solution was taken to be a sample that flowed down 
the tube. When a partial gel is formed, the compound sticks to the bottom of the test tube, while 
a little solvent (< 20%) flows down. 
Compounds 29 and 30 form gels (Table 4, entries 1 and 6) or partial gels (Table 4, entries 2, 3 and 
5). 
To check the structural properties of the gels formed, we carried out our studies only on the gel 
reported in entry 1 as an example of this class of compounds (Figure 66). 
 
 
Figure 66. a) Photograph of 29 in a 1:1 mixture of dichloromethane and ethyl acetate (10 mM solution); b) OM image 
of the same sample; scale bar: 500 μm. 
 
Then, the sample was left to dry in air to form the xerogel and was completely dry after 24 h at 20 
°C. The FTIR spectrum (1% in dry KBr) was recorded and compared it with the spectra of 29 in 
dilute solution (3 mM in dichloromethane) and as a precipitated material (1% in dry KBr) (Figure 
67). The spectra of both the precipitated sample and the xerogel showed the presence of a signal 
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at about 3310 cm-1, typical of C=O···H-N hydrogen bonds, whereas the 3 mM solution had a signal 
at 3430 cm-1, which was attributed to the presence of a free NH group. 
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Figure 67. FTIR absorption spectra in the N-H (left) and C=O (right) stretching regions for 29: a) 3 mM solution in pure 
CH2Cl2; b) solid as 1 % mixture with dry KBr; and c) xerogel as a 1 % mixture with dry KBr. 
 
Further investigations, using SEM, gave a better idea of the morphology of the xerogel (Figure 68): 
it forms long filaments highly interconnected and branched with a diameter of about 0.5 μm. They 
have a strong tendency to aggregate, forming a network of meshed and bundled architectural 
assemblies (Figure 68a). These observations fit with the OM images and the FTIR spectral analyses. 
The gel appears opaque, suggesting the existence of extended molecular assemblies in the wet 
gel.59 Moreover, the FTIR spectrum indicates that this molecule may assemble into an organized 
form by hydrogen-bonding interactions as soon as a limit concentration that favors the formation 
of β sheets is reached. 
 
 
                                               
59 Estroff, L. A. Hamilton, A. D. “Water gelation by small organic molecules” Chem. Rev. 2004, 104, 1201-1217; b) 
Mahmoudi, N.; Mehalebi, S.; Nicolai, T.; Durand, D.; Riaublank, A. “Light-scattering study of the structure of 
aggregates and gels formed by heat-denatured whey protein isolate and β-lactoglobulin at neutral pH” J. Agric. Food 
Chem. 2007, 55, 3104-3111 
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Figure 68. SEM picture (a) and XRD patterns (b) of the xerogel prepared from 29. In (a) the inset shows a high 
magnification of the wide view. The diffraction peaks have been indexed according to a tetragonal unit cell (a = 1.97 
nm, c = 2.67 nm). 
 
An additional clue to the presence of an ordered assembly of molecules in the xerogels is given by 
XRD analysis (Figure 68, b). The XRD pattern of the xerogel of 29 shows many sharp diffraction 
peaks and a broad band at around 2θ = 20°, which suggests the coexistence of amorphous and 
high crystalline phases. The diffraction peaks have been indexed according to a tetragonal unit cell 
(a = 1.97 nm, c = 2.67 nm). These unit cell parameters agree with long-range ordering and suggest 
that 29 may form crystalline multilayer structures within the self-assemblies. This observation 
agrees with that observed for 2-glucosamide-based bolaamphiphiles.60 
 
3.4.2 More complex gels 
 
In the previous chapter it was demonstrated the ability of the pseudopeptide L-Phe-D-Oxd to 
behave as LMWG when it is introduced in a more complex architecture. After the good results 
obtained with LMWG 29 and 30, it was decided to check if also other pseudopeptide that have 
been previously described are able to behave in the same way. 
A small library of stereoisomeric compounds, all containing a moiety of azelaic acid coupled with 
different pseudopeptides was prepared.  
Scheme 6 reports the general formula of the ten compounds: they are five benzyl esters and five 
carboxylic acids. These compounds were synthesized in solution, by standard coupling reaction.  
 
                                               
60
 Nakazawa, I. Masuda, M.; Okada, Y.; Hanada, T.; Yase, K.; Asai, M. Shimizu, T. “Spontaneous formation of helically 
twisted fibers from 2-glucosamide bolaamphiphiles: energy-filtering transmission electron microscopic observation and 
even-odd effect of connecting bridge” Langmuir 1999, 15, 4757-4764. 
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Scheme 6. Reagents and conditions (i) H2, Pd/C MeOH, r,t. 2 h; (ii) α- or β-amino acid (1 equiv.), HBTU (1 equiv.), TEA 
(3 equiv.) dry CH3CN, 40 min; (iii) TFA (18 equiv.), dry CH2Cl2, r. t., 4 h; (iv) azelaic acid (0.5 equiv.), HBTU (1 equiv.), TEA 
(3 equiv.) dry CH3CN, 40 min. 
 
The tendency of these compounds to form gels was checked with the tube inversion test. To 
prepare gels, compounds 32a-d, 33a-d and 34a-b were weighted out exactly in a test tube (8 mm 
wide), and then dissolved in the solvents reported in Table 5 (500 μl) to afford a 10 mM solution. 
79 
 
The tube was then shaken for a few minutes by hand and then sonicated for 15 min at room 
temperature, then it was left standing still overnight before checking the gel formation. 
 
Table 5. Gelling status of the molecules 32a-d, 33a-d and 34a-b. SP suspension, G gel, PG partial gel, S solution, P 
precipitate. 
Entry Solvent Compound After sonication After 2 h 
1 CH2Cl2/AcOEt 1:1 32a SP SP 
2 CH2Cl2/AcOEt 1:1 32b SP SP 
3 CH2Cl2/AcOEt 1:1 32c SP G 
4 CHCl3/AcOEt 1:1 32c SP SP 
5 AcOEt 32c PG PG 
6 Acetonitrile 32c PG PG 
7 CH2Cl2/AcOEt 1:1 32d SP G 
8 CHCl3/AcOEt 1:1 32d PG PG 
9 AcOEt 32d G G 
10 Acetonitrile 32d G G 
11 MeOH/H2O 1:1 33a S S 
12 MeOH/H2O 1:1 33b S S 
13 CH2Cl2 33c P P 
14 H2O 33c P P 
15 MeOH/H2O 1:1 33c S G 
16 i-PrOH/H2O 1:1 33c PG PG 
17 i-PrOH 33c PG G 
18 CH2Cl2 33d PG PG 
19 H2O 33d SP SP 
20 MeOH/H2O 1:1 33d S G 
21 i-PrOH/H2O 1:1 33d SP PG 
22 i-PrOH 33d P P 
23 CH2Cl2/AcOEt 1:1 34a SP G 
24 CH2Cl2 34a S S 
25 AcOEt 34a SP G 
26 MeOH 34b S S 
27 H2O 34b S S 
28 MeOH/H2O 1:1 34b SP G 
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The best outcome was obtained with a 1:1 mixture of dichloromethane/ethyl acetate for 9c, 9d 
and 11a, with AcOEt for 11a and with a 1:1 mixture of water and methanol for 10c and 10d and 
11b. These mixtures of solvents were used to check if the more expensive compounds containing 
the αMe-Phg moiety (9a, 9b, 10a and 10b) would form a gel. Unfortunately no gel formation was 
obtained in any case. 
 
3.4.3 Gels in the presence of metal ions 
 
The work was then continued only with compounds 32c, 32d, 33c and 33d to test their ability to 
generate a gelling status in the presence of several metal ions: Mg(II), Al(III), Zn(II), Cu(I) or Cu(II). 
The selection among the metal ion species was carried out trying to discriminate among two 
parameters: coordination chemistry and charge density. Mg(II) and Cu(II) have similar ionic radius 
(0.78 and 0.72 Å, respectively), but the former one forms mainly octahedral coordination 
compounds, while the latter one gives distorted octahedral coordination compounds that usually 
reorganize in tetrahedral or square planar geometries. Cu(I) ions and zinc ions have different ionic 
radius (0.325 and 0.632 Å, respectively), but both preferentially form tetrahedral coordination 
compounds, however, Zn(II) have also a strong tendency to give octahedral geometries. Al(III) 
(ionic radius 0.45 Å) can give coordination compounds having tetrahedral and octahedral 
geometries, being the latter more common in the presence of charged ligands.61 These metal ions 
have also different charge density: Al(III) > Zn(II) > Cu(II)  Mg(II) > Cu(I). The choice among the 
biological friendly chloride or bromide as counter anion was carried out in the view to give the gel 
a potential use of the gels to control the release of metal ions. As a consequence, we paid a price 
in term of solubility in organic solvents. 
Gels were prepared by suspension of an equimolecular amount of 32c (or 32d) and the inorganic 
salt, followed by sonication (see experimental). After 16 h, an homogeneous gel was formed. In 
the case of copper salts, the gel was pale green while in the other cases the gel was colorless. In 
the case of gels formed with 33c (or 33d) and the inorganic salt in methanol/water mixture, an 
homogeneous mixture was immediately formed and became a colorless gel after 16 h.  
                                               
61 Cotton, F. A.; Wilkinson, G.; Murillo, C. A.; Bochmann, M. 1999, Advanced inorganic chemistry, 6th edn. Wiley, New 
York. 
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The gel-sol transition temperature (Tgel) gives important information on the thermal stability of the 
gels prepared in different ways62 and was measured by the ball-dropping method.  
The results of the gelation experiments of molecules 32c, 32d, 33c and 33d in the presence of 
metal ions are reported in Table 6. 
 
Table 6. Gelling status of the molecules 32c, 32d, 33c and 33d in the presence of metal ions. The gel-sol transition 
temperature (Tgel) expressed in °C is reported in parenthesis. The gels that increase their Tgel (and consequently their 
thermal stability) in the presence of metal ions are in bold. 
Molecule (solvent) Metal ions free gel CuBr CuBr2 ZnBr2 AlCl3 MgBr2 
32c (CH2Cl2/AcOEt, 1:1) G (80) PG G (60) G (50) PG PG 
32d (CH2Cl2/AcOEt, 1:1) G (58) PG G (62) G (50) G (75) SP 
33c (MeOH/H2O, 1:1) G (75) PG SP G (59) SP G (42) 
33d (MeOH/H2O, 1:1) G (82) S G (68) G (92) PG S 
SP suspension, G gel, PG partial gel, S solution 
 
While all these molecules formed gels in the reported conditions, they behave differently, in the 
presence of these five metal ions. 
In the presence of Zn(II), they all formed gels, however, the strength of the gel was reduced, 
except for 33d. On the contrary, Cu(I) prevents the formation of gels in any case, as its presence in 
32d, 32c and 33c gave partial gels, while 33d gave a suspension. A very different result was 
obtained with Cu(II): 32d, 32c and 33d formed gels, while 33c associated in a suspension. In the 
presence of Al(III) or Mg(II), the four compounds afforded very different results, as reported in 
Table 6. Only 32d and 33c form a gel in the presence of Al(III) and Mg(II), respectively.  
In conclusion, among the tested molecules 32c is the best gelator in the presence of metal ions, it 
always associates in a gel-like form, either gel or partial gel. 32d failed to be in a gel-like form in 
the presence of Mg(II) only. 
To obtain additional information on the molecular association, the gel samples were left to dry in 
the air to form xerogels that were further analyzed using SEM and XRD. The results of the SEM 
observations and of the XRD analyses are reported in (Figure 69, Figure 70 and Figure 71). 
 
                                               
62
 a) Takahashi, K.; Sakai, M.; Kato, T. “Melting temperature of thermally reversible gel. VI. Effect of branching on the 
Sol-Gel transition of polyethylene gels” Polymer J. 1980, 12, 335-341; b) Yamanaka, M.; Fujii, H. “Chloroalkane gel 
formations by tris-urea low molecular weight gelator under various conditions” J Org Chem, 2009, 74, 5390-5394. 
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Figure 69. The SEM images of the xerogels formed by the molecule 32d: in the absence of metal ions (32d); the 
presence Cu(II) (32d_Cu(II)); in the presence of Zn(II) (32d_Zn) or in the presence of Al(III) (32d_Al) are shown on the 
left. The arrow in (32d_Al) indicates a crystalline aggregate made of an aluminium salt. On the right side, the 
corresponding X-ray powder diffraction patterns are reported. Bars indicate the diffraction peaks which could be 
associated with crystalline regions of 32d. Hash symbols indicate the diffraction peaks that can be associated with 
crystalline CuBr2. Asterisks indicate the diffraction peaks associated with an Al containing compound that could not be 
identified (crystals from this unidentified compound are shown by the arrow in 32d_Al). 
 
The molecular assembly of 32d in the xerogel is strongly affected by the presence of metal ions 
(Figure 69). The XDR data (Figure 69 right) show that 32d is present in a crystalline form in the 
xerogel (as proved by the presence of several diffraction peaks) and that this status is not affected 
by the presence of metal ions, indeed the main diffraction peaks associated with the molecular 
structure do not change in relative intensity and angular position. This outcome indicates that 
metal ions do not influence the crystallinity and aggregation of the 32d xerogels, therefore we can 
infer that the functional groups involved in the inter-molecular interactions responsible for the 
formation of the gel scaffold are not involved in the metal binding. In the XRD patterns from 
32d_Cu(II) and 32d_Al xerogels, additional diffraction peaks associable to metal ion salts are 
detectable. Interestingly, the presence in the gel of metal ions compound crystalline particles 
(Cu(II) and Al(III)) increases its thermal stability (Table 6).  
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Figure 70. The SEM images of the xerogels formed by: the molecule 32c (32c) in the absence of metal ions; the 
molecule 32c in the presence Cu(II) (32c_Cu(II)) or in the presence of Zn(II) (32c_Zn), are shown on the left. On the 
right side, the corresponding X-ray powder diffraction patterns are reported. Bars indicate the diffraction peaks which 
could be associated to crystalline regions of 32c. Hash symbols indicate the diffraction peaks that can be associated to 
crystalline CuBr2.  
 
The SEM morphologies and the XRD patterns of the 32c xerogels are reported in Figure 70. 32c 
associates forming a xerogel containing bundles of fibers that are branched, forming a complex 
web in which many holes are present. The presence of Cu(II) or Zn(II) changes the aggregation of 
32c, favouring the formation of highly twisted long rope-like aggregates, as previously observed 
for the 32d xerogels obtained in similar conditions. This effect is not surprising, considering that 
the skeleton of 32d and 32c are very similar. The presence of Zn(II) seems to favour the merging of 
the rope-like structure giving a more compact material. The 32c_Cu(II) xerogel hosts particles of 
crystalline copper bromide while the 32c_Zn xerogel contains any Zn(II) crystalline compound. The 
crystallinity of 32c in the xerogel increases in the presence of Cu(II), as revealed by the presence in 
the XRD pattern of more and more defined diffraction peaks. 
Similar analyses were carried out on the xerogels obtained from 33d and 33c (Figure 71). These 
compounds are very polar, as they contain a carboxylic group, and can form gels with mixtures of 
water and methanol. Besides its ability to form gels as a pure compound, 33d retains its ability to 
form gel in the presence of Cu(II) and Zn(II) only. In the xerogel status, 33d associates forming a 
porous structure in which no well defined structural motifs are observable. In the presence of 
Zn(II), 33d_Zn xerogel structure makes a more compact material, as could be foreseen considering 
the high thermal stability of the 33d_Zn gel (see Table 6). Also in this case we could suppose that 
the metal ions affects the way in which the molecular scaffolds make the gel. All the XRD patterns 
from 33d xerogels show only one diffraction peak, indicating that the molecules are associated in 
a poor ordered way. Weak diffraction peaks due to copper(II) bromide are observable only in the 
XRD pattern from the 33d_Cu(II) xerogel. 
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Figure 71. The SEM images of the xerogels formed by: the molecule 33d (33d) and the molecule 33c (33c) in the 
absence of metal ions; the molecule 33d in the presence Cu(II) ions (33d_Cu(II)) or in the presence of Zn ions 
(33d_Zn); the molecule 33c in the presence of Mg ions (33c_Mg) or in the presence of Zn ions (33c_Zn), are shown on 
the left. The arrow in (33c_Mg) indicates a crystalline aggregate made of a magnesium salt. On the right side, the 
corresponding X-ray powder diffraction patterns are reported. Bars indicate the diffraction peaks which could be 
associated to crystalline regions of 33d or 33c. Hash symbols indicate the diffraction peaks that can be associated to 
crystalline CuBr2.
63 Asterisks indicate diffraction peaks that cannot be univocally associated to specific crystalline 
forms. 
 
In the xerogel status, 33c associates in porous structures similar to those formed by 33d, also in 
the presence of Mg(II) or Zn(II). The 33c_Zn xerogel is morphological similar to that of 33c and 
makes entangled filaments that form a porous structure in which crystalline particles are 
embedded. On the contrary, the XRD pattern from 33c xerogel is characterized by the presence of 
several diffraction peaks indicating a crystalline molecular aggregation, that are reduced by the 
presence of Zn(II). Finally, the XRD pattern from the 33c xerogel hosting Mg(II) shows any 
diffraction peaks typical of the molecular packing, but shows only diffraction peaks due to 
unidentified mineral crystalline phases.  
The analysis of the results of the gelling experiments and the characterization of the xerogels can 
give some hints on the influence of the metal ions in the gelation process. Copper(I) ion has a 
negative effect on gel formation. This implies a weakening of the inter-molecular interactions 
making the gel. It may be related to its properties to give almost only complexes with tetrahedral 
coordination or to a strong change of the solvent features. Magnesium ions have also a negative 
role on the gelation capability of the molecules, as gel formation is inhibited except for 33c, in 
which the gel thermal stability is reduced with respect to the metal free one. This may suggest a 
weakening of the interactions among the 33c molecules due to Mg(II). These ions could interact 
                                               
63 Simon, A.; Oeckler, O. “Redetermination of the crystal structure of copper dibromide, CuBr2” Z. Kristallogr. 2000, 215, 
13-21. 
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with the molecules reducing their ability to form intermolecular bonds. Indeed, the periodic 
intermolecular interactions (i.e. the crystallinity) in the 33c xerogel is reduced by the presence of 
magnesium ions. Al(III) inhibits the gel formation, except for the molecule 32d. The 32d_Al gel 
increases its thermal stability with respect to pure 32d gel. This observation may suggest that 
Al(III) should strengthen the intermolecular interactions in the gel, although the crystallinity of the 
xerogel is not affected. Al(III) being present as salt particles may act also as filler, improving the 
mechanical properties of the gel. Al(III) can form tetrahedral compounds other than octahedral 
ones, as Mg(II) does; this coordination flexibility may be involved in the alteration of the gel 
properties. The high charge density of Mg(II) may also have a role in destabilizing the gel structure. 
Zn(II) does not inhibit the capability of the molecules to form gels. This means that the key 
molecular interaction forming the gel structure are not affected by the presence of Zn(II). These 
gels have thermal stability lower than the co-respective metal ion free 32d, 32c and 33c gels. Only 
33d forms a gel with higher thermal stability in the presence of Zn(II). Interestingly, the xerogels 
obtained in the presence of Zn(II) do not contain any crystalline salt particles; this may be due to 
Zn(II)-molecules interactions that prevent the salt precipitation or the re-precipitation of Zn(II) 
salts in an amorphous form. These interactions, or the presence of small amorphous particles, may 
strengthen molecular entanglements, as occurs for 33d, or weaken them, as occurs for 32d, 32c 
and 33c. 
Similar considerations may be applied to explain the effect of Cu(II) in the gel formation. However, 
in this case the xerogels obtained from the parent gels bearing Cu(II) always show the presence of 
particles of copper(II) bromide. Thus, it can be supposed that the interaction between copper(II) 
ions and the molecules is minimal or that is lost in the xerogel formation, although they are still 
trapped in the xerogel network. 
 
3.4.4 LMWGs as “Trojan Horses” 
 
Self-assembled physical gels may be employed in the field of localized drug delivery, as they can 
easily fit into any shape. For example, if a drug is mixed with a solution of LMWG, which forms a 
self-assembled gel on contact with bodily fluids (e.g., due to the resulting pH changes), it can be 
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delivered topically after tumor resection. On gelation, the gel can be held in the cavity, thereby 
allowing the drugs to act locally.64  
A topic of great interest is the delivery of platinum(II)-based anticancer agents, such as cisplatin, 
carboplatin and oxaliplatin, that are widely utilized in the clinic, although with numerous 
disadvantages, due to toxicity to “normal” tissues. 
The delivery of platinum(II)-based anticancer agents by means of self-assembled gels, made of 
stoichiometric amounts of LMWG and platinum(II) derivatives, could be a innovative answer 
against the high toxicity towards “normal” tissues. 
 
In this chapter it is discussed if the LMWG 30 can behave as “Trojan horse” and carry drug 
molecules into the cell. 
To check the cellular uptake by confocal laser scanning microscopy, three fluorescent compounds 
35, 36 and 37, all containing the fluorescent dansyl group (Dans)36 (Figure 72) were prepared. 
 
 
 
Figure 72. Chemical structure of the LMWHGs 30 and 35 and of the fluorescent moieties 36 and 37 described in this 
work. 
 
                                               
64 Ellis-Behnke, RG.; Liang, Y. X.; Tay, D. K. C.; Kau, P. W. F.; Schneider, G. E.; Zhang, S.; Wu, W.; So, K. F. “Nano 
hemostat solution: immediate hemostasis at the nanoscale” Nanomedicine, 2006, 2, 207-215. 
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Scheme 7. Synthesis of compound 35. Reagents and conditions (i) TFA (18 equiv.), dry CH2Cl2, r. t., 4 h; (ii) azelaic acid 
(0.5 equiv.), HBTU (1 equiv.), TEA (3 equiv.) dry CH3CN, 40 min (iii) H2, Pd/C MeOH, r. t. 2 h. 
 
First Gel1 (Table 7) was prepared with 30 and a mixture of water and ethanol in 9:1 ratio. 
 
Table 7. Gelling status of the molecules 30, 35, 36, 37 and their mixtures. 
Hydrogel LMWHG Weight (mg) Solvent (H2O/EtOH) outcome 
Gel1 30 3.7 9:1 gel 
Gel2 35 3.7 9:1 sol. 
Gel3 35 3.7 5:5 sol. 
Gel4 35 7.3 9:1 sol. 
Gel5 35 7.3 5:5 gel 
Gel6 
30 
35 
3.7 
0.4 
9:1 gel 
Gel7 
30 
36 
3.7 
0.4 
9:1 gel 
Gel8 
30 
37 
3.7 
0.4 
9:1 gel 
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Both samples were prepared with the previously described method and easily form gels. 
Interestingly, these LMWHG having hydrophilic carboxylic-acid moieties, located in the hydrophilic 
part of the molecule, provide reversible responsiveness to changes in pH. Indeed they are in gel a 
status up to pH  9. At higher pH, the gels undergoes in the sol status, due to the almost complete 
ionization of the carboxylate groups.65 
Then, following the same method, we checked if molecules containing the fluorescent dansyl 
group (Dans) may be used to prepare florescent hydrogels. 
First we tried with pure 35 (Gel2-4), but it is not a good gelator as 30. To form a gel, 35 requires a 
higher concentration of gelator (0.74% w/v compared to Gel1 that requires only 3.7% w/v of 30) 
and a 1:1 water/ethanol mixture, probably because 35 is less hydrophilic than 30.66 
So we decided to follow a different approach, preparing Gel6-7 with 30 as gelator, doped by little 
amount of the dansyl containing compounds 35, 36 and 37: they all readily form fluorescent 
hydrogels, that may be used to evaluate the cellular uptake of 30. 
Before evaluating the cellular uptake of the hydrogels, the structure of Gel1, and its corresponding 
xerogel, were analyzed by X-ray diffraction (XRD) and scanning electron microscopy (SEM). 
Hydrogel Gel1 is a strong and termoreversible gel (Figure 73a) with melting point at 45 °C. 
 
 
Figure 73. (a) Camera picture of Gel1 in an upside down glass test tube and (b) low-medium angle XRD pattern from a 
fragment of Gel1 collected at 100 K. In (b) the periodicities associate to diffraction rings due to the ordered assembly 
of Gel1 are indicated. Those not listed are due to ice. 
 
                                               
65 Greenfield, M. A.; Hoffman, J. R.; Olvera de la Cruz, M.; Stupp, S. I. “Tunable mechanics of peptide nanofiber gels” 
Langmuir, 2010, 26, 3641-3647. 
66 Brizard, A.; Oda, R.; Huc, I. “Chirality effects in self-assembled fibrillar networks” Top Curr. Chem. 2005, 256, 167-
218. 
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The XRD pattern from the hydrogel Gel1, collected at 100 K, is characterized by the presence of 
diffraction rings at low angle (indicated in Figure 73b) having periodicities of 2.2 nm, 1.7 nm, 1.4 
nm and 0.54 nm. The additional high angle diffraction rings not listed are due to the presence of 
ice.67 Any attempt to collect XRD data at room temperature, or at 100 K in the presence of 
cryprotectants, to avoid the formation of ice, failed in showing the low angle diffraction effects. 
The freeze drying of the hydrogel Gel1 produced the xerogel Gel1, which appeared as a fractured 
film (Figure 74a inset). 
 
 
Figure 74. (a) Scanning electron microscopy images of a xerogel Gel1 film fragment. In the inset a low magnification 
view of xerogel film fragments. (b) Powder XRD pattern of a powered sample of xerogel Gel1. Low-medium angle XRD 
patterns obtained in geometries having the X-ray beam normal (c) and parallel (d) to the surface of a xerogel film 
fragment. 
 
In this film, a fibrous structure is observed (Figure 74a). The fibers appear locally organized in 
bundles, which are randomly oriented. The powder XRD pattern of xerogel Gel1 shows several 
diffraction peaks at high and medium angles (Figure 2b), indicating the presence of ordered 
structures in the xerogel. The periodic distances at 1.8 nm and 0.54 nm were also observed in the 
diffraction pattern from the parent hydrogel Gel1. The XRD pattern from a film fragment of the 
                                               
67 Dowell, L. G.; Rinfret, A. P. “Low-temperature forms of Ice as studied by X-Ray diffraction” Nature, 1960, 188, 1144-
1148. 
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xerogel Gel1, which were obtained in geometries having the X-ray beam normal (c) and parallel (d) 
to the film surface (Figure 74c-d), show diffraction effects, arcs and rings, respectively, with the 
same periodicities at 2.5 nm, 2.2 nm, 1.7 nm, 1.05 nm, 0.67 nm and 0.49 nm. This different 
distribution of the intensity of diffraction indicates that the ordered regions are randomly oriented 
on the film surface and preferentially oriented in the film cross section. The arcs at 2.5 nm, 2.2 nm, 
1.7 nm, 1.05 nm, 0.67 nm, 0.54 nm and 0.49 nm are along the equatorial direction, while that at 
0.54 nm is along the meridional direction. These low angle periodicities could be associated to 
different diffraction orders of periodic distance of 2.5 nm. This observation, in agreement with a 
rough estimation the molecule Gel1 dimensions, may suggest a supramolecular assembly of Gel1 
molecule to form the fibrous structures. Moreover, XRD data and SEM observation show that in 
the xerogel the fibers align preferentially parallel to the film surface and may suggest that in the 
fiber the molecules are organized in layers (0.54 nm thick) and that they have their long axis (2.5 
nm) parallel to the fiber direction. It is important to note that the low angle periodicities observed 
in the xerogel were present also in the hydrogel. This indicates that the fiber structure is not 
generated by the freeze drying process but that is already present in the hydrogel. 
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Figure 75. Confocal laser scanning micrographs of IGROV1 exposed to Gel5 (a), to Gel6 (b), to Gel7 (c) and to Gel8 (d). 
The dansyl group fluorescence is shown in green. Scale bar 50 μm. 
 
Then we collected some information on the ability of fluorescent hydrogels Gel5-8 to cross the 
cellular membrane of the cancer cells, by means of confocal microscopy (Figure 75). It is worth 
mentioning that gel Gel5 is made of 35, while Gel6-8 are made of 30, doped with one of the dansyl 
containing compounds 35-37. IGROV-1 cells were grown on glass coverslips for 24 h before being 
exposed to hydrogels for 30 min. Confocal laser scanning microscopy shows that all the hydrogels 
internalizes in IGROV-1 cells (as indicated by the green fluorescence in the cytoplasm Figure 75), 
but very few green spots are present in Figure 75a, suggesting that hydrogel F is not well tolerated 
by the cells. 
To confirm these results, we evaluated the citotoxicity of the Gel1 (only 30), compared with the 
fluorescent hydrogels Gel5 (only 35) and Gel5-8 (doped 30). IGROV-1 cell growth was evaluated 
after 24 h treatment with the hydrogels. The results are reported in Figure 76 and shows that 35 
(Gel5) is citotoxic, while 30 is well tolerated by the cells, as the treatment with gels Gel5-8 and 
Gel6-8 does not significantly affect the cell proliferation. 
 
 
Figure 76. IGROV1 cell growth after 24 hour treatment with Gel1, Ge56-8. 
 
Thus LMWHG 30 may behave as an excellent Trojan horse as it is biologically inactive, is 
internalized by cells, cargo on it molecules of different sizes and is a good candidate to carry drug 
molecules. 
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3.5 The interaction of lipid modified pseudopeptides with lipid membranes 
 
In the previous chapter it was shown that the simple dipeptide Boc-L-Phe-D-Oxd-OBn (22) can 
form fibrous structures that are only stabilized by a single hydrogen bond forming both parallel or 
antiparallel β-sheet structures. 
Here, we investigate the behaviour of building block L-Phe-D-Oxd after adding lipid chain moieties 
to the N-terminus of the peptides and whether structure formation of the lipopeptides can be 
influenced by the presence of lipid membranes. Lipid modifications are known to play the decisive 
role in the formation of micelles, membranes, and other supramolecular structures due to the 
hydrophobic effect. In addition, lipid modification is a common motif for membrane binding of 
peptides and proteins.68 
The compounds analyzed in this work were synthesized in solution by a standard coupling reaction 
in the presence of HBTU and TEA in dry acetonitrile. These compounds are enantiomers, as fully 
labeled amino acids are available only in the L form as far as we know. Lipopetides 40 and 41 have 
been prepared by acylation of the Boc-L-[U-13C,15N]-Phe-D-Oxd-OBn, with fully deuterated 
hexanoic acid-d11 and dodecanoic acid-d23, respectively, after removal of the Boc moiety with 
trifluoroacetic acid. With the same approach, lipopeptides 42 and 43 were prepared by acylation 
of the Boc-D-Phe-L-[U-13C,15N]-Oxd-OBn, with the fully deuterated hexanoic and dodecanoic acid. 
The four compounds were purified by flash chromatography and fully characterized (Scheme 8).  
 
                                               
68
a) Casey, P. J. “Protein lipidation in cell signaling” Science, 1995, 268, 221-225; b) Brunsveld, L.; Waldmann, H.; 
Huster, D. “Membrane binding of lipidated Ras peptides and proteins - The structural point of view” Biochim. Biophys. 
Acta, Biomembr. 2009, 1788, 273-288. 
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Scheme 8. Synthesis of the investigated lipopeptides in the different 
13
C and 
15
N labeled forms (labeled atoms are 
marked by asterisks), note the -L-Phe-D-Oxd- and -D-Phe-L-Oxd- versions. D: deuterium. Reagents and conditions (i) 
TFA (18 equiv.), dry CH2Cl2, r. t., 4 h; (ii) hexanoic acid-d11 and dodecanoic acid-d23 (1 equiv.), HBTU (1 equiv.), TEA (3 
equiv.) dry CH3CN, 40 min (iii) Boc-L-Phe-OH (1 equiv.), HBTU (1 equiv.), TEA (2 equiv.) dry CH3CN, 40 min; 
 
It was first investigated the properties of the peptide's lipid chains in the crystalline state using 
solid-state 2H NMR. Typical NMR spectra are shown in Figure 77. In particular for the C6 peptide 
chain, the spectra can be well understood from a superposition of two Pake doublets, one with a 
quadrupolar splitting of 111 kHz and one with a quadrupolar splitting of 27 kHz. The large 
Pake doublet can be assigned to the methylene groups of the chain, which experience an almost 
fully rigid conformation. For a rigid methylene group, the quadrupolar splitting is 125.25 kHz. 
Therefore, the chain methylene groups exhibit an order parameter of 0.89 indicating that the lipid 
chain modifications of crystalline molecule 40 are almost fully rigid and well ordered. The smaller 
quadrupolar splitting can be assigned to the terminal methyl group undergoing fast rotation about 
the C5-C6. The small isotropic peak indicates a very small fraction of isotropically mobile lipid 
chain most likely due to packing defects in the crystalline material.  
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Figure 77. 115 MHz 2H NMR spectra of lipopeptide 40 (A, C, E) and 41 (B, D, F) in the crystalline state (A, B), in POPC 
membranes (C, D) and of the central part of the spectrum of the lipopeptides in POPC membranes (E, F) to highlight 
the membrane bound part of the lipopeptides. A numerical simulation of the membrane bound fraction of the 
lipopeptide spectrum as described in the text is given in red. The spectra were measured at a temperature of 310 K. 
 
Molecule 41, featuring the longer C12 lipid modification, shows a more complicated 2H-NMR 
spectrum. While the general width of the NMR spectrum is similar to that of peptide 40, it is no 
longer detected the two well resolved Pake doublets. In contrast, the spectral intensity of each set 
of the two quadrupolar splittings is redistributed towards the center. Apparently, the long C12 
lipid modification of the peptide cannot form a rigid and well packed assembly allowing molecular 
motions in the μs correlation time window to take place. 
To gain more understanding about the secondary structure of these molecules, it was also carried 
out 13C CP MAS NMR studies on these crystalline materials. 13C CP MAS NMR spectra of molecules 
40, 41 and 42, 43 are shown in Figure 78 and Figure 79, respectively. 
 
 
Figure 78. Proton decoupled 188 MHz 
13
C CP MAS NMR spectra of 
13
C-Phe labeled version of lipopeptide 40 (A, C) and 
41 (B, D) in the crystalline state (A, B) and bound to POPC membranes (C, D). Peaks arising from phospholipid 
95 
 
molecules are marked with “L”; ssb denotes spinning side bands. The spectra were measured at an MAS frequency of 
7000 Hz and temperature of 310 K. 
 
 
Figure 79. Proton decoupled 188 MHz 13C CP MAS NMR spectra of 13C-Oxd labeled version of lipopeptide 42 (A, C) and 
43 (B, D) in the crystalline state (A, B) and bound to a POPC membrane (C, D). Peaks arising from phospholipid 
molecules are marked with “L”, ssb denotes spinning side bands. The spectra were measured at a MAS frequency of 
7000 Hz and temperature of 310 K. 
 
All signals from the 13C labeled amino acids are well resolved showing typical line widths of  1 
ppm, indicative of a rather high structural homogeneity. The chemical shifts for the Oxd amino 
acid were assigned by proton driven spin diffusion experiments with varying mixing times to follow 
the magnetization transfer from the CH3 group to the Cα and Cβ carbon of Oxd. Due to its dipolar 
nature the magnetization transfer is more efficient towards the Cβ carbon, resulting in faster cross 
peak build up, which allowed assignment of the peaks in the spectrum. Since the isotropic 13C 
chemical shift values are known to be sensitive to the secondary structure, it could be confirmed 
that the Phe residue of molecules 40 and 41 is in a β-sheet conformation in agreement with 
previous results on non-lipid-modified analogs of these compounds (chemical shifts are given in 
Table 8 and Table 9). The Phe Cα peak also has a minor contribution at lower field, which is 
indicative of a small portion of peptide in random coil conformation. For the Oxd amino acid, no 
chemical shift reference data are available; therefore, no information about secondary structure 
could be deduced from the 13C NMR spectra. 
 
Table 8.
 13
C Chemical shift and C-H order parameter for lipopeptides 40, 42 
  13C Chemical CH Order 13C Chemical Shift in CH Order 
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Shift 
Crystalline/ppm 
Parameter S, 
Crystalline 
POPC Membranes/ppm Parameter S in 
POPC Membranes 
Phe-Cα 53.4a 0.86 53.5 0.99 
Phe-Cβ 38.2 0.91 38.6 0.92 
Phe-CO 173.4 — 173.5 — 
Phe-C1-C6 125-130 0.52 125-130 0.30 
Oxd-Cα 66.0 0.89 66.2 0.86 
Oxd-Cβ 77.0 0.88 77.2 0.91 
Oxd-CH3 17.4 0.31 17.2 0.28 
Oxd-CO 165.7 — 165.8 — 
 
Table 9. 13C Chemical shift and C-H order parameter for lipopeptide 41, 43 
  13C Chemical 
Shift 
Crystalline/ppm 
CH Order 
Parameter S, 
Crystalline 
13C Chemical Shift in 
POPC Membranes/ppm 
CH Order 
Parameter S in 
POPC Membranes  
Phe-Cα 53.3a 0.82 53.1b 0.84 
Phe-Cβ 38.5 0.97 38.4 0.64 
Phe-CO 173.4 — 173.4 — 
Phe-C1-C6 125-130 0.58 125-130 0.28 
Oxd-Cα 65.8 0.88 66.0 0.93 
Oxd-Cβ 77.0 0.89 77.0 0.96 
Oxd-CH3 17.1 0.31 17.3 0.19 
Oxd-CO 165.6 — 165.9 — 
a Minor contribution at 54.7 ppm. b Minor contribution at 55.5 ppm.  
 
1H-13C dipolar coupling measurements confirmed the high rigidity of the molecules in the 
crystalline state already inferred from the 2H NMR data. Order parameters well above 0.8 were 
determined for the backbone and side-chain sites of the labeled amino acids, except for the 
methyl group of Oxd (Table 8 and Table 9). 
As discussed above, lipid modification is a common motif for membrane binding of peptides and 
proteins. Here, it is interesting in the question whether the insertion of the lipopeptide into the 
membrane would take place and, if so, whether it occurred as a monomer or as the fiber-like 
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aggregates that were detected in the absence of membranes. To this end, the peptides were 
allowed to mix with synthetic POPC molecules and to form lipid membranes with inserted peptide 
molecules. To confirm that intact lipid membranes in the biologically relevant liquid-crystalline 
phase state were formed, static 31P NMR measurements of the samples were carried out. Typical 
static 31P are shown in Figure 80. The 31P NMR spectra showed the characteristic anisotropic line 
shapes with a Δσ on the order of 42-44 ppm, confirming that all preparations formed stable POPC 
membrane stacks with the lipopeptide incorporated. Only in the spectrum of POPC in the 
presence of the short chain lipopeptide 40 a small isotropic peak is visible, which accounts for 
10% of the spectral intensity. 
  
 
Figure 80. Static 31P NMR spectra (black) of (A) pure POPC, (B) lipopeptide 40 in POPC and (C) lipopeptide 41 in POPC 
and the respective numerical simulations of the lineshape (red). The spectra were measured at 310 K. 
 
In order to study if the lipid chains are actually also inserted into the membrane, we carried out 2H 
NMR measurements of the lipid modifications of the lipopeptides. Figure 77 shows the 2H NMR 
spectra of molecules 40 and 41 in the presence of POPC (molar mixing ratio 1 : 5). Rather drastic 
alterations of the spectral line shapes compared to those of the crystalline material were 
observed. It was still observed the broad Pake spectra with a quadrupolar splitting of 104 kHz at 
the basis of the NMR spectra. However, in addition to this line shape, It was also detected a 
narrower 2H NMR spectrum with maximal quadrupolar splittings of about 27 kHz for lipopeptide 
41 and 18 kHz for lipopeptide 40 and that is reminiscent of the superposition of motionally 
averaged Pake spectra as observed for chain deuterated phospholipid molecules.69 This part of 
spectral intensity could be assigned to the C6 and C12 peptide chains that are highly mobile and 
truly inserted into the liquid crystalline membrane environment stemming from monomeric 
                                               
69 Huster, D.; Yao, X.; Hong, M. “1D sensitivity-enhanced 1H spin diffusion experiment for determining membrane 
protein topology” J. Am. Chem. Soc. 2002, 124, 874-883. 
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membrane inserted lipopeptides.70 This can be appreciated in a magnification of the spectra 
shown in Figure 77C and F and would suggest that part of the lipopeptide remains aggregated 
most likely in a fibrillar state, while the other part is monomeric and rather mobile in the liquid-
crystalline membrane. 
It was attempted to quantify the relative portions of the two states of the peptide by integrating 
the intensity in the 2H NMR spectra. The line shapes for the membrane bound component were 
simulated,71 so that the amount of the membrane bound lipopeptides could be estimated to be 
48% for lipopeptide 40 and 29% for lipopeptide 41. It has been reported before, that high 
peptide-to-lipid mixing ratios can lead to unwanted peptide aggregation. Therefore, they were 
also studied samples of the lipopeptides in a highly diluted mixture (1 : 50, mol/mol). Interestingly, 
the 2H NMR spectra remained nearly identical, suggesting that peptide aggregation/fibril 
formation was not affected by the preparation and, therefore, not an artifact of the preparation. 
They were also detected 13C CPMAS NMR spectra of molecules 40-43 in POPC lipid membranes 
(the spectra are shown in Figure 78 and Figure 79). There are only marginal chemical shift 
differences (see Table 8 and Table 9), indicating that the secondary structure of the molecules 
does not change upon membrane insertion. This also supports the previous conclusion that a large 
portion of the molecules remains in the fibrillar aggregate, which it forms in the crystalline state. 
Further, even those molecules that are immersed in the membranes as putative monomers show 
a very similar structure. The Phe peaks show some broader base and a minor contribution with a 
Cα chemical shift more indicative of random coil structure. This contribution is also seen in the 
crystalline form of the dipeptide. However, the Oxd residues exhibit narrow and well defined NMR 
signals without indication for a different secondary structure. 
Finally, the C-H order parameter of the labeled Phe and Oxd amino acids of the lipopeptides 
incorporated in POPC membranes from the C-H dipolar coupling were measured using DIPSHIFT 
experiments. For all labeled carbons relatively high order parameters were observed. Such a 
behavior, which is typical for fibrillar peptides/proteins, shows that there is not much space for 
conformational flexibility and motion in the backbone of the molecules.72 
                                               
70 Huster, D.; Vogel, A.; Katzka, C.; Scheidt, H. A.; Binder, H.; Dante, S.; Gutberlet, T.; Zschörnig, O.; Waldmann, H.; 
Arnold, K. “Membrane Insertion of a lipidated Ras peptide studies by FTIR, solid-state NMR and Neutron Diffraction 
Spectroscopy” J. Am. Chem. Soc. 2003, 125, 4070-4079. 
71 Vogel, A.; Tan, K.-T.; Waldmann, H.; Feller, S. E.; Brown, M. F.; Huster, D. “Flexibility of Ras lipid modifications studies 
by 2H solid-state NMR and molecular dynmaics simulations” Biophys. J. 2007, 93, 2697-2712. 
72
 Helmus, J. J.; Surewicz, K.; Surewicz, W. K.; Jaroniec, C. P. “Conformational flexibility of Y145Stop human prion 
protein amyloid fibrils probed by solid-state nuclear magnetic resonance spectroscopy” J. Am. Chem. Soc. 2010, 132, 
2393-2403. 
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Apparently, the N-terminal lipid modification does not seem to interfere with the general property 
of this peptide to form highly ordered nanofiber-like materials. On the contrary, the 2H NMR 
results suggest that the lipid chains also appear to be well aligned, which may provide an 
additional intermolecular stabilization in addition to the single hydrogen bond that has been found 
before. 
The situation changes partially when the peptides are allowed to interact with lipid membranes. 
As lipid modifications represent a common motif for membrane binding of membrane-associated 
proteins and peptides, we studied the interaction of the lipidated dipeptides with POPC 
membranes. Spin diffusion experiments showed that the peptides were indeed associated with 
the membranes. While we did not detect any major secondary structure changes in the peptide 
backbone associated with membrane binding, the 2H NMR spectra of the lipid chains of the 
peptide allowed us to detect two populations of peptide molecules. One portion of oligomeric 
lipopeptides was found to closely resemble the crystalline nanofibers detected in the absence of 
any membranes and another portion of monomeric dipeptides were identified that are immersed 
into the lipid membrane. 
The membrane propensity of the lipopeptides can be explained by the hydrophobic effect. 
Partitioning of lipidated peptides into the lipid water interface of a membrane can be understood 
from thermodynamic principles.  
The peptides are not soluble in aqueous environment; this fact may explain why more than half of 
the lipidated dipeptides remain aggregated even in the presence of membranes and only a smaller 
portion forms monomers that are inserted into the membranes. This suggests that the 
intermolecular forces that lead to fiber formation of the peptides must be relatively strong and are 
not easily dissolved in the case where the membrane becomes the solvent. However, it should be 
stressed that lipidated peptides do not generally tend to aggregate in the membrane environment. 
It was previously reported that the dipeptide Boc-L-Phe-D-Oxd-OBn is stabilized only by a single 
hydrogen bond. This would certainly not suffice to keep the peptides aggregated in the presence 
of membranes. Clearly, the highly ordered lipid modifications also contribute to the intermolecular 
forces that keep the peptides in the nanostructured form. Only part of the peptide aggregates are 
dissolved in the membrane and will most likely occur in a monomeric form. These molecules are 
also relatively mobile in the membrane, the lipid modifications undergo fast motions comparable 
to those of the lipid chains of the phospholipids. Here, the intermolecular forces between adjacent 
peptides, which stabilize the nanofibered structure of the dipeptide in the absence of membranes 
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are replaced by interactions of the peptide with the membrane that in particular occur in the lipid 
-water interface of the bilayer. 
The structural findings of this study are summarized in a cartoon shown in Figure 81. In the 
crystalline state, the peptides form parallel β-sheets and the N-terminal lipid modifications are 
highly ordered in the all trans state (A). In the lipid membrane (B), two populations of lipopeptides 
are observed. First, aggregated nanofibers remain undetected and may due to their 
hydrophobicity be buried in the liquid crystalline membrane or could occur clustered on the 
membrane surface. Second, also monomeric molecules have been detected that are inserted in 
the membrane, these molecules show higher mobility and are characterized by highly mobile lipid 
modifications that undergo fast trans-gauche isomerizations just as the lipid chains of the POPC 
molecules in the host membrane. 
 
 
 
Figure 81. The cartoon summarizes the major findings of the current study. In the absence of membranes, 
lipopeptides form highly ordered β-sheet like nanofibers with the lipid modifications in a rigid all trans conformation 
(A). When lipid membranes are present, larger peptide aggregates can bind to the membrane surface or insert into 
the membrane, but also dissociate and insert into the membrane as monomers, most likely with the lipid modification 
facing the membrane interior (B). 
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4 Tetramic Acids: new scaffolds for foldamers  
4.1 Introduction 
 
The synthesis and characterization of oligomers programmed to fold and self assemble into 
secondary structures is always open. Nowadays, a new frontier of foldamer research is based on 
searching new scaffolds with a variety of properties. 
When developing new scaffold, large screening of molecules from chiral pool can provide hits that 
could eventually be optimized to afford candidate foldamers.  
In this chapter is presented the synthesis and in the derivatization of 1-acyl 3-carboxy tetramic 
acids, as they are constrained amino acid mimetics, contain an endocyclic carbonyl group and may 
be functionalized in several ways, thus they be may applied to the formation of pseudopeptide 
foldamers.  
The heterocyclic core of tetramic acids (pyrrolidine-2,4-diones, Figure 82) is a recurrent motif 
among natural products originating from a variety of marine and terrestrial species such as 
sponges, cyanobacteria, bacteria and fungi. Their study has experienced a renaissance due to the 
high incidence of biological activities and because of their challenging structural complexity. A 
steadily increasing number of reports have been dealing with the isolation of new derivatives, with 
aspects of their biosyntheses and their medicinal potential as well as with the refinement of 
synthetic strategies including parallel and combinatorial approaches.73  
The number of natural derivatives is over 150 and further progress was made towards an 
understanding of their biosyntheses and multi- accepted bioactivity. The spectrum of their 
physiological activities is as broad as that of tetramic acids with a focus on antibiotic, antiviral and 
antineoplastic properties. the most frequent and pharmacologically most interesting derivatives 
are those featuring 3-acyl residues. This has been explained by their ability to chelate 
biochemically indispensable metal ions and to mimic phosphate groups in the binding site of 
kinases and phosphatases.  
Tetramic acids are very polar and scarcely reactive and may be prepared with several methods. 
The most simple one is the activation of a Boc-protected amino acid with EDC, condensation with 
Meldrum’s acid, and finally cyclization to give the Boc-protected pyrrolidine-2,4-diones. The 
                                               
73 Schobert, R.; Schlenk, A. “Tetramic and tetronic acids: an update on new derivatives and biological aspects” Bioorg. 
Med. Chem. 2008, 16, 4203-4221. 
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following N-deprotection may be accomplished with TFA treatment giving the parent pyrrolidine-
2,4-diones.74 Another straightforward method is the condensation of methyl (E)-4-chloro-3-
methoxy-2-butenoate with a 2-amino alcohol in the presence of triethylamine.75  
The reactions of the tetramic acid ring itself which can be summarized as follows: (a) reaction with 
electrophilic species (e.g. aldehydes, bromine or nitrating agents) at C-3, (b) with nucleophilic 
species (eg. hydrazine) at (2-4, (c) acylation on O-4 or,76 under certain conditions, C-3, and (d) with 
organometallic bases (eg. n-butyllithium) metallation occurs at C-3 (Figure 82). 
 
 
 
Figure 82. The heterocyclic core of tetramic acids and its main derivatization reactions. 
 
However, the functionalization of this kind of heterocycle is often a difficult task, due to their low 
reactivity and to the equilibrium between the ketonic and enolic form, especially for 3-acyl 
derivatives, the most common ones (Figure 83). 
 
                                               
74 a) Jouin, P.; Castro, B.; Nisato, D. “Stereospecific synthesis of N-protected statine and its analogues via chiral 
tetramic acid” J. Chem. Soc., Perkin Trans. 1, 1987, 1177-1182; b) Ma, D.; Ma, J.; Ding, W.; Dai, L. “An improved 
procedure to homochiral cyclic statines An improved procedure to homochiral cyclic statines” Tetrahedron: 
Asymmetry, 1996, 7, 2365-2370; c) Courcambeck, J.; Bihel, F.; de Michelis, C.; Quéléver, G.; Kraus, J. L. “Design of 
potential new HIV protease inhibitors: enantioconvergent synthesis of new pyrrolidin-3-ol, and pyrrolidin-3-one peptide 
conjugates” J. Chem. Soc., Perkin Trans. 1, 2001, 2, 1421-1430. 
75 Lan, H.-Q.; Ye, J.-L.; Wang, A.-E.; Ruan, Y.-P.; Huang, P.-Q. “A flexible asymmetric approach to methyl 5-
alkyltetramates and its application in the synthesis of cytotoxic marine natural product belamide A” Chem.-Eur. J. 
2011, 17, 958-968; b) Jiang, L.-J.; Lan H.-Q.; Zheng, J.-F.; Ye, J.-L.; Huang, P.-Q. “A flexible approach to methyl (5S)-5-
alkyltetramate derivatives” Synlett, 2009, 297-301; d). Laffan, D. D. P.; Panziger, M.; Duc, L.; Evans, A. R.; McGarrity, J. 
F.; Meul T. “An efficient synthesis of racemic 4-Hydroxy-2-oxo-1-pyrrolidineacetamide (Oxiracetam) using tetramic-acid 
intermediates” Helv. Chim. Acta, 1992, 75, 892-900. 
76 Hosseini, M.; Grau, J. S.; Sørensen, K. K.; Søtofte, I.; Tanner, D.; Murrayb, A.; Tønder, J. E. “Short and efficient 
diastereoselective synthesis of pyrrolidinone-containing dipeptide analogues” Org. Biomol. Chem. 2007, 5, 2207-2210. 
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Figure 83. The tautomeric behavior of 3-acyltetramic acids. It involves two sets of rapidly interchanging internal 
tautomers [a  b] and [c  d], where each set arises through proton transfer along the intramolecular hydrogen 
bond, together with two pairs of lowly interconverting external tautomers [a, b]  [c, d], arising from the rotation of 
the acyl side chain. 
 
Very interesting are the studies reported by Tønder et al.77 who have developed a straightforward 
strategy for the synthesis of N-acylates, O-alkylated pyrrolidin-2-ones by functionalization of 
tetramic acids, that leads to the formation of dipeptidomimetics comprising a pyrrolidinone and a 
protected amino acid. They have also reported an optimized two-step reductive amination 
procedure, which provides a small library of pyrrolidinone-containing dipeptide analogs. Another 
interesting approach to the synthesis of N-Boc 5-substituted tetramic acids is the cyclization of N-
hydroxysuccinimide esters of Boc-protected α-amino acids.78 The desired products have been 
obtained in two steps, by coupling of the α-amino acid derivatives with an alkyl malonate in the 
                                               
77
 a) Hosseini, M.; Kringelum, H.; Murray, A.; Tønder, J. E. “Dipeptide analogues containing 4-ethoxy-3-pyrrolin-2-ones” 
Org. Lett. 2006, 8, 2103-2106; b) Hosseini, M.; Tanner, D.; Murrayb, A.; Tønder, J. E. “Pyrrolidinone-modified di- and 
tripeptides: highly diastereoselective preparation and investigation of their stability” Org. Biomol. Chem. 2007, 5, 
3486-3494. 
78 a) Matiadis, D.; Igglessi-Markopoupou, O. “Design and synthesis of optically active esters of γ-amino-β-oxo acids as 
precursors for the synthesis of tetramic acids derived from L-Serine, L-Tyrosine, and L-Threonine” Eur. J. Org. Chem. 
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2010, 66, 3944-3950; c) Prousis, K. C.; Detsi, A.; Igglessi-Markopoulou, O. “A traceless solid-phase approach to 
functionalized tetramic acids and 2-Amino-4-pyrrolinones” Synlett, 2005, 2763-2766; d) Detsi, A.; Afantitis, A.; 
Athanaselli, G.; Markopoulos, J.; Igglessi-Markopoulou, O.; Skylaris C.-K. “Cyclisation of novel amino oxo esters to 
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amino acids mediated by 1-Hydroxybenzotriazole” Synlett, 2001, 1653-1655; f) Petroliagi, M.; Igglessi-Markopoulou, O. 
“An efficient synthesis of novel N-acetyl-3-alkanoyl and 3-dienoyl tetramic acids” J. Chem. Soc., Perkin Trans. 1 (1997), 
p. 3543-3548; g) A. Detsi, J. Markopoulos, O. Igglessi-Markopoulou “Reactions of N-hydroxysuccinimide esters of N-
alkoxycarbonyl-α-amino acids with active methylene compounds. Synthesis of 3-substituted tetramic acids” Chem. 
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presence of NaH, with the formation of γ-amino-β-oxoalkanoates, that in turn cyclize under basic 
conditions to give the desired compounds. 
1-Acyl 3-carboxy tetramic acids are constrained β-amino acids, where the carbonyl unit is placed 
between the two functions, thus it forces the two carbonyls in the trans conformation, following 
the same effect that we have observed for the 4-carboxy-oxazolidin-2-ones (Figure 84). As a 
consequence of this disposition, this scaffold may behave as a reverse-turn mimic, if it is 
introduced in the middle of a polypeptide chain, or it may promote the formation of new 
foldamers, if it is introduced in more complex structures. Although many examples of nonpeptidic 
reverse-turn surrogates have been reported, it is still challenging to find a new type of nonpeptidic 
scaffold that can adopt a highly populated reverse-turn conformation in solution79 and that may 
be regarded as constrained pseudo-β-prolines. 
 
 
Figure 84. (a) Preferential conformation of 4-carboxy-oxazolidin-2-ones and (b) possible preferential conformation of 
1-acyl 3-carboxy tetramic acids. 
 
4.2 Synthesis of the heterocycles 
We report here a one-pot synthesis of poly-substituted tetramic acids (4-hydroxy-2-oxo-1H-
pyrrole-1,3(2H,5H)-dicarboxylates) and of the corresponding six-membered rings (4-hydroxy-2-
oxo-5,6-dihydropyridine-1,3(2H)-dicarboxylates) starting from benzyl malonate and N-
hydroxysuccinimide esters of Boc-protected amino acids (Scheme 9). As a first attempt, we utilized 
the protocol described by Igglessi-Markopoulou et al.78a that allows obtaining γ-amino β-oxo acids 
by reaction of N-hydroxysuccinimide esters of Boc-protected amino acids with alkyl malonate. 
 
                                               
79
 Gante, J. “Peptidomimetics-Tailored Enzyme Inhibitors” Angew. Chem., Int. Ed. Engl. 1994, 33, 1699-1720. 
105 
 
 
Scheme 9. Reagents and conditions: (i) Na
+ -
CH(CO2Bn)2 (1.5 equiv), dry THF, 30 min at 0 °C then 2h at rt; (ii) 2 M 
NaOH (166 equiv), BnOH, 2 h, rt. 
 
As the final scope is the formation of a free carboxy unit, the reaction was performed with benzyl 
malonate, as the benzyl unit may be removed easily by hydrogenolysis. So benzyl malonate was 
treated with NaH in dry THF, followed by the N-hydroxysuccinimide esters, to afford the desired γ-
amino β-oxo benzyl esters 47a-d in high yield. This reaction allows obtaining the desired 
compound 47, starting from both α- and β-amino acids (Scheme 9). The following cyclization was 
performed in benzyl alcohol and aqueous 2 M NaOH. While satisfactory yields were obtained for 
the synthesis of both 4-hydroxy-2-oxo-1H-pyrrole-1,3(2H,5H)-dicarboxylates 48a and 48b (60% 
and 52%, respectively), the synthesis of 4-hydroxy-2-oxo-5,6-dihydropyridine-1,3(2H)-
dicarboxylates 48c and 48d afforded very unsatisfactory results, as 48c was obtained only in traces 
from 47c and 48d in 26% yield from 47d. No racemization occurred in the formation of 48b (after 
analysis with HPLC equipped with a chiral column AD, n-hexane/iso-propanol 8:2, flow: 0.5 
mL/min), probably due to the mild reaction conditions. 
Then 48a was deprotected from the Boc moiety by reaction with trifluoroacetic acid in dry 
dichloromethane, for further derivatizations. The desired product was obtained in high yield. 
Unfortunately, the following N-acylation reaction, performed with standard coupling conditions 
(HBTU or HATU, in the presence of tertiary amines) was totally unsuccessful, as the heterocyclic 
nitrogen of this compound is very unreactive. In effect, this reaction has been previously reported 
only in hard conditions,77a by reaction with a lithium base (n-BuLi or LiHMDS), followed by addition 
of an activated ester (Fmoc-AA-OPfp) at -50 °C. 
To overcome this problem, we reversed the step order, making the coupling before the cyclization 
(Scheme 10). Thus four dipeptides were prepared containing both α- and β-amino acids, in both 
positions. Then the carboxy moieties were activated as the corresponding N-hydroxysuccinimide 
esters and treated with the sodium anion of the benzyl malonate to obtain the corresponding γ-
amino β-oxo acids, as previously reported in Scheme 9. Much to our surprise, the expected 
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products were not obtained, as the reaction proceeded directly to the formation of the 
heterocyclic rings. The reaction yield was further optimized with the addition of 2.5 equiv of base.  
 
 
Scheme 10. Reagents and conditions: (i) Na+ -CH(CO2Bn)2 (1.5 equiv), dry THF, 16 h, rt. 
 
The different behavior between Boc-AA-OSu and Boc-AA-AA-OSu may be ascribed to the 
secondary amide involved in the cyclization, that is more acidic than the carbamate involved in the 
cyclization of Boc-AA-OSu. The heterocycles 49-d are obtained in good to high yield and can be 
further derivatized simply by removing the Boc or benzyl ester protecting groups. 
Finally, the achiral 49d was further derivatized to check if this new class of compounds may be 
utilized to promote the formation of reverse-turn mimics, as they may be considered as a mimic of 
the Gly-Pro moiety, that is often present in the β-turn motifs. Thus we replaced the OBn group 
with H-Ala-OMe that contains the small methyl ester. Of course, if a longer peptide chain has to be 
introduced, benzyl-protected amino acids are preferred. 
After hydrogenolysis of the benzyl ester with H2 and Pd/C, the acid was coupled with H-Ala-OMe, 
but the coupling reaction produced only a mixture of products, probably due to the free hydroxyl 
group, that was then protected by methylation of the Li anion with (trimethylsilyl)diazomethane 
(Scheme 11). The product 50 was obtained in good yield and the deprotected by reaction with H2 
and Pd/C to form the free acid 51, that was coupled with H-Ala-OMe in the presence of HBTU and 
TEA. The derivative 52 was obtained in high yield after purification. 
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Scheme 11. Reagents and conditions: (i) LiHMDS (1.1 equiv), dry THF, 10 min, rt (ii) (trimethylsilyl)diazomethane (8 
equiv), dry THF, 3 h, rt (iii) H2, Pd/C, MeOH, 6 h, rt; (iv) HCl·H-Ala-OMe (1 equiv), HBTU (1.1 equiv), TEA (3 equiv), 
CH3CN, 2 h, rt. 
 
4.3 Conformational analysis of 52 
Information on the preferred conformation of the compound 52 in solution was obtained by FT-IR 
and 1H NMR techniques. The FT-IR absorption spectrum of 52 was obtained as 3 mM solution in 
methylene chloride, as at this concentration self-aggregation is usually unimportant (Figure 85). 
The IR spectrum of 52 shows the presence of a non-hydrogen-bonded amide N-H bands (3438, 
above 3400 cm-1) and of a large band located at 3327 cm-1, that suggests that an equilibrium takes 
place, involving a hydrogen-bonded amide protons bands. 
 
 
Figure 85. FT-IR absorption spectrum in the N-H stretching region for 3 mM concentration samples of 55 in pure 
CH2Cl2 at room temperature. 
 
The in-solution conformation of 52 was investigated also by 1H NMR spectroscopy and MD 
simulations; NMR analyses were conducted using standard techniques at 400 MHz in CDCl3. The 
1H 
NMR analysis of 52 revealed a single set of sharp resonances, indicating conformational 
homogeneity or a fast equilibrium between conformers. 
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To verify the IR outcome and to check which hydrogen-bonded amide proton is involved in the 
equilibrium, some 1H NMR spectra of 52 have been recorded, as a function of the addition of 
increasing amounts of DMSO-d6, to check the dependence of NH proton chemical shifts from 
DMSO-d6 (Figure 86a); this solvent is a strong hydrogen-bonding acceptor and, if it is bound to a 
free NH proton, it will be expected to dramatically move its chemical shift downfield. The titration 
of the NH bonds shows that NH-Ala is poorly bonded (Δδ=0.68 ppm), while the NH-Boc is an 
equilibrium between a hydrogen-bonded and an open conformation (Δδ=0.48 ppm). A strong 
hydrogen-bonded conformation would require a lower Δδ outcome (Δδ≤0.15 ppm). 
 
 
Figure 86. (a) Variation of NH proton chemical shift (ppm) of 52 as a function of increasing percentages of DMSO-d6 to 
the CDCl3 solution (v/v) (concentration: 3 mM); (b) variation of NH proton chemical shift (ppm) of 52 as a function the 
temperature (°C) for 10 mM samples measured in CDCl3. 
 
Some more information have been obtained, by recoding the 1H NMR spectrum of a 10 mM 
sample of 52 in CDCl3 at different temperature, to check the dependence of the NH proton from 
the temperature (Figure 86b). 
This test points out the presence of hydrogen-bonded amide protons, as in CDCl3 a small 
temperature coefficient (≤3 ppb/K in absolute value) indicates the presence of a hydrogen-bonded 
amide proton,80 while protons, which participate to an equilibrium between hydrogen-bonded and 
non-hydrogen-bonded state show a larger temperature coefficient. In DMSO-d6 the temperature 
coefficients can be bigger, so that a hydrogen-bonded amide proton can have a value of -4 ppb/K 
or smaller in absolute value. The analysis of the variation of the NH chemical shift with the 
temperature furnish a result, that is, in agreement both with the titration and with the IR 
                                               
80 Yang, J.; Gellman, S. H. “Energetic superiority of two-center hydrogen bonding relative to three-center hydrogen 
bonding in a model system” J. Am. Chem. Soc., 1998, 120, 9090-9091. 
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spectrum, because a Δδ of -6.0 ppb/K for NH-Ala shows that no hydrogen bond is formed, while -
3.0 ppb/K for NH-Boc suggests the formation of a weak hydrogen bond. 
To have more information on the in-solution preferred conformation, 52 was further analyzed by 
2D ROESY experiments performed on a 10 mM solution of 52 in CDCl3 (mixing time 0.500 s). 
Several cross peaks were obtained (see Supplementary data), the most interesting ones (Figure 87, 
red arrows) are the cross peak between the β-AlaNH and the methylene at the C5 of the 
heterocycle, and the cross peak between the CHα-Ala and the Boc group. This cross peak shows 
that one chain lays nearby to the other, thus suggesting that this molecule is a good candidate for 
the formation of a reverse-turn motif. 
 
 
Figure 87. NOE enhancements as gathered from the ROESY analysis spectrum of 55 (10 mM solution in CDCl3, mixing 
time 0.500 s). 
 
Furthermore a strong signal was observed between the NH-Ala and the OMe heterocyclic group 
and two weaker signals between CHα-Ala and CO2Me and CHα-Ala and OMe. 
MD simulations25 furnished some more hints on the preferred in-solution conformation of 52. 
Structures consistent with the spectroscopic analyses were obtained by restrained MD 
simulations, using the distances derived from ROESY as constraints, and minimized with AMBER 
force field (see Supplementary data).81 To investigate the dynamic behavior of 52, some structures 
were analyzed by unrestrained MD for 500 ns. 
                                               
81
 Cornell, W. D.; Cieplak, P.; Bayly, C.; Gould, I. R.; Merz, K. M.; Ferguson, D. M.; Spellmeyer, D. C.; Fox, T;. Caldwell, J. 
W.; Kollman P. A. “A second generation force field for the simulation of proteins, nucleic acids, and organic molecules”  
J. Am. Chem. Soc., 1995, 117, 5179-5197. 
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The simulation of the more stable structure revealed a strong propensity to maintain the folded 
conformations, with the occurrence of an explicit H-bond between β-AlaNH and the heterocyclic 
C=O, in agreement to the IR and 1H NMR results (Figure 88). 
 
 
 
Figure 88. Representative low-energy structure of 52 obtained by unrestrained MD simulation, performed on the 
lower-energy structure consistent with ROESY analysis, calculated by restrained MD. 
 
With this work, we demonstrated that N-Boc dipeptides activated as their O-succinimidyl esters 
(Boc-AA-AA-OSu), with the sodium anion of dibenzyl malonate, can spontaneously cyclize to five 
or six-member rings. The conformational study of 52 suggests the formation of a hydrogen bond 
between the β-AlaNH and the carbonyl at C2 of the heterocycle. Further studies are currently 
ongoing on more complex structures containing polysubstituted tetramic acids or their six-
membered ring analogs to check if they are able to promote the formation of new foldamers. 
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5 Conclusions 
 
This thesis deals with the synthesis and the conformation analysis of hybrid foldamers containing 
the 4-carboxyoxazolidin-2-one unit or related molecules, in which an imido-type function is 
obtained by coupling the nitrogen of the heterocycle with the carboxylic acid moiety of the next 
unit.  
The imide group is characterized by a nitrogen atom connected to an endocyclic and an exocyclic 
carbonyl, which tend always to adopt the trans conformation. As a consequence of this locally 
constrained disposition effect, these imide-type oligomers are forced to fold in ordered 
conformations. 
The synthetic approach is highly tuneable with endless variations, so, simply by changing the 
design and the synthesis, a wide variety of foldamers with the required properties may be 
prepared “on demand”.  
Thus a wide variety of unusual secondary structures and interesting supramolecular materials may 
be obtained with hybrid foldamers. 
The behaviour in the solid state of some of these compounds has been analyzed in detail, thus 
showing the formation of different kinds of supramolecular materials that may be used for several 
applications.  
A winning example is the production of a bolaamphiphilic gelators that may also be doped with 
small amounts of dansyl containing compounds, needed to show the cellular uptake into IGROV-1 
cells, by confocal laser scanning microscopy. These gels are readily internalized by cells and are 
biologically inactive, making them very good candidates in the promising field of drug delivery. 
In the last part of the thesis, a particular attention was directed to the search of new scaffolds that 
behave as constrained amino acid mimetics, showing that tetramic acids derivatives could be good 
candidates for the synthesis and applications of molecules having an ordered secondary structure. 
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6 Experimental Section 
 
Boc-L-Phe-L-Oxd-OBn 1.  
A solution of Boc-L-Phe-OH (0.50 g, 1.89 mmol) and HBTU (0.72 g, 1.89 mmol) in dry acetonitrile 
(40 mL) was stirred in a nitrogen atmosphere for 10 min at room temperature. Then l-Oxd-OBn 
(0.44 g, 1.89 mmol) in dry acetonitrile (10 mL) was added dropwise at room temperature, followed 
by TEA (3.78 mmol, 0.52 mL). The solution was stirred for 50 min in a nitrogen atmosphere, and 
then acetonitrile was removed under reduced pressure and replaced with ethyl acetate. The 
mixture was washed with brine (1 × 30 mL), 1 N aqueous HCl (1 × 30 mL), and a concentrated 
solution of NaHCO3 (1 × 30 mL), dried over sodium sulfate, and concentrated in vacuo. The 
product was obtained pure after silica gel chromatography (90:10 c-Hex/ethyl acetate → 70:30 c-
Hex/ethyl acetate as eluant) in 84% (0.77 g) overall yield as a waxy solid.     
   = -2.1 (c 1.0, CHCl3). 
IR (CH2Cl2, 3 mM): ν 3442, 1799, 1761, 1738, 1717 cm
-1. IR (solid, 1% in KBr): ν 3354, 3436, 3354, 
1791, 1739, 1725, 1690 cm-1. 1H NMR (CDCl3): δ 1.25 (s, 9H, t-Bu), 1.48 (d, 3H, Me, J = 6.4 Hz), 2.50 
(dd, 1H, J = 9.6, 13.6 Hz, CHH-Ph), 3.22 (dd, 1H, J = 3.3, 13.6 Hz, CHH-Ph), 4.50-4.58 (m, 2H, CHN-
Oxd + CHO-Oxd), 4.84 (d, 1H, J = 8.8 Hz, NH), 5.16 (AB, 2H, J = 12.4 Hz), 5.57 (dt, 1H, J = 4.0, 9.6 
Hz), 7.12-7.33 (m, 10H, 2 × Ph). 13C NMR (CDCl3): δ 28.0, 37.6, 53.9, 67.7, 67.8, 73.3, 73.6, 79.6, 
126.6, 126.8, 128.1, 128.2, 128.3, 128.6, 129.3, 134.3, 135.8, 151.3, 155.0, 167.5. Anal. Calcd for 
C26H30N2O7: C, 64.72; H, 6.27; N, 5.81. Found: C, 64.69; H, 6.25; N, 5.78. 
 
Boc-L-Phe-L-Oxd-OH 2.  
Compound 1 (0.72 mmol, 0.48 g) was dissolved in MeOH (30 mL) under nitrogen. C/Pd (35 mg, 
10% w/w) was added under nitrogen. A vacuum was created inside the flask using the vacuum 
line. The flask was then filled with hydrogen using a balloon (1 atm). The solution was stirred for 
16 h under a hydrogen atmosphere. The product was obtained pure in 98% yield (0.28 g) as an oil, 
after filtration through filter paper and concentration in vacuo. 1H NMR (CD3OD): δ 1.37 (s, 9H, t-
Bu), 1.62 (d, 3H, Me, J = 6.4 Hz), 2.71 (dd, 1H, J = 10.8, 14.0 Hz, CHH-Ph), 3.35 (m, 1H, CHH-Ph), 
4.65 (d, 1H, J = 4.4 Hz, CHN-Oxd), 4.80 (m, 1H, CHO-Oxd), 5.59 (dd, 1H, J = 3.2, 10.8 Hz), 7.21-7.44 
(m, 5H, Ph). 13C NMR (CD3OD): δ 21.2, 28.6, 38.2, 56.2, 62.9, 76.0, 80.7, 127.7, 129.3, 130.4, 138.5, 
153.8, 158.0, 171.3, 174.3. Anal. Calcd for C19H24N2O7: C, 58.16; H, 6.16; N, 7.14. Found: C, 58.13; 
H, 6.19; N, 7.12. 
 
H-L-Phe-L-Oxd-OBn·CF3CO2H 3.  
A solution of 1 (0.52 mmol, 0.25 g) and TFA (9.36 mmol, 0.720 mL) in dry methylene chloride (20 
mL) was stirred at room temperature for 4 h; then the volatiles were removed under reduced 
pressure, and the corresponding amine salt was obtained pure in 99% yield (0.26 g) as a waxy 
solid, without further purification. 1H NMR (CDCl3): δ 1.52 (d, 3H, Me, J = 3.96 Hz), 2.77 (dd, 1H, J = 
9.2, 14.4 Hz, CHH-Ph), 3.37 (dd, 1H, J = 3.8, 14.4 Hz, CHH-Ph), 4.51-4.64 (m, 2H, CHN-Oxd + CHO-
Oxd), 5.15 (AB, 2H, J = 11.6 Hz), 5.57 (m, 1H, NH), 7.08-7.40 (m, 10H, 2 × Ph). 13C NMR (CDCl3): δ 
19.6, 19.8, 35.2, 53.8, 60.1, 60.3, 65.0, 67.6, 67.7, 73.5, 73.9, 127.4, 127.5, 127.6, 127.8, 128.0, 
128.3, 128.4, 128.5, 131.5, 133.2, 150.4, 159.6 (q, CF3), 166.0, 167.8. Anal. Calcd for C23H23F3N2O7: 
C, 55.65; H, 4.67; N, 5.64. Found: C, 55.68; H, 4.68; N, 5.61. 
 
Boc-(l-Phe-l-Oxd)2-OBn 4.  
A solution of 2 (0.20 g, 0.52 mmol) and HBTU (0.20 g, 0.52 mmol) in dry acetonitrile (20 mL) was 
stirred in a nitrogen atmosphere for 10 min at room temperature. Then a mixture of 3 (0.52 mmol) 
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and TEA (1.56 mmol, 0.22 mL) in dry acetonitrile (10 mL) was added dropwise at room 
temperature. The solution was stirred for 50 min in a nitrogen atmosphere, and then acetonitrile 
was removed under reduced pressure and replaced with ethyl acetate. The mixture was washed 
with brine (1 × 30 mL), 1 N aqueous HCl (1 × 30 mL), and a concentrated solution of NaHCO3 (1 × 
30 mL), dried over sodium sulfate, and concentrated in vacuo. The product was obtained pure 
after silica gel chromatography (90:10 c-Hex/ethyl acetate → 70:30 c-Hex/ethyl acetate as eluant) 
in 80% yield (0.32 g) as a white solid. M. p.: 81-82 °C.     
   = -26 (c 1.0, CHCl3). IR (CH2Cl2, 3 mM): ν 
3427, 1789, 1752, 1711 cm-1. IR (solid, 1% in KBr): ν 3362, 1785, 1752, 1707 cm-1. 1H NMR (CDCl3): 
δ 1.22-1.30 (m, 15H, 2 × Me + t-Bu), 2.46-2.59 (m, 2H, 2 × CHH-Ph), 3.08-3.46 (m, 2H, 2 × CHH-Ph), 
4.12-4.68 (m, 4H, 2 × CHN-Oxd + 2 × CHO-Oxd), 4.89 (bs, 1H, NH), 5.06-5.24 (m, 2H, OCH2Ph), 5.44-
5.60 (m, 1H, CHN-CH2Ph), 5.86-5.93 (m, 1H, CHN-CH2Ph), 6.63 (d, 1H, J = 8.4 Hz, NH), 6.89-7.47 (m, 
15H, 3 × Ph). 13C NMR (CDCl3): δ 14.2, 20.4, 21.0, 21.2, 26.9, 27.8, 28.2, 37.9, 53.0, 54.2, 55.4, 60.4, 
61.2, 61.5, 62.6, 68.3, 73.9, 74.2, 79.8, 80.2, 126.7, 126.8, 127.0, 127.1, 127.2, 128.4, 128.5, 128.8, 
129.5, 130.1, 134.4, 135.7, 136.1, 151.4, 151.6, 155.2, 158.7, 163.8, 166.7, 166.9, 167.5, 167.7, 
171.2, 171.3, 171.7, 171.9, 172.7, 173.4. Anal. Calcd for C40H44N4O11: C, 63.48; H, 5.86; N, 7.40. 
Found: C, 63.49; H, 5.88; N, 7.43. 
 
Boc-(L-Phe-L-Oxd)2-OH 5.  
Compound 4 (0.40 mmol, 0.30 g) was dissolved in MeOH (30 mL) under nitrogen. C/Pd (35 mg, 
10% w/w) was added under nitrogen. A vacuum was created inside the flask using the vacuum 
line. The flask was then filled with hydrogen using a balloon (1 atm). The solution was stirred for 
16 h in a hydrogen atmosphere. The product was obtained pure in 97% yield (0.26 g) as a waxy 
solid, after filtration through filter paper and concentration in vacuo. 1H NMR (CD3OD): δ 1.15-1.30 
(m, 9H, t-Bu), 1.37-1.48 (m, 6H, 2 × Me), 2.48 (dd, 1H, J = 10.8, 14.0 Hz, CHH-Ph), 2.77 (dd, 1H, J = 
10.4, 14.4 Hz, CHH-Ph), 3.10-3.33 (m, 2H, 2 × CHH-Ph), 4.44-4.52 (m, 2H, 2 × CHN-Oxd), 4.61-4.69 
(m, 2H, 2 × CHO-Oxd), 5.32-5.39 (m, 1H, NH), 5.65-5.74 (m, 1H, NH), 7.05-7.33 (m, 10H, 2 × Ph). 13C 
NMR (CD3OD): δ 20.6, 28.6, 37.4, 38.0, 55.3, 56.1, 63.0, 63.3, 76.2, 76.4, 80.6, 127.6, 127.8, 129.2, 
130.4, 137.8, 138.5, 163.8, 154.1, 158.0, 170.1, 171.4, 173.0, 174.1. Anal. Calcd for C33H38N4O11: C, 
59.45; H, 5.75; N, 8.40. Found: C, 59.41; H, 5.74; N, 8.38. 
 
Boc-(L-Phe-L-Oxd)3-OBn 6.  
A solution of 5 (0.168 g, 0.25 mmol) and HBTU (0.095 g, 0.25 mmol) in dry acetonitrile (20 mL) was 
stirred in a nitrogen atmosphere for 10 min at room temperature. Then a mixture of 3 (0.25 mmol) 
and TEA (0.75 mmol, 0.104 mL) in dry acetonitrile (10 mL) was added dropwise at room 
temperature. The solution was stirred for 50 min in a nitrogen atmosphere, and then acetonitrile 
was removed under reduced pressure and replaced with ethyl acetate. The mixture was washed 
with brine (1 × 30 mL), 1 N aqueous HCl (1 × 30 mL), and a concentrated solution of NaHCO3 (1 × 
30 mL), dried over sodium sulfate, and concentrated in vacuo. For the purification from 
tetramethylurea and the byproduct, the residue was suspended in cyclohexane and sonicated for 
15 min to dissolve the byproduct. Compound 6 was filtered, dried in vacuo, and obtained pure in 
73% yield (0.18 g) as a white solid. M. p.: 79-80 °C.     
   = -30 (c 0.3, CHCl3). IR (CH2Cl2, 3 mM): ν 
3442, 1789, 1752, 1718 cm-1. IR (solid, 1% in KBr): ν 3371, 1788, 1754, 1714 cm-1. 1H NMR (CDCl3): 
δ 1.05-1.68 (m, 18H, 3 × Me + t-Bu), 2.58-2.94 (m, 3H, 3 × CHH-Ph), 3.27-3.51 (m, 3H, 3 × CHH-Ph), 
4.20-4.87 (m, 6H, 3 × CHN-Oxd + 3 × CHO-Oxd), 4.94 (bs, 1H, NH), 5.05-5.18 (m, 2H, OCH2Ph), 5.82-
6.07 (m, 3H, 3 × CHN-CH2Ph), 6.75 (bs, 1H, NH), 6.89-7.47 (m, 25H, 5 × Ph), 7.17 (bs, 2H, 2 × NH), 
7.34 (bs, 1H, NH). 13C NMR (CDCl3): δ 20.3, 21.1, 27.8, 28.2, 37.2, 37.7, 53.1, 54.3, 60.3, 61.7, 62.7, 
63.0, 68.2, 74.0, 74.2, 74.4, 80.0, 126.9, 127.1, 128.4, 128.8, 129.2, 129.6, 129.9, 134.5, 135.9, 
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151.0, 151.7, 155.2, 155.6, 167.0, 167.6, 171.1, 171.4. Anal. Calcd for C54H58N6O15: C, 62.90; H, 
5.67; N, 8.15. Found: C, 62.87; H, 5.65; N, 8.18. 
 
H-(L-Phe-L-Oxd)2-OBn·CF3CO2H 7. 
A solution of 2 (0.52 mmol, 0.39 g) and TFA (9.36 mmol, 0.720 mL) in dry methylene chloride (20 
mL) was stirred at room temperature for 4 h; then the volatiles were removed under reduced 
pressure, and the corresponding amine salt was obtained pure in 96% yield (0.38 g) as a waxy 
solid. 1H NMR (CDCl3): δ 1.34-1.52 (m, 6H, 2 × Me), 2.49-2.90 (m, 2H, 2 × CHH-Ph), 3.01-3.35 (m, 
2H, 2 × CHH-Ph), 4.19-4.68 (m, 4H, 2 × CHN-Oxd + 2 × CHO-Oxd), 4.89-5.18 (m, 1H, NH), 5.30-5.81 
(m, 2H, 2 × CHN-CH2Ph), 7.05-7.35 (m, 15H, 3 × Ph). 
13C NMR (CDCl3): δ 20.5, 20.9, 27.7, 28.1, 36.1, 
36.6, 37.7, 38.8, 53.2, 53.7, 54.3, 55.5, 61.5, 62.2, 68.4, 74.4, 127.1, 127.3, 128.5, 128.7, 128.8, 
129.0, 129.3, 129.5, 129.6, 134.3, 134.8, 151.7, 159.4 (q, CF3), 167.5, 171.1. Anal. Calcd for 
C37H37F3N4O11: C, 57.66; H, 4.84; N, 7.27. Found: C, 57.68; H, 4.83; N, 7.30. 
 
Boc-(L-Phe-L-Oxd)4-OBn 8.  
A solution of 5 (0.16 g, 0.24 mmol) and HBTU (0.091 g, 0.24 mmol) in dry acetonitrile (20 mL) was 
stirred in a nitrogen atmosphere for 10 min at room temperature. Then a mixture of 3 (0.24 mmol) 
and TEA (0.72 mmol, 0.100 mL) in dry acetonitrile (10 mL) was added dropwise at room 
temperature. The solution was stirred for 50 min in a nitrogen atmosphere, and then acetonitrile 
was removed under reduced pressure and replaced with ethyl acetate. The mixture was washed 
with brine (1 × 30 mL), 1 N aqueous HCl (1 × 30 mL), and a concentrated solution of NaHCO3 (1 × 
30 mL), dried over sodium sulfate, and concentrated in vacuo. For the purification from 
tetramethylurea and the byproduct, the residue was suspended in cyclohexane and sonicated for 
15 min to dissolve the byproduct. Compound 8 was filtered, dried in vacuo, and obtained pure in 
70% yield (0.22 g) as a white solid. M. p.: 87-88 °C.     
   = -28.0 (c 1.0, CHCl3). IR (CH2Cl2, 3 mM): ν 
3428, 1789, 1707 cm-1. IR (solid, 1% in KBr): ν 3361, 1791, 1749, 1714 cm-1. 1H NMR (CDCl3): δ 1.10-
1.38 (m, 21H, 4 × Me + t-Bu), 2.71-3.30 (m, 8H, 4 × CH2-Ph), 4.07-4.64 (m, 8H, 4 × CHN-Oxd + 4 × 
CHO-Oxd), 4.79-5.17 (m, 3H, OCH2Ph + NH), 5.40-6.13 (m, 4H, 4 × CHN-CH2Ph), 6.98-7.33 (m, 28H, 
5 × Ph + 3 × NH), 7.47 (bs, 1H, NH). 13C NMR (CDCl3): δ 20.3, 20.6, 20.9, 28.3, 37.0, 37.8, 38.4, 53.1, 
53.7, 54.1, 61.7, 62.7, 68.3, 73.9, 74.5, 74.9, 79.9, 126.8, 126.9, 127.2, 127.4, 128.4, 128.5, 128.8, 
129.7, 134.5, 135.5, 136.0, 151.3, 151.8, 152.1, 155.2, 167.3, 168.0, 171.3. Anal. Calcd for 
C68H72N8O19: C, 62.57; H, 5.56; N, 8.58. Found: C, 62.55; H, 5.54; N, 8.61. 
 
Boc-(L-Phe-L-Oxd)4-OH 9.  
Compound 8 (0.30 mmol, 0.36 g) was dissolved in MeOH (30 mL) under nitrogen. C/Pd (35 mg, 
10% w/w) was added under nitrogen. A vacuum was created inside the flask using the vacuum 
line. The flask was then filled with hydrogen using a balloon (1 atm). The solution was stirred for 
16 h under a hydrogen atmosphere. The product was obtained pure in 98% yield (0.28 g) as a 
white solid, after filtration through filter paper and concentration in vacuo. M. p.: 76 °C. 1H NMR 
(CDCl3): δ 1.20-1.61 (m, 21H, 4 × Me + t-Bu), 2.52-2.68 (m, 1H, 1 × CHH-Ph), 2.72-3.02 (m, 3H, 1 × 
CHH-Ph, 2 × CHH-Ph), 4.46-4.83 (m, 6H, 3 × CHN-Oxd + 3 × CHO-Oxd), 5.44-5.94 (m, 4H, 4 × CHN-
CH2Ph), 7.12-7.56 (m, 20H, 4 × Ph). 
13C NMR (CD3OD): δ 19.2, 19.9, 35.8, 36.0, 36.6, 53.0, 54.8, 
61.8, 62.0, 75.1, 76.3, 79.3, 126.4, 127.9, 128.0, 129.0, 136.6, 137.2, 152.2, 152.6, 169.1, 171.4, 
171.6, 172.8. Anal. Calcd for C61H66N8O19: C, 60.29; H, 5.47; N, 9.22. Found: C, 60.32; H, 5.46; N, 
9.20. 
 
Boc-(L-Phe-L-Oxd)6-OBn 10. 
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A solution of 9 (0.13 g, 0.11 mmol) and HBTU (0.09 g, 0.11 mmol) in dry acetonitrile (20 mL) was 
stirred in a nitrogen atmosphere for 10 min at room temperature. Then a mixture of 7 (0.09 g, 
0.11 mmol) and TEA (0.33 mmol, 0.05 mL) in dry acetonitrile (15 mL) was added dropwise at room 
temperature. The solution was stirred for 50 min in a nitrogen atmosphere, and then acetonitrile 
was removed under reduced pressure and replaced with ethyl acetate. The mixture was washed 
with brine (1 × 30 mL), 1 N aqueous HCl (1 × 30 mL), and a concentrated solution of NaHCO3 (1 × 
30 mL), dried over sodium sulfate, and concentrated in vacuo. For the purification from 
tetramethylurea and the byproduct, the residue was suspended in cyclohexane and sonicated for 
15 min to dissolve the byproduct. Compound 9 was filtered, dried in vacuo, and obtained pure as a 
white solid in 68% (0.14 g) yield. M. p.: 92-93 °C.     
   : -30 (c 1.0, CHCl3). IR (CH2Cl2, 3 mM): ν 
3411, 3328, 1789, 1733, 1699 cm-1. IR (solid, 1% in KBr): ν 3330, 1790, 1747, 1701, 1650 cm-1. 1H 
NMR (CDCl3): δ 0.97-1.64 (m, 27H, 6 × Me + t-Bu), 2.69-3.42 (m, 12H, 8 × CH2-Ph), 4.11-4.75 (m, 
12H, 6 × CHN-Oxd + 6 × CHO-Oxd), 5.01-5.77 (m, 3H, OCH2Ph + NH), 5.39-6.11 (m, 6H, 6 × CHN-
CH2Ph), 6.67 (bs, 1H, NH), 6.93-7.45 (m, 39H, 7 × Ph + 4 × NH). 
13C NMR (CDCl3): δ 13.1, 19.3, 19.7, 
20.0, 27.7, 28.6, 35.7, 36.7, 37.3, 37.7, 51.9, 52.3, 52.6, 53.0, 60.7, 61.5, 61.6, 67.2, 72.8, 73.2, 
74.0, 78.9, 125.8, 126.3, 127.5, 127.6, 127.7, 128.4, 128.6, 133.6, 134.4, 134.5, 134.8, 150.2, 150.9, 
165.8, 166.3, 166.8, 170.2, 170.4, 170.6. Anal. Calcd for C96H100N12O27: C, 62.20; H, 5.44; N, 9.07. 
Found: C, 62.22; H, 5.46; N, 9.11. 
 
cyclo-(L-Val-L-Oxd-D-Ala-D-Oxd-L-Asp(OcHex)-L-Oxd-Gly-D-Oxd) 11. 
A solution of 21 (0.075 mmol, 79 mg) and TFA (1.35 mmol, 0.1 mL) in dry methylene chloride 
(10 mL) was stirred 4 h at room temperature, then the volatiles were removed under reduced 
pressure and the product was obtained pure in quantitative yield without any further purification. 
To a stirred solution of CF3CO2
- +NH3-L-Val-L-Oxd-D-Ala-D-Oxd-L-Asp(OcHex)-L-Oxd-Gly-D-Oxd-OH, 
(0.075 mmol, 80 mg) in dry acetonitrile (80 mL) under inert atmosphere were added HATU 
(0.082 mmol, 32 mg) and then TEA (0.225 mmol, 0.054 mL) at room temperature. The solution was 
stirred 45 min under inert atmosphere, then acetonitrile was removed under reduced pressure. 
The crude was washed with acetonitrile to remove all the by-products. 11 was obtained as a white 
solid in 62% yield after HPLC (H2O/acetonitrile 80:20 → 70:30 as eluant). M. p. = 187 °C;     
   = + 
21 (c 0.1,CH2Cl2); ); IR (CH2Cl2, 1 mM): ν = 3409, 2862, 1800, 1703, 1513, 1356 cm
-1; 1 H NMR 
(DMSO-d6): δ 0.96 (d, 3 H, J = 7.2 Hz Me Val), 1.09 (d, 3 H, J = 6.8 Hz Me Val), 1.38-1.73 (m, 18 H, 
4Me Oxd + 6 H cHex), 1.84 (bs, 2 H, CH2 cHex), 1.92 (bs, 2 H, CH2 cHex), 2.43 (bs, 1 H, CH(CH3)2), 
3.07 (m, 2 H, CH2 Asp), 4.27-4.87 (m, 10 H, 4CHN Oxd + 4CHO Oxd + CH2α Gly), 5.59 (m, 1 H, CHα 
Ala), 5.84 (m, 1 H, CHα Val), 5.85 (m, 1 H, CHα Asp), 8.95 (bs, 1 H, NH Val), 9.09 (bs, 1 H, NH Ala), 
9.21 (bs, 1 H, NH Asp), 9.30 (bs, 1 H, NH Gly); 13 C NMR (DMSO-d6): δ 17.6, 17.8, 18.4, 20.0, 20.5, 
23.8, 25.7, 29.0, 30.5, 31.6, 31.8, 36.6, 48.1, 49.5, 49.7, 62.5, 73.4, 75.4, 75.7, 79.1. Anal. Calcd. for 
C40H52N8O18: C, 51.50; H, 5.62; N, 12.01. Found: C, 51.47; H, 5.63; N, 12.00. 
 
Boc-L-Val-L-Oxd-OBn 12. 
Yield = 90%; waxy solid;     
   = -16.0 (c 0.1,CH2Cl2); IR (CH2Cl2, 3 mM): ν = 3442, 1793, 1753, 
1708 cm-1; 1 H NMR (CDCl3): δ 0.80 (d, 3 H, J = 7 Hz, Me Val), 1.08 (d, 3 H, J = 7 Hz, Me Val), 1.41 (s, 
9 H, tBu), 1.57 (d, 3 H, J = 5.4 Hz, Me Oxd), 2.25 (bs, 1 H, CH(CH3)2), 4.58 (m, 2 H, CHN + CHO Oxd), 
5.07 (d, 1 H, J = 8.6 Hz, NH), 5.21 (m, 2 H, OCH2Ph), 5.46 (dd, 1 H, J = 3.4, 9.6 Hz, CHα Val), 7.25-7.48 
(m, 5 H, Ph); 13 C NMR (CDCl3): δ 15.9, 20.0, 21.3, 28.6, 30.8, 57.4, 62.0, 68.3, 73.8, 80.1, 128.7, 
129.1, 134.8, 151.5, 156.1, 167.9. Anal. Calcd. for C22H30N2O7: C, 60.82; H, 6.96; N, 6.45. Found: C, 
60.80; H, 6.99; N, 6.43. 
 
Boc-D-Ala-D-Oxd-OBn 13. 
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Yield = 81%; waxy solid;     
   = +44.1 (c 1.0, CH2Cl2); IR (CH2Cl2, 3 mM): ν = 3439, 1794, 1755, 
1718 cm-1; 1 H NMR (CDCl3): δ 1.31 (d, 3 H, J = 7.6 Hz), 1.42 (s, 9 H, tBu), 1.51 (d, 3 H, J = 6.4 Hz, Me 
Oxd), 4.50-4.58 (m, 2 H, CHN + CHO Oxd), 5.14 (bs, 1 H), 5.17 (AB, 2 H, J = 12.0 Hz), 5.35 (dq, 1 H, 
J = 7.6 Hz, CHα Ala), 7.25-7.40 (m, 5 H, Ph); 
13 C NMR (CDCl3): δ 17.8, 20.9, 28.1, 48.8, 61.4, 67.9, 
73.5, 79.7, 128.2, 128.4, 128.7, 134.3, 151.1, 154.9, 167.4, 173.9. Anal. Calcd. for C20H26N2O7: C, 
59.10; H, 6.45; N, 6.89. Found: C, 59.08; H, 6.47; N, 6.93. 
 
Boc-L-Asp(OcHex)-L-Oxd-OBn 14. 
Yield = 70%; M. p. = 110 °C;     
   = -20.9 (c 1.0, CH2Cl2); IR (CH2Cl2, 3 mM): ν = 3408, 2959, 1794, 
1707, 1364 cm-1; 1 H NMR (CDCl3): δ 1.48-1.67 (m, 15 H, 9 H tBu + 6 H cHex), 1.72 (d, 3 H, J = 4.7 Hz, 
Me Oxd), 1.89 (bs, 2 H, CH2 cHex), 1.99 (bs, 2 H, CH2 cHex), 2.85 (m, 1 H CHH Asp), 3.11 (m, 1 H, 
CHH Asp), 4.74 (m, 2 H CHN + CHO Oxd), 4.98 (bs, 1 H, NH), 5.37 (m, 2 H, OCH2Ph), 5.76 (m, 1 H, 
CHα Αsp), 7.49-7.58 (m, 5 H, Ph); 
13 C NMR (CDCl3,): δ 21.5, 24.0, 25.8, 28.7, 31.77, 36.7, 50.8, 62.0, 
68.5, 73.9, 74.3, 128.8, 129.3, 135.0, 151.8, 167.9, 171.9. Anal. Calcd. for C27H36N2O9: C, 60.89; H, 
6.81; N, 5.26. Found: C, 60.93; H, 6.78; N, 5.29. 
 
Boc-Gly-D-Oxd-OBn 15. 
Yield = 78%; waxy solid;     
   = +37.0 (c 0.1, CH2Cl2); IR (CH2Cl2, 3 mM): ν = 3442, 1795, 1757, 1712, 
1605, 1511 cm-1; 1 H NMR (CDCl3): δ 1.47 (s, 9 H, tBu), 1.57 (d, 3 H, J = 6.6 Hz, Me Oxd), 4.42 (dd, 
1 H, J = 4.5, 19.5 Hz, CHα Gly), 4.55 (d, 1 H, J = 4.2 Hz CHN Oxd), 4.62 (dq, 1 H, J = 6.3, 10.8 Hz, CHO 
Oxd), 4.74 (dd, 1 H, J = 6.6, 19.5 Hz, CHα Gly), 5.10 (bs, 1 H, NH), 5.26 (m, 2 H, OCH2Ph), 7.34-7.46 
(m, 5 H, Ph); 13 C NMR (CDCl3): δ 21.1, 26.8, 28.2, 30.8, 44.7, 61.4, 68.0, 74.1, 128.3, 128.7, 134.5, 
151.7, 167.5, 170.0. Anal. Calcd. for C19H24N2O7: C, 58.16; H, 6.16; N, 7.14. Found: C, 58.13; H, 6.20; 
N, 7.11. 
 
Boc-L-Val-L-Oxd-D-Ala-D-Oxd-OBn 16. 
To a stirred solution of Boc-L-Ala-L-Oxd-OH (0.60 mmol, 200 mg) and HBTU (0.60 mmol, 228 mg) in 
dry acetonitrile (10 mL) under inert atmosphere was added a mixture of CF3COO
- +H3N-D-Ala-D-
Oxd-OBn (0.60 mmol, 250 mg) and TEA (1.8 mmol, 0.25 mL) in dry acetonitrile (5 mL) at room 
temperature. The solution was stirred 45 min under inert atmosphere, then acetonitrile was 
removed under reduced pressure and replaced with ethyl acetate (30 mL). The mixture was 
washed with brine (30 mL), 1 M HCl (20 mL) and NaHCO3 5% (20 mL) and then dried over Na2SO4, 
then ethyl acetate was eliminated under reduced pressure. The product was obtained pure after 
flash chromatography (eluant: cyclohexane/ethyl acetate 8:2) in 80% yield. M. p. = 175 °C; 
    
   = + 41.5 (c 0.1, CH2Cl2); IR (CH2Cl2, 3 mM): ν = 3420, 1791, 1702, 1503, 1362 cm
-1; 1 H NMR 
(CDCl3): δ 0.80 (d, 3 H, J = 7 Hz, Me Val), 1.08 (d, 3 H, J = 7 Hz, Me Val), 1.41 (m, 12 H, 9 H, tBu + 3 H 
Me Ala), 1.57 (m, 6 H, 2 Me Oxd), 2.25 (bs, 1 H, CH(CH3)2), 4.41 (d, 1 H, J = 4.8 Hz, CHN Oxd), 4.5-
4.7 (m, 2 H, CHN Oxd + CHO Oxd), 4.83 (m, 1 H, CHO Oxd), 5.07 (bs, 1 H, NH Val), 5.21 (m, 2 H, 
OCH2Ph), 5.40 (m, 1 H, CHα Val), 5.60 (m, 1 H, CHα Ala), 6.80 (bs, 1 H, NH Ala), 7.25-7.48 (m, 5 H, 
Ph); 13 C NMR (CDCl3): δ 14.5, 16.3, 18.1, 20.1, 20.9, 21.5, 28.6, 30.9, 48.7, 60.7, 61.7, 63.0, 68.5, 
74.2, 80.1, 128.8, 129.1, 129.2. 134.6, 151.4, 166.9, 167.7, 172.7, 174.3. Anal. Calcd. for 
C30H40N4O11: C, 56.95; H, 6.37; N, 8.86. Found: C, 56.92; H, 6.36; N, 8.86. 
 
Boc-L-Val-L-Oxd-D-Ala-D-Oxd-OH 17. 
To a stirred solution of Boc-L-Val-L-Oxd-D-Ala-D-Oxd-OBn 16 (0.3 mmol, 190 mg) in ethyl acetate 
(5 mL) 10% palladium on charcoal (3 mg) was added. The mixture was stirred under hydrogen 
atmosphere for 2 h. Then the catalyst was filtered on a celite pad and the mixture was 
concentrated. The product 17 was obtained pure in 87% yield without any further purification. M. 
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p. = 180 °C;     
   = + 29.0 (c 0.1,CH2Cl2); IR (nujol): ν = 3397, 1792, 1691, 1462, 1372 cm
-1; 1 H NMR 
(CD3OD): δ 0.85 (d, 3 H, J = 7 Hz, Me Val), 1.04 (d, 3 H, J = 6.8 Hz, Me Val), 1.45-1.58 (m, 18 H, 9 H, 
tBu + 6 H 2Me Oxd + 3 H Me Ala), 2.18 (bs, 1 H, CH(CH3)2), 4.43 (d, 1 H, J = 4 Hz, CHN Oxd), 4.58-
4.74 (m, 3 H, 2 CHO Oxd + CHN Oxd), 5.35 (m, 1 H, CHα Val), 5.54 (m, 1 H, CHα Ala), 6.71 (d, 1 H, 
J = 8.8 Hz, NH Val), 8.91 (d, 1 H, J = 7.4 Hz, NH Ala); 13 C NMR (CDCl3): δ 15.7, 16.3, 18.8, 19.6, 20.2, 
27.6, 30.3, 57.5, 62,8, 75.0, 75.3, 79.5, 152.8, 169.0, 172.5, 173.2. Anal. Calcd. for C23H34N4O11: C, 
50.92; H, 6.32; N, 10.33. Found: C, 50.89; H, 6.34; N, 10.32. 
 
Boc-L-Val-L-Oxd-D-Ala-D-Oxd-L-Asp(OcHex)-L-Oxd-OBn 18. 
To a stirred solution of Boc-L-Val-L-Oxd-D-Ala-D-Oxd-OH (0.096 mmol, 52 mg) and HATU 
(0.096 mmol, 36 mg) in dry acetonitrile (10 mL) under inert atmosphere was added a mixture of 
CF3COO
- +H3N-L-Asp(OcHex)-L-Oxd-OBn (0.096 mmol, 52 mg) and TEA (1.8 mmol, 0.25 mL) in dry 
acetonitrile (5 mL) at room temperature. The solution was stirred 45 min under inert atmosphere, 
then acetonitrile was removed under reduced pressure and replaced with ethyl acetate (30 mL). 
The mixture was washed with brine (30 mL), 1 M HCl (20 mL) and NaHCO3 5% (20 mL) and then 
dried over Na2SO4, then ethyl acetate was eliminated under reduced pressure. Yield = 65%; M. p. = 
150 °C;     
   = + 6 (c 0.1, CH2Cl2); IR (CH2Cl2, 3 mM): ν = 3409, 2859, 1794, 1708, 1512, 1363 cm
-1; 
1 H NMR (CDCl3): δ 0.81 (d, 3 H, J = 6.8 Hz, Me Val), 1.06 (d, 3 H, J = 6.8 Hz, Me Val), 1.42-1.64 (m, 
27 H, 9 H, tBu + 9 H 3Me Oxd + 3 H Me Ala + 6 H cHex), 1.72 (bs, 2 H, CH2 cHex), 1.81 (bs, 2 H, CH2 
cHex), 2.30 (bs, 1 H, CH(CH3)2), 2.76 (dd, 1 H, J = 6.8, 16.4 Hz, CHH Asp), 2.88 (m, 1 H, OCH cHex), 
2.96 (dd, 1 H, J = 4.8, 16.8 Hz, CHH Asp), 4.38 (m, 2 H, 2 CHN Oxd), 4.57 (m, 2 H, CHN Oxd + CHO 
Oxd), 4.78 (m, 2 H, CHO Oxd), 5.07 (bs, 1 H, NH Val), 5.20 (m, 2 H, CH2Ph), 5.39 (bs, 1 H, CHα Val), 
5.58 (m, 1 H, CHα Ala), 5.78 (m, 1 H, CHα Asp), 6.77 (bs, 1 H, NH Ala), 7.22 (bs, 1 H, NH Asp); 
13 C 
NMR (CDCl3): δ 16.2, 20.1, 21.0, 21.4, 24.0, 25.5, 28.6, 31.2, 31.7, 35.8, 48.8, 49.7, 61.7, 62.8, 68.5, 
74.4, 128.7, 128.8, 129.2, 134.7, 151.7, 156.2, 166.9, 167.5, 169.6. Anal. Calcd. for C45H60N6O17: C, 
56.48; H, 6.32; N, 8.78. Found: C, 56.49; H, 6.36; N, 8.82. 
 
Boc-L-Val-L-Oxd-D-Ala-D-Oxd-L-Asp(OcHex)-L-Oxd-OH 19. 
For the synthetic details, see above the preparation of 17, starting from 18. Yield 86%; M. p. = 
184 °C;     
   = + 21.0 (c 0.1,CH2Cl2); IR (nujol): ν = 3394, 2364, 1790, 1693, 1461, 1374 cm
-1; 1 H 
NMR (CD3OD): δ 0.86 (d, 3 H, J = 6.9 Hz Me Val), 1.06 (d, 3 H, J = 6.9 Hz, Me Val), 1.37-1.59 (m, 
27 H, 9 H, tBu + 9 H 3Me Oxd + 3 H Me Ala + 6 H cHex), 1.78 (bs, 2 H, CH2 cHex), 1.87 (bs, 2 H, CH2 
cHex), 2.28 (bs, 1 H, CH(CH3)2), 2.63 (m, 1 H, CHH Asp), 3.10 (dd, 1 H, J = 3.6, 16.8 Hz, CHH Asp), 
4.48-4.65 (m, 4 H, 3CHN Oxd + CHO Oxd), 4.73-4.82 (m, 2 H, 2CHO Oxd), 5.35 (m, 1 H, CHα Val), 
5.51 (m, 1 H, CHα Ala), 5.90 (m, 1 H, CHα Asp), 6.72 (d, 1 H, J = 9 Hz, NH Val), 8.92 (d, 1 H, J = 6.6 Hz, 
NH Ala), 9.10 (d, 1 H, J = 8.1 Hz, NH Asp); 13 C NMR (CD3OD): δ 15.7, 16.2, 18.9, 19.5, 20.1, 23.5, 
25.3, 27.5, 30.3, 31.4, 35.7, 62.5, 62.7, 73.6, 75.2, 78.2, 78.6, 79.5, 152.6, 155.4, 169.0, 169.5, 
170.3, 173.1. Anal. Calcd. for C38H54N6O17: C, 52.65; H, 6.28; N, 9.69. Found: C, 52.63; H, 6.31; N, 
9.69. 
 
Boc-L-Val-L-Oxd-D-Ala-D-Oxd-L-Asp(OcHex)-L-Oxd-Gly-D-Oxd-OBn 20. 
For the synthetic details, see above the preparation of 18, starting from 15 and 19. Yield = 40%; M. 
p. = 184 °C;     
   = + 34.0 (c 0.1,CH2Cl2); IR (CH2Cl2, 3 mM): ν = 3410, 2937, 1795, 1701, 1507, 
1394 cm-1; 1 H NMR (DMSO-d6): δ 0.76 (d, 3 H, J = 6.4 Hz, Me Val); 0.90 (d, 3 H, J = 6.4 Hz, Me Val), 
1.26 (d, 3 H, J = 6.8 Hz, Me Ala), 1.35 (m, 21 H, 9 H tBu + 6 H 2Me Oxd + 6 H cHex), 1.42 (d, 3 H, 
J = 6 Hz, Me Oxd), 1.47 (d, 3 H, J = 6 Hz, Me Oxd), 1.63 (bs, 2 H, CH2 cHex), 1.73 (bs, 2 H, CH2 cHex), 
2.11 (m, 1 H, CH(CH3)2), 2.45 (m, 1 H, CHH Asp), 2.88 (m, 1 H, CHH Asp), 4.38-4.70 (m, 9 H, 4CHN 
Oxd + 3CHO Oxd + CH2α Gly), 4.83 (m, 1 H, CHO Oxd), 5.13-5.24 (m, 3 H, OCH2Ph + CHα Val),5.40 
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(m,1 H, CHα Ala), 5.70 (m, 1 H, CHα Asp), 6.86 (d, 1 H, J = 7.6 Hz, NH Val), 8.80 (m, 1 H, NH Gly), 8.89 
(d, 1 H, J = 8 Hz, NH Ala), 9.09 (d, 1 H, J = 7.6 Hz, NH Asp); 13 C NMR (DMSO-d6): δ = 15.9, 17.7, 19.9, 
20.9, 21.1, 23.7, 25.6, 28.9, 30.3, 31.6, 61.6, 62.4, 65.6, 67.9, 73.2, 74.8, 78.9, 79.7, 80.1, 128.7, 
129.0, 129.2, 135.9, 152.9, 156.4, 168.0, 168.6, 169.2, 172.7, 173.4. Anal. Calcd. for C52H68N8O21: C, 
54.73; H, 6.01; N, 9.82. Found: C, 54.72; H, 6.03; N, 9.80. 
 
Boc-L-Val-L-Oxd-D-Ala-D-Oxd-L-Asp(OcHex)-L-Oxd-Gly-D-Oxd-OH 21. 
For the synthetic details, see above the preparation of 17, starting from 20. M. p. = 190 °C; 
    
   = + 27.0 (c 0.1,CH2Cl2); IR (nujol): ν = 3371, 1793, 1691, 1540, 1458, 1377 cm
-1; 1 H NMR 
(CD3OD): δ 0.86 (d, 3 H, J = 6.9 Hz Me Val), 1.06 (d, 3 H, J = 6.9 Hz, Me Val), 1.32-1.61 (m, 27 H, 9 H 
tBu + 12 H 4Me Oxd + 6 H cHex), 1.78 (bs, 2 H, CH2 cHex), 1.85 (bs, 2 H, CH2 cHex), 2.23 (bs, 1 H, 
CH(CH3)2), 2.64 (m, 1 H, CHH Asp), 3.07 (m, 1 H, CHH Asp), 4.50-5.0 (m, 10 H, 4CHN Oxd + 4CHO 
Oxd + CH2α Gly), 5.36 (m, 1 H, CHα Val), 5.50 (m, 1 H, CHα Ala), 5.85 (m, 1 H, CHα Asp), 8.90 (d, 1 H, 
J = 5.7 Hz, NH Ala), 9.09 (d, 1 H, J = 6.9 Hz, NH Asp); 13 C NMR (CD3OD): δ 15.7, 16.2, 18.8, 19.5, 
19.6, 20.1, 23.4, 25.3, 27.5, 31.3, 35.7, 43.3, 49.6, 57.5, 61.9, 62.5, 62.7, 73.7, 75.0, 75.2, 75.6, 
79.5, 152.5, 153.0, 168.8, 169.7, 170.3, 173.1. Anal. Calcd. for C45H62N8O21: C, 51.42; H, 5.95; N, 
10.66. Found: C, 51.38; H, 5.92; N, 10.69. 
 
Boc-L-Phe-D-Imz-OBn 23. 
DBU (0.127 mL, 0.85 mmol) was added to a stirred solution of Boc-L-Phe-D-Asn-OBn (0.2 g, 0.43 
mmol) in THF (20 mL). The mixture was stirred for 10 min. Then, PhI(OAc)2 (274 mg, 0.85 mmol) 
was added and the mixture was stirred at room temperature for 45 min. After this time, a few 
drops (<1 mL) of H2O were added, and the mixture was stirred for another 15 min. The reaction 
mixture was gently concentrated. The resulting yellow liquid was dissolved in ethyl acetate and 
washed with H2O, dried over Na2SO4, filtered, concentrated, and dried under a vacuum. The crude 
was purified by flash chromatography (cyclohexane/ethyl acetate 1:1 as eluant) and 1 was 
obtained pure in 65% yield. M. p. = 68 °C;     
   = +0.081 (c 1.0, CH2Cl2); IR (CH2Cl2, 10 mM): ν 
3444, 1759, 1716, 1689 cm-1; IR (1% in dry KBr): ν 3391, 1761, 1687 cm-1; 1H NMR (CDCl3, 300 
MHz): δ 1.42 (s, 9H, t-Bu), 2.95 (dd, 1H, J = 7.5, 13.8 Hz, CHN-CHH-Ph), 3.2 (dd, 1H, J = 4.8, 13.5 Hz, 
CHN-CHH-Ph), 3.4 (dd, 1H, J = 3.0, 9.3 Hz, NCHH), 3.7 (t, 1H, J = 9.9 Hz, NCH), 4.8 (m, 1H, NCHH), 
5.2-5.4 (m, 3H, OCH2Ph + Boc-NH), 5.85 (bs, 1H, NH), 5.95 (m, 1H, CHN-CHH-Ph), 7.2-7.4 (m, 10H, 
2 × Ph); 13C NMR (CDCl3, 75 MHz): δ 28.5, 39.9, 40.6, 54.1, 55.4, 68.0, 127.0, 128.6, 129.0, 129.9, 
135.2, 136.6, 154.7, 155.0, 169.1, 172.7. 
 
Boc-L-Phe-D-Oxd-(S)-β3-hPhg-OBn 24. 
A solution of Boc-L-Phe-D-Oxd-OH (0.27 mmol, 0.10 g) and HBTU (0.3 mmol, 0.12 g) in dry 
acetonitrile (25 mL) was stirred under inert atmosphere for 10 min at room temperature. Then a 
mixture of H-(S)-β3-hPhg-OBn·TFA (0.27 mmol, 0.10 g) and TEA (0.81 mmol, 0.12 mL) in dry 
acetonitrile (10 mL) was added at room temperature. The solution was stirred for 40 min under 
inert atmosphere, and then acetonitrile was removed under reduced pressure and replaced with 
ethyl acetate. The mixture was washed with brine, 1 N aqueous HCl (3 × 30 mL), and 5% aqueous 
NaHCO3 (1 × 30 mL), dried over sodium sulfate, and concentrated in vacuo. The product was 
obtained pure after silica gel chromatography (cyclohexane/ethyl acetate 8:2 as eluant) in 80% 
yield. M. p. = 168 °C;  α  
   = +14.0 (c 1.0 in CH2Cl2); IR (CH2Cl2, 10 mM): ν 3437 (N-H), 3366 (N-H), 
1789 (C=O), 1716 (C=O), 1696 (C=O) cm-1; IR (1% in dry KBr): ν 3358 (N-H), 3318 (N-H), 1785 (C=O), 
1763 (C=O), 1735 (C=O), 1719 (C=O), 1701 (C=O), 1687 (C=O) cm-1; 1H NMR (CDCl3, 400 MHz; 25 
°C): δ = 1.32 (d, 3H, 3J(H,H) = 7.2 Hz, Me-Oxd), 1.33 (s, 9H, t-Bu), 2.84-2.92 (m, 2H, CHH-Phe + 
CHH-hPhg), 2.97 (dd, 1H, 3J(H,H) = 7.2, 15.6 Hz, CHH-Phe), 3.12 (dd, 1H, 3J(H,H) = 6.0, 13.6 Hz, 
119 
 
CHH-hPhg), 4.32 (d, 1H, 3J(H,H) = 2.8 Hz, CHN-Oxd), 4.66 (dq, 1H, 3J(H,H) = 2.8, 7.2 Hz, CHO-Oxd), 
5.03 (bs, 1H, NH-Boc), 5.05 (AB, 2H, 2J(H,H) = 12.0 Hz, OCH2Ph), 5.46 (dt, 1H, 3J(H,H) = 7.2, 7.2 Hz, 
CHN-Phe), 5.64-5.67 (m, 1H, CHN-hPhg), 7.21-7.38 ppm (m, 16H, NH-hPhg + 3 x Ph); 13C NMR 
(CDCl3, 100 MHz, 25 °C): δ = 21.1, 28.5, 40.7, 50.6, 54.1, 62.9, 66.8, 80.8, 126.8, 127.6, 128.0, 
128.4, 128.5, 128.7, 129.0, 129.6, 151.83, 166.69 ppm; elemental analysis calcd. (%) for 
C35H39N3O8: C, 66.76; H, 6.24; N, 6.67; found: C 66.71, H 6.25, N 6.66. 
 
Boc-L-Phe-D-Oxd-(R)-β3-hPhg-OBn 25. 
A solution of Boc-L-Phe-D-Oxd-OH 22 (0.27 mmol, 0.10 g) and HBTU (0.3 mmol, 0.12 g) in dry 
acetonitrile (25 mL) was stirred under inert atmosphere for 10 min at room temperature. Then a 
mixture of H-(R)-β3-hPhg-OBn·TFA (0.27 mmol, 0.10 g) and TEA (0.81 mmol, 0.12 mL) in dry 
acetonitrile (10 mL) was added at room temperature. The solution was stirred for 40 min under 
inert atmosphere, and then acetonitrile was removed under reduced pressure and replaced with 
ethyl acetate. The mixture was washed with brine, 1 N aqueous HCl (3 × 30 mL), and 5% aqueous 
NaHCO3 (1 × 30 mL), dried over sodium sulfate, and concentrated in vacuo. The product was 
obtained pure after silica gel chromatography (cyclohexane/ethyl acetate 8:2 as eluant) in 81% 
yield. M. p. = 160 °C;     
   = +35.9 (c 1.0, CH2Cl2); IR (CH2Cl2, 10 mM): ν 3436 (N-H), 3350 (N-H), 
1788 (C=O), 1716 (C=O), 1693 (C=O), 1679 (C=O) cm-1; IR (1% in dry KBr): ν 3381 (N-H), 3323 (N-H), 
1764 (C=O), 1742 (C=O), 1719 (C=O), 1701 (C=O), 1691 (C=O), 1684 (C=O) cm-1; 1H NMR (CDCl3, 
400 MHz): δ = 1.23 (s, 9H, t-Bu), 1.31 (d, 3H, 3J(H,H) = 6.8 Hz, Me-Oxd), 2.85-2.92 (m, 2H, CHH-Phe 
+ CHH-hPhg), 2.99 (dd, 1H, 3J(H,H) = 8.4, 15.6 Hz, CHH-Phe), 3.15 (dd, 1H, 3J(H,H) = 6.0, 13.6 Hz, 
CHH-hPhg), 4.32 (d, 1H, 3J(H,H) = 4.0 Hz, CHN-Oxd), 4.672 (dq, 1H, 3J(H,H) = 4.0, 6.8 Hz, CHO-Oxd), 
5.00 (d, 1H, 3J(H,H) = 4 Hz, NH-Boc), 5.07 (s, 2H, OCH2Ph), 5.46 (dt, 1H, 3J(H,H) = 6.0, 8.4 Hz, CHN-
Phe), 5.67-5.5.75 (m, 1H, CHN-hPhg), 7.20-7.36 (m, 15H, 3 x Ph), 7.54 ppm (d, 1H, 3J(H,H) = 7.6 Hz, 
NH-hPhg); 13C NMR (CDCl3, 100 MHz): δ = 21.1, 28.4, 29.9, 31.1, 37.6, 40.7, 50.9, 53.9, 62.7, 66.8, 
75.3, 81.0, 126.4, 127.6, 127.7, 128.4, 128.5, 128.7, 128.8, 129.1, 129.6, 135.4, 135.7, 135.8, 140.5, 
151.9, 167.1, 170.5, 173.6 ppm; elemental analysis calcd. (%) for C35H39N3O8: C, 66.76; H, 6.24; N, 
6.67; found: C 66.75, H 6.25, N 6.65. 
 
Boc-L-Phe-L-Phe-D-Oxd-OBn 26. 
A solution of Boc-L-Phe-D-Oxd-OBn 22 (2 mmol, 0.96 g) and TFA (36 mmol, 2.78 mL) in dry 
dichloromethane (20 mL) was stirred at room temperature for 4 h, then the volatile compounds 
were removed under reduced pressure and the corresponding amine salt was obtained in 
quantitative yield without the need for further purification. 
A solution of Boc-L-Phe-OH (1.38 g, 0.52 mmol) and HBTU (0.4 g, 1.04 mmol) in dry acetonitrile (22 
mL) was stirred under a nitrogen atmosphere for 10 min at room temperature. Then, a mixture of 
the previously obtained amine salt (1.04 mmol) and TEA (3.2 mmol, 0.47 mL) in dry acetonitrile (15 
mL) was added dropwise at room temperature. The solution was stirred for 40 min under a 
nitrogen atmosphere, then acetonitrile was removed under reduced pressure and replaced with 
ethyl acetate. The mixture was washed with brine, 1 n aqueous HCl (3 × 30 mL), and with 5 %(w/v) 
aqueous NaHCO3 (1 × 30 mL), dried with sodium sulfate and concentrated in vacuo. The pure 
product was obtained after silica gel chromatography [CH2Cl2 100 % → CH2Cl2/ethyl acetate 
(80:20) as eluent] in 78 % (0.98 g) overall yield; m. p. 68 °C.     
   = +34 (c 1.0, CH2Cl2). IR (CH2Cl2, 3 
mM): ν 3415, 1798, 1753, 1713, 1688 cm-1. IR (1 % in dry KBr): ν 3327, 3307, 1794, 1746, 1714, 
1686, 1658 cm-1. 1H NMR (CDCl3, 400 MHz): δ = 1.52-1.56 (m, 12 H, Me + tBu), 2.87-3.05 (m, 4 H, 
2 × CHN-CH2-Ph), 3.11 (dd, J = 5.2, 12.4 Hz, 1 H, CHN-CH2-Ph), 4.20-4.35 (m, 2 H, CHN-Oxd + CHN-
CH2-Ph), 4.45-4.52 (m, 1 H, CHO-Oxd), 4.95 (br. s, 1 H, NH-Boc), 5.2, 2 H, J = 111 (AB system, 6 Hz, 
CH2OBn), 5.80-6.03 (m, 1 H, NH-Boc), 6.42 (br. s, 1 H, NH-Phe), 7.05-7.36 (m, 15 H, 3 × Phe) ppm. 
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13C NMR (CDCl3, 100 MHz): δ = 20.4, 21.3, 28.5, 38.5, 38.6, 53.1, 55.8, 60.7, 62.0, 68.3, 70.7, 73.9, 
126.7, 127.5, 128.6, 128.8, 128.9, 129.0, 129.6, 135.6, 167.5, 170.4, 170.6 ppm. C35H39N3O8 
(629.3): calcd. C 67.76, H 6.24, N 6.67; found C 67.79, H 6.21, N 6.68. 
 
Boc-L-Phe-L-Phe-D-Pro-OBn 27. 
For the synthesis, see Ref [82] 
 
Boc-L-Phe-L-Phe-D-Pro-OBn 28. 
A solution of Boc-L-Phe-D-Pro-OBn 27 (2 mmol, 0.96 g) and TFA (36 mmol, 2.78 mL) in dry 
dichloromethane (20 mL) was stirred at room temperature for 4 h, then the volatile compounds 
were removed under reduced pressure and the corresponding amine salt was obtained in 
quantitative yield without the need for further purification. 
A solution of Boc-L-Phe-OH (1.38 g, 0.52 mmol) and HBTU (0.4 g, 1.04 mmol) in dry acetonitrile (22 
mL) was stirred under a nitrogen atmosphere for 10 min at room temperature. Then, a mixture of 
the previously obtained amine salt (1.04 mmol) and TEA (3.2 mmol, 0.47 mL) in dry acetonitrile (15 
mL) was added dropwise at room temperature. The solution was stirred for 40 min under a 
nitrogen atmosphere, then acetonitrile was removed under reduced pressure and replaced with 
ethyl acetate. The mixture was washed with brine, 1 N aqueous HCl (3 × 30 mL), and with 5 %(w/v) 
aqueous NaHCO3 (1 × 30 mL), dried with sodium sulfate and concentrated in vacuo. The pure 
product was obtained after silica gel chromatography [CH2Cl2 100 % → CH2Cl2/ethyl acetate 
(80:20) as eluent] in yield 79 %; m. p. 55 °C.     
   = +35 (c 1.0, CHCl3). IR (CH2Cl2, 3 mM): ν 3418, 
1742, 1711, 1673, 1645 cm-1. IR (1 % in dry KBr): ν 3419, 3285, 1747, 1712, 1633 cm-1. 1H NMR 
(CDCl3, 400 MHz): δ = 1.41 (s, 9 H, tBu), 1.77-1.95 (m, 4 H, NCH2CH2CH2CH-CO), 2.80-3.18 (m, 6 H, 
NCH2CH2CH2CH-CO + 2 × CH-CH2-Ph), 4.31-4.43 (m, 2 H, 2 × CH-CH2-Ph), 4.83-5.00 (m, 2 H, 
NCH2CH2CH2CH-CO + NH), 6.72 and 6.96 (d, J = 8 Hz, 1 H, NH, mixture of conformers), 7.18-7.38 
(m, 15 H, 3 × Ph) ppm. 13C NMR (CDCl3, 100 MHz, mixture of conformers): δ = 22.4 and 24.3 , 26.9 
and 28.3, 28.9 and 31.0, 37.5 and 38.3, 39.7, 46.6 and 46.8, 51.9 and 52.4, 55.4, 58.8 and 59.5, 
66.7 and 67.3, 79.9, 126.7, 126.8, 127.0, 128.1, 128.2, 128.4, 128.5, 128.7, 129.2, 129.5, 135.2 and 
135.6, 136.2 and 136.6, 155.2, 169.5, 170.5, 171.4, 172.0 ppm. C35H41N3O6 (599.3): calcd. C 70.10, 
H 6.89, N 7.01; found C 70.05, H 6.85, N 6.99. 
 
CH2(C3H6CO-L-Phe-D-Oxd-OBn)2 29.  
A solution of Boc-L-Phe-D-Oxd-OBn (2 mmol, 0.96 g) and TFA (36 mmol, 2.78 mL) in dry 
dichloromethane (20 mL) was stirred at room temperature for 4 h, then the volatile compounds 
were removed under reduced pressure and the corresponding amine salt was obtained pure in 
quantitative yield without further purification. 
A solution of azelaic acid (0.98 g, 0.52 mmol) and HBTU (0.4 g, 1.04 mmol) in dry acetonitrile (22 
mL) was stirred under nitrogen atmosphere for 10 min at room temperature. Then, a mixture of 
the previously obtained amine salt (1.04 mmol) and TEA (3.2 mmol, 0.47 mL) in dry acetonitrile (15 
mL) was added dropwise at room temperature. The solution was stirred for 40 min under a 
nitrogen atmosphere then acetonitrile was removed under reduced pressure and replaced with 
ethyl acetate. The mixture was washed with brine, 1 N aqueous HCl (3 × 30 mL), and 5 % (w/v) 
aqueous NaHCO3 (1 × 30 mL), dried with sodium sulfate and concentrated in vacuo. The pure 
product was obtained after silica gel chromatography [CH2Cl2 100 % → CH2Cl2/ethyl acetate 
(80:20) as eluent] in 64 % (1.17 g) overall yield; m. p. 207 °C.     
   = 45.0 (c 0.1, CHCl3). IR (CH2Cl2, 
                                               
82 Becerril, J.; Burguete, M. I.; Escuder, B.; Galindo, F.; Gavara, R.; Miravet, J. F.; Luis, S. V.; Peris, G. “Self-assembly of 
small peptidomimetic cyclophanes” Chem. Eur. J. 2004, 10, 3879-3890. 
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3 mM): ν 3428, 1789, 1754, 1707, 1672 cm-1. IR (1 % in dry KBr): ν 3309, 1793, 1765, 1736, 1708, 
1650 cm-1. 1H NMR (DMSO-d6, 300 MHz): δ = 0.95-1.18 [m, 10 H, CH2(CH2)5CH2], 1.20-1.40 [m, 4 H, 
CH2(CH2)5CH2], 1.50 (d, J = 6.3 Hz, 6 H, OCHCH3), 2.00 (m, 4 H, CH2CO), 2.70 (dd, J = 10.8, 13.5 Hz, 2 
H, CHN-CHH-Ph), 3.10-3.20 (dd, J = 3.3, 13.5 Hz, 2 H, CHN-CHH-Ph), 4.65 (d, J = 4.2 Hz, 2 H, CHN), 
4.80-4.90 (m, 2 H, OCH), 5.18 (d, J = 12.3 Hz, 2 H, OCHHPh), 5.25 (d, J = 12.6 Hz, 2 H, OCHHPh), 5.8 
(m, 2 H, CHN-CH2Ph), 7.20-7.40 (m, 20 H, 4 × Ph), 8.25 (d, J = 8.7 Hz, 2 H, NH) ppm. 
13C NMR 
(DMSO-d6, 75 MHz): δ = 14.8, 15.3, 21.1, 25.9, 29.0, 35.7, 37.7, 38.5, 51.0, 53.1, 55.4, 62.0, 67.7, 
74.3, 127.2, 128.6, 128.8, 128.9, 129.2, 129.8, 136.0, 138.0, 152.5, 168.6, 172.7, 173.2 ppm. 
C51H56N4O12 (916.4): calcd. C 66.80, H 6.16, N 6.11; found C 66.75, H 6.19, N 6.07. 
 
CH2(C3H6CO-L-Phe-D-Oxd-OH)2 30. 
Compound 29 (1 mmol, 0.92 g) was dissolved in MeOH (35 mL) under nitrogen. Pd/C (50 mg, 10 % 
w/w) was added under nitrogen. Vacuum was created inside the flask by using the vacuum line. 
The flask was then filled with hydrogen by using a balloon (1 atm). The solution was stirred for 2 h 
under a hydrogen atmosphere. The pure product was obtained in quantitative yield (0.73 g) after 
the solution was filtered through a Celite pad using ethyl acetate and concentrated in vacuo; m. p. 
201 °C.     
   = -36.0 (c 1.2, MeOH). 1H NMR (CD3OD, 400 MHz): δ = 1.06-1.47 [m, 10 H, 
CH2(CH2)5CH2], 1.58 (d, J = 6.4 Hz, 6 H, OCHCH3), 2.03-2.15 [m, 4 H, CH2(CH2)5CH2], 2.91 (dd, J = 9.6, 
13.6 Hz, 2 H, CHN-CHHPh), 3.14 (dd, J = 5.2, 13.6 Hz, 2 H, CHN-CHHPh), 4.00 (d, J = 5.6 Hz, 2 H, 
CHN-CHHPh), 4.62-4.87 (m, 2 H, OCH), 5.80 (m, 2 H, CHN-CH2Ph), 7.20-7.40 (m, 20 H, 4 × Ph) ppm. 
13C NMR (CD3OD, 100 MHz): δ = 19.8, 25.3, 28.3, 28.5, 35.2, 37.6, 52.7, 61.7, 74.4, 126.5, 128.0, 
129.1, 136.6, 151.1, 153.3, 169.7, 172.7, 174.4 ppm. C37H44N4O12 (736.3): calcd. C 60.32, H 6.02, N 
7.60; found C 60.36, H 6.04, N 7.55. 
 
Boc-L-Phe-D-Oxd-(R)-Me-Phg-OBn 31a. 
A solution of Boc-L-Phe-D-Oxd-OH (0.27 mmol, 0.10 g) and HBTU (0.3 mmol, 0.12 g) in dry 
acetonitrile (25 mL) was stirred under inert atmosphere for 10 min at room temperature. Then a 
mixture of CF3COO
- +H3N-(R)-Me-Phg-OBn (0.27 mmol, 0.10 g) and TEA (0.81 mmol, 0.12 mL) in 
dry acetonitrile (10 mL) was added at room temperature. The solution was stirred for 40 min 
under inert atmosphere, then acetonitrile was removed under reduced pressure and replaced 
with ethyl acetate. The mixture was washed with brine, 1 N aqueous HCl (3 9 30 mL) and with 5% 
aqueous NaHCO3 (1 9 30 mL), dried over sodium sulphate and concentrated in vacuo. The product 
was obtained pure after silica gel chromatography (cyclohexane/ethyl acetate 8:2 as eluant) in 80 
% yield. M. p. = 128 °C;     
   = 88.9 (c 1.1, CH2Cl2); IR (CH2Cl2, 3 mM): ν 3,437, 3,389, 3,336, 1,788, 
1,737, 1,701, 1,678 cm-1; IR (1% in dry KBr): ν 3,390, 3,324, 1,783, 1,748, 1,716, 1,689 cm-1; 1H 
NMR (400 MHz, CDCl3): δ 1.25 (d, 6H, J = 6.3 Hz), 1.55 (s, 9H), 1.97 (s, 3H), 2.84 (dd, 1H, J = 8.0, 
13.2 Hz), 3.07 (dd, 1H, J = 6.0, 13.2 Hz), 4.29 (d, 1H J = 3.6 Hz), 4.43 (m, 1H), 4.91 (d, 1H, J = 5.2 Hz), 
5.05 (AB, 2H, J = 12.4 Hz), 5.69 (m, 1H), 7.12-7.16 (m, 2H), 7.22-7.34 (m, 11H), 7.44-7.49 (m, 2H), 
7.61 (s, 1H); 13C NMR (75 MHz, CDCl3): δ 21.4, 21.9, 28.4, 30.2, 38.0, 53.9, 62.7, 63.6, 67.8, 75.0, 
80.1, 126.3, 127.7, 128.2, 128.5, 128.7, 128.9, 129.1, 129.7, 135.5, 136.2, 151.9, 173.3. Anal. calcd. 
for C35H39N3O8: C, 66.76; H, 6.24; N, 6.67; Found: C, 66.81; H, 6.20; N, 6.64. 616 N.  
 
Boc-L-Phe-D-Oxd-(S)-Me-Phg-OBn 31b.  
A solution of Boc-L-Phe-D-Oxd-OH (0.27 mmol, 0.10 g) and HBTU (0.3 mmol, 0.12 g) in dry 
acetonitrile (25 mL) was stirred under inert atmosphere for 10 min at room temperature. Then a 
mixture of CF3COO
- +H3N-(S)-aMe-Phg-OBn (0.27 mmol, 0.10 g) and TEA (0.81 mmol, 0.12 mL) in 
dry acetonitrile (10 mL) was added at room temperature. The solution was stirred for 40 min 
under inert atmosphere, then acetonitrile was removed under reduced pressure and replaced 
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with ethyl acetate. The mixture was washed with brine, 1 N aqueous HCl (3 9 30 mL) and with 5% 
aqueous NaHCO3 (1 9 30 mL), dried over sodium sulphate and concentrated in vacuo. The product 
was obtained pure after silica gel chromatography (cyclohexane/ethyl acetate 8:2 as eluant) in 80 
% yield. M. p. = 196 °C;     
   = 17.3 (c 0.25, CH2Cl2); IR (CH2Cl2, 3 mM): ν 3,434, 3,385, 1,789, 
1,737, 1,720, 1,703 cm-1; IR (1% in dry KBr): ν 3,389, 3,309, 1,768, 1,742, 1,718, 1,701, 1,687 cm-1; 
NMR (400 MHz, CDCl3): δ 1.26 (d, 6H, J = 6.6 Hz), 1.55 (s, 9H), 1.98 (s, 3H), 2.89 (m, 1H), 3.11 (m, 
1H), 4.30 (m, 1H), 4.56 (m, 1H), 5.12 (AB, 2H, J = 12.4 Hz), 5.16 (bs, 1H), 5.71 (q, 1H, J = 6.8 Hz), 
7.16-7.42 (m, 16H); 13C NMR (75 MHz, CDCl3): δ 21. 3, 28.5, 30.2, 54.3, 63.2, 68.0, 74.5, 126.4, 
127.6, 128.3, 128.6, 128.8, 129.0, 129.8, 136.4, 151.8, 166.4, 173.8, 183.2. Anal. calcd. for 
C35H39N3O8: C, 66.76; H, 6.24; N, 6.67; Found: C, 66.73; H, 6.19; N, 6.70. 
 
General method for the preparation of compounds 32a-d. 
A solution of fully protected tripeptide (2 mmol) and TFA (36 mmol, 2.78 mL) in dry methylene 
chloride (20 mL) was stirred at room temperature for 4 h, then the volatiles were removed under 
reduced pressure and the corresponding amine salt was obtained pure in quantitative yield 
without further purification. 
A solution of azelaic acid (0.98 g, 0.52 mmol) and HBTU (0.4 mg, 1.04 mmol) in dry acetonitrile (22 
mL) was stirred under inert atmosphere for 10 min at room temperature. Then a mixture of the 
previously obtained amine salt (1.04 mmol) and TEA (3.2 mmol, 0.47 mL) in dry acetonitrile (15 
mL) was added dropwise at room temperature. The solution was stirred for 40 min under inert 
atmosphere, then acetonitrile was removed under reduced pressure and replaced with ethyl 
acetate. The mixture was washed with brine, 1 N aqueous HCl (3 × 30 mL) and with 5% aqueous 
NaHCO3 (1 × 30 mL), dried over sodium sulphate and concentrated in vacuo. The product was 
obtained pure after silica gel chromatography (DCM 100% → DCM/acetato di etile 80:20 as 
eluant). 
 
CH2(C3H6CO-L-Phe-L-Oxd-(R)-αMe-Phg-OBn)2 32a.  
M. p. = 76 °C;     
   = +22.0 (c 1.0, CHCl3); IR (CH2Cl2, 3 mM): ν 3,343, 3,374, 3,366, 3,335, 1,787, 
1,771, 1,738, 1,732, 1,683, 1,674 cm-1; IR (1% in dry KBr): ν 3,392, 3,370, 1,734, 1,701, 1,653 cm-1; 
NMR (400 MHz, CDCl3): δ 0.98-1.44 (m, 16H), 1.88-2.05 (m, 4H), 1.96 (s, 6H), 2.92 (m, 2H), 3.17 (m, 
2H), 4.24 (m, 2H), 4.41 (m, 2H), 5.12 (AB, 4H, J = 12.4 Hz), 5.28 (m, 2H), 5.78 (bs, 1H), 6.10 (bs, 1H), 
7.05-7.37 (m, 29H), 7.44 (m, 2H), 7.81 (m, 1H); 13C NMR (50 MHz, CDCl3): δ 21.0, 24.6, 24.7, 28.3, 
28.4, 28.5, 35.3, 36.8, 53.0, 62.4, 62.7, 67.5, 74.4, 126.3, 127.3, 127.4, 128.1, 128.2, 128.4, 128.7, 
129.3, 135.2, 139.4, 151.6, 166.6, 171.7, 173.0, 173.6. Anal. calcd. for C69H74N6O14: C, 68.41; H, 
6.16; N, 6.94. Found: C, 68.37; H, 6.19; N, 6.99. 
 
CH2(C3H6CO-L-Phe-D-Oxd-(S)-αMe-Phg-OBn)2 32b. 
M. p. = 150 °C;     
   = + 92.0 (c 1, CHCl3); IR (CH2Cl2, 3 mM): ν 3,433, 3,385, 3,323, 3,304, 1,787, 
1,737, 1,714, 1,677 cm-1; IR (1% in KBr): ν 3,422, 3,327, 3,284, 1,781, 1,749, 1,706, 1,684, 1653, 
1642 cm-1; 1H NMR (400 MHz, CDCl3): δ 0.88-1.41 (m, 16H), 1.65-2.02 (m, 4H), 1.96 (s, 6H), 2.94 
(m, 2H), 3.18 (m, 2H), 4.24 (m, 2H), 4.42 (m, 2H), 5.08 (AB, 4H, J = 12.0 Hz), 5.28 (m, 2H), 5.71 (bs, 
2H), 6.05 (bs, 2H), 7.05-7.35 (m, 30H), 7.40 (bs, 1H), 7.78 (s, 1H); 13C NMR (100 MHz, CDCl3): δ 
14.1, 20.8, 21.0, 21.8, 24.5, 28.5, 29.6, 35.2, 36.7, 53.0, 53.4, 60.3, 62.2, 63.0, 67.3, 74.6, 81.4, 
126.1, 127.3, 127.9, 128.0, 128.1, 128.3, 128.7, 129.2, 135.4, 151.6, 166.9, 171.6, 173.4. Anal. 
calcd. for C69H74N6O14: C, 68.41; H, 6.16; N, 6.94. Found: C, 68.45; H, 6.20; N, 6.91. 
 
CH2(C3H6CO-L-Phe-D-Oxd-(S)-β
3-hPhg-OBn)2 32c.  
123 
 
M. p. = 129 °C;     
   = + 32.0 (c 1.0, CH2Cl2); IR (CH2Cl2, 3 mM): ν 3,435, 3,319, 1,788, 1,735, 1,675, 
1,655 cm-1; IR (1% in KBr): ν 3,411, 3,309, 3,088, 1,772, 1,732, 1,715, 1,650, 1,556, 1,531 cm-1; 1H 
NMR (400 MHz, CDCl3): δ 1.08-1.52 (m, 16H), 1.92-2.15 (m, 4H), 2.81-2.99 (m, 6H), 3.18 (m, 2H), 
4.12 (m, 2H), 4.39 (m, 1H), 4.58 (m, 1H), 5.05 (m, 2H), 5.13 (m 1H), 5.15 (s, 2H), 5.52 (m, 1H), 5.75 
(m, 1H), 6.03 (m, 1H), 7.15-7.38 (m, 30H), 7.41 (d, 1H, J = 6 Hz), 7.85 (d, 1H, J = 6.4 Hz); 13C NMR 
(50 MHz, CDCl3): δ 21.0, 24.8, 28.5, 29.7, 35.3, 36.4, 40.8, 50.3, 53.2, 56.9, 62.5, 66.5, 75.2, 126.8, 
127.5, 127.6, 128.2, 128.4, 128.7, 128.9, 129.2, 135.0, 135.7, 140.6, 151.0, 166.4, 170.1, 175.5, 
174.3. Anal. calcd. for C69H74N6O14: C, 68.41; H, 6.16; N, 6.94. Found: C, 68.44; H, 6.17; N, 6.92. 
 
CH2(C3H6CO-L-Phe-D-Oxd-(R)-β
3-hPhg-OBn)2 32d. 
M. p. = 179 °C;     
   = + 44.0 (c 1.1, CHCl3); IR (CH2Cl2, 3 mM): ν 3,433, 3,323, 1,785, 1,735, 1,719, 
1,672, 1,658 cm-1; IR (1% in dry KBr): ν 3,310, 3,298, 1,773, 1,734, 1,718, 1,653 cm-1; 1H NMR (400 
MHz, CDCl3): δ 1.09-1.58 (m, 16H), 1.85-2.05 (m, 4H), 2.85-3.21 (m, 8H), 4.11 (m, 2H), 4.39 (m, 1H), 
4.62 (m, 1H), 5.05 (m, 2H), 5.13 (m 1H), 5.17 (s, 2H), 5.42 (m, 1H), 5.65 (m, 1H), 6.12 (m, 1H), 7.05-
7.41 (m, 31H), 7.96 (m, 1H); 13C NMR (50 MHz, CDCl3): δ 20.8, 24.7, 28.3, 35.2, 36.5, 40.5, 41.1, 
50.6, 53.3, 62.5, 66.5, 75.3, 82.1, 126.4, 127.4, 128.1, 128.5, 128.8, 129.2, 135.1, 135.6, 140.6, 
143.5, 151.7, 167.1, 170.5, 172.9, 174.3. Anal. calcd. for C69H74N6O14: C, 68.41; H, 6.16; N, 6.94. 
Found: C, 68.47; H, 6.19; N, 6.91. 
 
General method for the preparation of compounds 33a-d. 
Compound 32a-d (1 mmol) was dissolved in MeOH (35 mL) under nitrogen. C/Pd (50 mg, 10% 
w/w) was added under nitrogen. A vacuum was created inside the flask using the vacuum line. The 
flask was then filled with hydrogen using a balloon (1 atm). The solution was stirred for 4 h under a 
hydrogen atmosphere. The product was obtained pure after filtration through a Celite pad using 
ethyl acetate and concentration in vacuo. 
 
CH2(C3H6CO-L-Phe-D-Oxd-(R)-αMe-Phg-OH)2 33a. 
M. p. = 98 °C;     
   = +52.0 (c 0.6, MeOH); 1H NMR (CD3OD, 400 MHz): δ 0.90-1.61 (m, 16H), 1.92-
2.10 (m, 4H), 1.97 (s, 6H), 2.92 (m, 2H), 3.16 (m, 2H), 3.60-3.95 (m, 2H),4.42-4.60 (m, 4H), 5.95 (m, 
2H), 7.05-7.60 (m, 20H); 13C NMR (CD3OD, 100 MHz): δ 19.4, 19.7, 21.3, 22.3, 25.3, 28.4, 28.6, 
30.0, 35.1, 36.9, 52.8, 53.7, 61.7, 62.9, 74.6, 77.0, 125.7, 125.9, 126.5, 127.0, 127.1, 127.7, 127.8, 
128.0, 128.7, 129.1, 136.5, 136.8, 152.3, 167.5, 169.5, 172.3, 174.8. Anal. calcd. for C55H62N6O14: C, 
64.07; H, 6.06; N, 8.15. Found: C, 64.11; H, 6.01; N, 8.12. 
 
CH2(C3H6CO-L-Phe-D-Oxd-(R)-αMe-Phg-OH)2 33b. 
M. p. = 115 °C;     
   = -4.5 (c 1.2, MeOH); 1H NMR (CD3OD, 400 MHz): δ 90-1.70 (m, 16H), 1.85 (s, 
6H), 1.90-2.25 (m, 4H), 2.88 (m, 2H), 3.95 (m, 1H), 4.20 (m, 1H), 4.48-4.65 (m, 4H), 5.98 (m, 2H), 
7.11-7.58 (m, 20H); 13C NMR (CD3OD, 100 MHz): δ 19.4, 19.7, 22.0, 25.4, 28.4, 28.6, 29.3, 35.2, 
37.4, 52.8, 62.6, 74.4, 125.9, 126.1, 126.2, 127.2, 127.9, 128.0, 128.2, 128.7, 129.1, 136.6, 140.6, 
152.4, 167.7, 168.0, 172.2, 174.4. Anal. calcd. for C55H62N6O14: C, 64.07; H, 6.06; N, 8.15. Found: C, 
64.11; H, 6.10; N, 8.12. 
 
CH2(C3H6CO-L-Phe-D-Oxd-(S)-β
3-hPhg-OH)2 33c. 
M.p. = 117 °C;     
   = -31.7 (c 1.3, MeOH); 1H NMR (CD3OD, 400 MHz): δ 1.05-1.59 (m, 16H), 2.03-
2.25 (m, 4H), 2.71-2.94 (m, 4H), 3.10-3.35 (m, 4H), 4.41 (M, 2H), 4.51-4.78 (m, 4H), 5.38 (m, 2H), 
5.98 (m, 2H), 7.05-7.43 (m, 20H); 13C NMR (CD3OD, 100 MHz): δ 19.6, 25.5, 28.7, 35.3, 37.6, 40.7, 
50.4, 53.0, 60.8, 63.1, 65.9, 75.2, 126.4, 126.8, 127.3, 128.2, 128.4, 129.4, 136.7, 143.6, 160.3, 
174.8. Anal. calcd. for C55H62N6O14: C, 64.07; H, 6.06; N, 8.15. Found: C, 64.00; H, 6.04; N, 8.19. 
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CH2(C3H6CO-L-Phe-D-Oxd-(R)-β
3-hPhg-OH)2 33d. 
M. p. = 140 °C;     
   = +29.0 (c 1.0, MeOH); 1H NMR (CD3OD, 400 MHz): δ 0.82-1.59 (m, 16H), 
2.03-2.35 (m, 4H), 2.61-2.98 (m, 4H), 3.15-3.40 (m, 4H), 4.41 (M, 2H), 4.48-4.90 (m, 4H), 5.38 (m, 
2H), 5.95 (m, 2H), 7.05-7.43 (m, 20H); 13C NMR (CD3OD, 100 MHz): δ 19.7, 20.0, 25.4, 28.3, 28.4, 
29.1, 35.4, 37.2, 40.3, 46.5, 48.1, 50.7, 63.1, 75.6, 126.1, 128.3, 128.4, 137.8, 142.0, 153.6, 168.2, 
172.3, 173.0, 174.4. Anal. calcd. for C55H62N6O14: C, 64.07; H, 6.06; N, 8.15. Found: C, 64.15; H, 
6.04; N, 8.14. 
 
CH2(C3H6CO-L-Phe-L-Phe-D-Oxd-OBn)2 34a.  
A solution of Boc-L-Phe-L-Phe-D-Oxd-OBn (2 mmol) and TFA (36 mmol, 2.78 mL) in dry 
dichloromethane (20 mL) was stirred at room temperature for 4 h, then the volatile compounds 
were removed under reduced pressure and the corresponding amine salt was obtained pure in 
quantitative yield without further purification. 
A solution of azelaic acid (0.98 g, 0.52 mmol) and HBTU (0.4 g, 1.04 mmol) in dry acetonitrile (22 
mL) was stirred under nitrogen atmosphere for 10 min at room temperature. Then, a mixture of 
the previously obtained amine salt (1.04 mmol) and TEA (3.2 mmol, 0.47 mL) in dry acetonitrile (15 
mL) was added dropwise at room temperature. The solution was stirred for 40 min under a 
nitrogen atmosphere then acetonitrile was removed under reduced pressure and replaced with 
ethyl acetate. The mixture was washed with brine, 1 N aqueous HCl (3 × 30 mL), and 5 % (w/v) 
aqueous NaHCO3 (1 × 30 mL), dried with sodium sulfate and concentrated in vacuo. The pure 
product was obtained after silica gel chromatography [CH2Cl2 100 % → CH2Cl2/ethyl acetate 
(80:20) as eluent] in 57 %; m. p. 175 °C.     
   = +19 (c 0.9, CHCl3). IR (CH2Cl2, 3 mM): ν 3440, 3358, 
3309, 1773, 1748, 1716, 1655 cm-1. IR (1 % in dry KBr): ν 3297, 1644, 1795, 1740, 1710 cm-1. 1H 
NMR (CDCl3, 400 MHz): δ = 1.16-1.21 [m, 10 H, CH2(CH2)5CH2], 1.48 (d, J = 6.4 Hz, 6 H, 2 × CH3Oxd), 
2.10-2.18 [m, 4 H, CH2(CH2)5CH2], 2.52-3.04 (m, 8 H, 4 × CHN-CH2-Ph), 3.93 (d, J = 4.8 Hz, 1 H, CHN-
Oxd), 4.40 (m, 1 H, CHO-Oxd), 4.46 (m, 1 H, CHN-Oxd), 4.67 (m, 1 H, CHO-Oxd), 5.15 (m, 4 H, 2 × 
CH2OBn), 5.32 (br. s, 2 H, 2 × NH), 5.92 (br. s, 1 H, NH), 7.08-7.36 (m, 30 H, 6 × Phe) ppm. 
13C NMR 
(CDCl3, 100 MHz, mixture of conformers): δ = 21.0, 21.2, 24.6, 25.3, 25.4, 28.6, 28.8, 29.6, 30.9, 
33.9, 36.2, 36.3, 37.8, 38.0, 38.3, 38.6, 52.9, 53.0, 54.0, 54.2, 61.7, 61.8, 67.3, 68.0, 73.7, 126.9, 
128.2, 128.5, 128.7, 129.4, 130.0, 134.6, 135.3, 136.3, 136.4, 150.3, 151.2, 167.3, 170.4, 170.5, 
170.7, 170.8, 171.3, 171.8, 177.6, 177.7, 177.8 ppm. C69H74N6O14 (1210.5): calcd. C 68.41, H 6.16, N 
6.94; found C 68.38, H 6.18, N 6.94. 
 
CH2(C3H6CO-L-Phe-L-Phe-D-Oxd-OH)2 34b.  
Compound 33a (1 mmol, 0.92 g) was dissolved in MeOH (35 mL) under nitrogen. Pd/C (50 mg, 
10 % w/w) was added under nitrogen. Vacuum was created inside the flask by using the vacuum 
line. The flask was then filled with hydrogen by using a balloon (1 atm). The solution was stirred 
for 2 h under a hydrogen atmosphere. The pure product was obtained in quantitative yield (0.73 g) 
after the solution was filtered through a Celite pad using ethyl acetate and concentrated in vacuo 
m.p. 52 °C.     
   = +2 (c 0.49, MeOH). 1H NMR (CD3OD, 400 MHz): δ = 1.14-1.25 [m, 10 H, 
CH2(CH2)5CH2], 1.43-1.57 (m, 6 H, 2 × CH3Oxd), 2.12-2.25 [m, 4 H, CH2(CH2)5CH2], 2.71-2.88 (m, 8 H, 
4 × CHN-CH2-Ph), 3.06-3.25 (m, 2 H, 2 × CHN-CH2-Ph), 4.29-4.65 (m, 4 H, 2 × CHO-Oxd + 2 × CHN-
Oxd), 5.50-5.62 (m, 2 H, 2 × CHN-CH2-Ph), 6.98-7.33 (m, 20 H, 6 × Phe) ppm. 
13C NMR (CD3OD, 100 
MHz): δ = 14.0, 19.8, 24.6, 25.3, 28.6, 33.5, 35.3, 37.0, 37.3, 37.4, 52.9, 53.4, 54.0, 65.5, 74.6, 
126.2, 126.3, 126.5, 128.0, 128.5, 128.9, 129.2, 129.8, 136.3, 137.0, 137.1, 171.6, 171.8, 173.4, 
174.5, 174.7, 176.2 ppm. C55H62N6O14 (1030.4): calcd. C 64.07, H 6.06, N 8.15; found C 64.03, H 
6.05, N 8.17. 
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CH2(C3H6CO-L-Phe-D-Oxd-L-Lys(Dansyl)OH)2 35. 
As described in [23], compound CH2[C3H6CO-L-Phe-D-Oxd-L-Lys(Dansyl)-OBn]2 (0.06 mmol, 0.1 g) 
was dissolved in MeOH (20 mL) under nitrogen. C/Pd (20 mg) was added under nitrogen. A 
vacuum was created inside the flask using the vacuum line. The flask was then filled with hydrogen 
using a balloon (1 atm). The solution was stirred for 5 hours under a hydrogen atmosphere. The 
product was obtained pure in quantitative yield after filtration through a celite pad using MeOH 
and concentration in vacuo. M. p. = 125-126 °C;     
   = + 22.7 (c 0.3, MeOH); 1H NMR (CD3OD, 400 
MHz): δ 0.86-1.66 (28H, m, COCH2(CH2)5 + 2 x CH(CH2)3CH2NH + 2 x OCHCH3), 1.90-2.08 (4H, m, 2 x 
COCH2), 2.62-2.81 (18H, m, 2 x CHN-CHH-Ph + 2 x CH2-NH-SO2 + 2 x N(CH3)2), 3.06-3.15 (2H, m, 2 x 
CHN-CHH-Ph), 4.08-4.20 (2H, m, 2 x CH(Lys), 4.27(2H, d, J = 5.2 Hz, 2 x CHNOxd), 4.45- 4.55 (2H, m, 
2 x CHO-Oxd), 5.72-5.82 (2H, m, 2 x CH(Phe), 7.04- 7.26 (14H, m, 2 x Ph + 2 x H-61 + 2 x H-31), 7.42-
7.52 (4H, m, 2 x H-71 + 2 x H-41), 8.04-8.12 (2H, m, 2 x NH(Phe)), 8.06-8.27 (4H, m, 2 x H-21 + 2 x H-
81), 8.41-8.49 (2H, m, 2 x NHSO2); 
13C NMR (CD3OD, 100 MHz): δ 21.8, 24.7, 27.6, 30.6, 30.9, 32.5, 
37.4, 39.3, 39.7, 44.5, 46.7, 55.4, 65.5, 77.3, 117.3, 121.4, 125.2, 128.9, 130.0, 130.3, 131.0, 131.3, 
131.8, 137.9, 138.8, 154.0, 154.5, 171.1, 174.8, 177.0. Anal. Calcd. for C73H90N10O18S2: C, 60.07; H, 
6.21; N, 9.60. Found: C, 60.03; H, 6.19; N, 9.57. 
 
Dansylamide 36 may be purchased by Sigma-Aldrich. 
 
Dansylpyrrolidine 37.  
A solution of dansyl chloride (1.11 mmol, 0.3 g) and pyrrolidine (0.55 mmol, 0.5 mL) in dry 
dichloromethane (20 mL) was stirred under nitrogen atmosphere for 2 hours at room 
temperature. The mixture was washed with brine (1 x 30 mL), 1 N aqueous HCl (2 x 30 mL) and the 
organic layer was dried over sodium sulfate and concentrated in vacuo. The product was obtained 
pure without further purification as a green solid in 86% overall yield. M.p. = 102 °C; 1H NMR 
(CDCl3, 400 MHz): δ 1.75-1.81 (4H, m, 2 x NCH2CH2), 2.83 (6H, s, N(CH3)2, 3.27-3.33 (4H, m, 2 x 
NCH2CH2), 7.13 (1H, d, J = 8.0 Hz, H-61), 7.45-7.52 (2H, m, H-31 + H-71), 8.17 (1H, d, J = 8.0 Hz, H-
41), 8.44 (1H, d, J = 8.4 Hz, H-21), 8.52 (1H, d, J = 7.2 Hz, H-81); 13C NMR (CDCl3, 100 MHz): δ 25.4, 
45.3, 47.4, 115.0, 129.7, 123.1, 127.8, 129.5, 129.9, 130.1, 130.5, 134.2, 151.5. 
 
Boc-L-Phe-D-Oxd-L-Lys(Dansyl)OBn 38. 
A solution of Boc-L-Lys(Dansyl)-OBn (0.22 mmol, 0.13 g) and TFA (4.06 mmol, 0.31 mL) in dry 
dichloromethane (10 mL) was stirred at room temperature for 4 h, then the volatiles were 
removed under reduced pressure and the corresponding amine salt was obtained pure in 
quantitative yield without further purification.  
A solution of Boc-L-Phe-D-Oxd-OH (0.22 mmol, 0.09 g) and HBTU (0.22 mmol, 0.9 g) in dry 
acetonitrile (15 mL) was stirred under nitrogen atmosphere for 10 min at room temperature. Then 
a mixture of the previously obtained amine salt (0.22 mmol) and TEA (0.67 mmol, 0.24 mL) in dry 
acetonitrile (10 mL) was added dropwise at room temperature. The solution was stirred for 40 min 
under nitrogen atmosphere, then the acetonitrile was removed under reduced pressure and 
replaced with ethyl acetate. The mixture was washed with brine (1 x 15 mL), 1 N aqueous HCl (1 x 
15 mL) and with 5% (w/v) aqueous NaHCO3 (1 x 15mL), dried over sodium sulfate and 
concentrated in vacuo. The product was obtained pure after silica gel chromatography (c-
hexane/ethyl acetate 85:15 → c-hexane/ethyl acetate 70:30 as eluant) in 69% overall yield. M. p. = 
177-178 °C;     
   = + 26.9 (c 0.5, CHCl3); IR (CH2Cl2, 3 mM): ν 3682, 3599, 3432, 3348, 1787, 1740, 
1696 cm-1; 1H NMR (CDCl3, 400 MHz): δ 0.78-0.91 (1H, m, CHCH2CHH), 1.15-1.85 (17H, m, 
CH2CHHCH2CH2NH + OCHCH3 + t-Bu), 2.74-3.00 (9H, CHN-CHH-Ph + CH2-NH-SO2 + N(CH3)2), 3.08-
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3.18 (1H, m, CHN-CHH-Ph), 4.28 (1H, d, J = 5.2 Hz, CHNOxd), 4.49-4.62 (2H, m, CH(Lys) + CHO-Oxd), 
5.12 (2H, AB, J1 = 44 Hz, J2 = 12.4 Hz, CH2OBn), 5.03 (1H, d, J = 12.4 Hz, CHHPh), 5.15 (1H, d, J = 
12.4 Hz, CHHPh), 5.44 (1H, bs, NH-Boc), 5.51 (1H, d, J = 6.4 Hz, CONH), 5.58-5.70 (1H, m, CH(Phe)), 
7.15- 7.35 (13H, m, 2 x Ph + H-61 + H-31 + NH(Phe)), 7.46-7.55 (2H, m, H-71 + H-41), 8.21 (1H, d, J = 
7.6 Hz, H-21), 8.34 (1H, d, J = 8.8 Hz, H-81), 8.53 (1H, d, J = 8.8 Hz, NHSO2); 
13C NMR (CDCl3, 100 
MHz): δ 15.2, 20.8, 22.0, 28.2, 42.5, 45.3, 51.8, 54.0, 63.1, 65.8, 67.0, 74.7, 80.6, 115.2, 118.9, 
123.2, 127.2, 128.2, 128.4, 128.6, 129.4, 129.5, 129.6,129.9, 130.2, 135.0, 135.2, 135.5, 151.4, 
167.1, 171.0, 174.1. Anal. Calcd. for C37H47N5O10S: C, 58.95; H, 6.28; N, 9.29. Found: C, 59.03; H, 
6.23; N, 9.24. 
 
CH2(C3H6CO-L-Phe-D-Oxd-L-Lys(Dansyl)OBn)2 39. 
A solution of Boc-L-Phe-D-Oxd-L-Lys(Dansyl)-OBn (0.24 mmol, 0.2 g) and TFA (4.32 mmol, 0.33 mL) 
in dry methylene chloride (10 mL) was stirred at room temperature for 4 h, then the volatiles were 
removed under reduced pressure and the corresponding amine salt was obtained pure in a 
quantitative yield without further purification.  
A solution of azelaic acid (0.12 mmol, 0.02 g) HBTU (0.26 mmol, 0.1 g) in dry acetonitrile (15 mL) 
was stirred under nitrogen atmosphere for 10 min at room temperature. Then a mixture of the 
previously obtained amine salt (0.24 mmol) and TEA (0.72 mmol, 0.1 mL) in dry acetonitrile (10 
mL) was added dropwise at room temperature. The solution was stirred for 40 min under nitrogen 
atmosphere, then the acetonitrile was removed under reduced pressure and replaced with ethyl 
acetate. The mixture was washed with brine (1 x 15 mL), 1 N aqueous HCl (1 x 15 mL) and with 5% 
(w/v) aqueous NaHCO3 (1 x 15 mL), dried over sodium sulfate and concentrated in vacuo. The 
product was obtained pure after silica gel chromatography (dichloromethane 100% → 
dichloromethane/ethyl acetate 80:20 as eluant) in 64% overall yield. M. p. = 125-126 °C;     
   = + 
20.3 (c 0.2, CHCl3); IR (CH2Cl2, 3 mM): ν 3686, 3607, 1791, 1743, 1680 cm
-1; 1H NMR (DMSO-d6, 400 
MHz): δ 0.80-1.03 (10H, m, COCH2CH2(CH2)3 + 2 x CHCH2CH2), 1.05-1.31 (8H, m, 2 x COCH2CH2 + 2 x 
CH2CH2NH), 1.35 (6H, d, J = 7.6 Hz, 2 x OCHCH3), 1.44-1.61 (4H, m, 2 x CHCH2), 1.85-2.03 (4H, m, 2 
x COCH2), 2.62-2.73 (8H, m, 2 x CHN-CHH-Ph + 2 x CH2-NH-SO2), 2.79 (12H, s, 2 x N(CH3)2), 3.03-
3.12 (2H, m, 2 x CHN-CHH-Ph), 4.14-4.23 (2H, m, 2 x CH(Lys), 4.39-4.48 (4H, m, 2 x CHNOxd + 2 x 
CHO-Oxd), 5.02-5.10 (4H, m, 2 x CH2OBn), 5.69-5.80 (2H, m, 2 x CH(Phe), 7.15- 7.35 (20H, m, 4 x 
Ph), 7.53-7.62 (4H, m, 2 x H-61 + 2 x H-31), 7.82-7.88 (2H, m, 2 x H-71), 8.07 (2H, d, J = 8.0 Hz, 2 x H-
41), 8.18 (2H, d, J = 8.8 Hz, 2 x NH(Phe)), 8.27 (2H, d, J = 8.8 Hz, 2 x H-21), 8.44 (2H, d, J = 8.8 Hz, 2 x 
H-81), 8.71 (2H, d, J = 8.8 Hz, 2 x NHSO2); 
13C NMR (DMSO-d6, 100 MHz): δ 25.4, 27.2, 30.2, 33.4, 
33.7, 35.5, 40.2, 43.4, 47.3, 50.2, 57.0, 57.5, 60.0, 67.0, 71.2, 80.1, 120.3, 128.7, 131.7, 133.0, 
133.2, 133.6, 134.2, 134.3, 140.9, 141.1, 142.3, 156.5, 157.3, 172.8, 176.4, 177.2, 177.4, 179.8. 
Anal. Calcd. for C87H102N10O18S2: C, 63.72; H, 6.27; N, 8.54. Found: C, 63.76; H, 6.30; N, 8.55. 
 
General method for the preparation of lipopetides 40, 41, 42 or 43. 
A solution of labeled Boc-L-Phe-D-Oxd-OBn (0.5 mmol) and TFA (9 mmol, 0.7 mL) in dry methylene 
chloride (10 mL) was stirred at room temperature for 4 h, then the volatiles were removed under 
reduced pressure and the corresponding amine salt was obtained pure in quantitative yield 
without further purification.A solution of carboxylic acid [CD3-(CD2)4-COOH or CD3-(CD2)10-COOH] 
(0.5 mmol) and HBTU (0.2 g, 0.52 mmol) in dry acetonitrile (15 mL) was stirred under nitrogen 
atmosphere for 10 min at room temperature. Then, a mixture of the previously obtained amine 
salt (0.5 mmol) and TEA (1.6 mmol, 0.34 mL) in dry acetonitrile (10 mL) was added dropwise at 
room temperature. The solution was stirred for 40 min under nitrogen atmosphere, and then 
acetonitrile was removed under reduced pressure and replaced with ethyl acetate. The mixture 
was washed with brine, 1 N aqueous HCl (3 × 30 mL), and with 5% (w/v) aqueous NaHCO3 (1 × 30 
127 
 
mL), dried over sodium sulphate and concentrated in vacuo. The product was obtained pure after 
silica gel chromatography (cyclohexane/ethyl acetate 9 : 1 → 7 : 3 as eluant). 
 
CD3(CD2)4CO-L-[U-
13C,15N-Phe]-D-Oxd-OBn 40.  
Yield 70%; m. p. = 145 °C;     
   = -53.0 (c 0.8 in CHCl3); IR (CH2Cl2, 3 mM): ν 3428, 1793, 1703, 
1671 cm-1; 1H NMR (CDCl3, 200 MHz): δ 1.44 (d, 3H, J = 6.4 Hz, OCHCH3), 2.78 and 3.24 (m, 2H, 
CHN-CH2-Ph), 4.35 (d, 1H, J = 4.0 Hz, CHN), 4.52 (dq, 1H, J = 4.0, 6.4 Hz, CHO), 5.21 (s, 2H, OCH2Ph), 
5.70 and 6.44 (m, 1H, CHN-CH2Ph), 5.78 and 6.23 (d, 1H, J = 8.0 Hz, NH), 6.62-7.00 and 7.41-7.78 
(m, 5H, Ph), 7.10-7.37 (m, 5H, Ph). 
 
CH3(CH2)10CO-L-[U-
13C,15N-Phe]-D-Oxd-OBn 41.  
Yield 68%; m. p. = 140 °C;     
   = -50.0 (c 1.3 in CHCl3); IR (CH2Cl2, 3 mM): ν 3428, 1793, 1716, 
1671 cm-1; 1H NMR (CDCl3, 200 MHz): δ 1.44 (d, 3H, J = 6.2 Hz, OCHCH3), 2.71 and 3.42 (m, 2H, 
CHN-CH2-Ph), 4.35 (d, 1H, J = 4.0 Hz, CHN), 4.54 (dq, 1H, J = 4.0, 6.2 Hz, CHO), 5.22 (s, 2H, OCH2Ph), 
5.71 and 6.45 (m, 1H, CHN-CH2Ph), 5.79 and 6.23 (d, 1H, J = 8.0 Hz, NH), 6.65-7.00 and 7.38-7.79 
(m, 5H, Ph), 7.18-7.37 (m, 5H, Ph). 
 
CD3(CD2)4CO-D-Phe-L-[U-
13C,15N]-Oxd-OBn 42.  
Yield 67 %; m. p. = 145 °C;     
    -61.0 (c 0.8 in CHCl3); IR (CH2Cl2, 3 mM): ν 3424, 1785, 1703, 
1667 cm-1; 1H NMR (CDCl3, 200 MHz): δ 1.13 and 1.78 (q, 3H, J = 5.0 Hz, OCHCH3), 3.04 (dd, 1H, J = 
7.0, 14.0 Hz, CHN-CHH-Ph), 3.20 (dd, 1H, J = 5.4, 13.4 Hz, CHN-CHH-Ph), 3.97 and 4.75 (m, 1H, 
CHN), 4.16 and 4.95 (m, 1H, CHO), 5.22 (s, 2H, OCH2Ph), 6.07 (m, 2H, CHN-CH2Ph + NH), 7.12-7.40 
(m, 10H, Ph). 
 
CD3(CD2)10CO-D-Phe-L-[U-
13C,15N]-Oxd-OBn 43.  
Yield 66%; m. p. = 128 °C;     
   = -39.0 (c 0.7 in CHCl3); IR (CH2Cl2, 3 mM): ν 3428, 1789, 1712, 
1675 cm-1; 1H NMR (CDCl3, 200 MHz): δ 1.13 and 1.78 (q, 3H, J = 5.6 Hz, OCHCH3), 3.05 (dd, 1H, J = 
6.6, 13.8 Hz, CHN-CHH-Ph), 3.20 (dd, 1H, J = 5.6, 13.8 Hz, CHN-CHH-Ph), 3.97 and 4.75 (m, 1H, 
CHN), 4.16 and 4.93 (m, 1H, CHO), 5.22 (s, 2H, OCH2Ph), 6.05 (m, 2H, CHN-CH2Ph + NH), 7.08-7.42 
(m, 10H, Ph). 
 
Boc-L-[U-13C,15N]-Phe-D-Oxd-OBn 44.  
To a stirred solution of Boc-L-[U-13C,15N]-Phe-OH (0.67 g, 2.5 mmol) in dry acetonitrile (20 mL), 
HBTU (0.98 g, 2.6 mmol), then D-Oxd-OBn (0.59 g, 2.5 mmol) and lastly triethylamine (0.75 mL, 5 
mmol) were added. The mixture was stirred over 1 h, then acetonitrile was removed under 
reduced pressure and replaced by ethyl acetate. The mixture was washed with brine, 1 N aqueous 
HCl (1 × 15 mL), and 5% aqueous NaHCO3 (1 × 15 mL), dried over sodium sulphate and 
concentrated in vacuo. The product was obtained pure in 88% yield (0.90 g) as a solid after silica 
gel chromatography (cyclohexane/ethyl acetate 8 : 2 → 1 : 1 as eluant). 1H NMR (CDCl3, 200 MHz): 
δ 1.39 (s, 9H, t-Bu), 1.42 (d, 3H, J = 6.6 Hz, OCHCH3), 2.50-2.89 and 3.15-3.65 (m, 2H, CHN-CH2-Ph), 
4.34 (d, 1H, J = 4.0 Hz, CHN), 4.53 (dq, 1H, J = 4.0, 6.6 Hz, CHO), 4.95 and 5.41 (bs, 1H, NH), 5.22 (s, 
2H, OCH2Ph), 5.42 and 6.19 (m, 1H, CHN-CH2Ph), 6.72-7.00 and 7.43-7.78 (m, 5H, Ph), 7.10-7.37 
(m, 5H, Ph). 
 
L-[U-13C,15N]-Oxd-OBn 45.  
To a stirred solution of L-[U-13C,15N]-Thr-OH (1.21 mmol, 0.15 g) in 1 M NaOH (4 mL) a solution of 
triphosgene (1.21 mmol, 0.36 g) in dioxane (2.5 mL) was added dropwise at room temperature. 
The mixture was stirred for 3 h and then concentrated under reduced pressure. The residue was 
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washed with warm acetonitrile to solubilize the product that was obtained pure after filtration and 
concentration of the liquid. The residue was dissolved in acetone (10 mL) and 
diisopropylethylamine (2.42 mmol, 0.42 mL), then benzyl bromide (1.21 mmol, 0.14 mL) was 
added dropwise at room temperature. The mixture was stirred overnight, then the acetone was 
removed under reduced pressure and replaced by ethyl acetate. The mixture was washed with 
water (3 × 10 mL), dried over sodium sulphate and concentrated in vacuo. The product was 
obtained pure in 88% yield (0.26 g) as a solid after silica gel chromatography (cyclohexane/ethyl 
acetate 8 : 2 as eluant). 1H NMR (CDCl3, 200 MHz): δ 1.25 and 1.88 (q, 3H, J = 6.2 Hz, OCHCH3), 
3.66 and 4.37 (m, 1H, CHN), 4.42 and 5.16 (m, 1H, CHO), 5.22 (s, 2H, OCH2Ph), 5.81 and 6.29 (dd, 
1H, J = 3.8, 5.8 Hz, NH), 7.12-7.40 (m, 10H, Ph). 
 
Boc-D-Phe-L-[U-13C,15N]-Oxd-OBn 46.  
For the preparation see above, starting from Boc-D-Phe-OH and L-[U-13C,15N]-Oxd-OBn. 1H NMR 
(CDCl3, 200 MHz): δ 1.10 and 1.73 (q, 3H, J = 5.8 Hz, OCHCH3), 1.39 (s, 9H, t-Bu), 2.98 (dd, 1H, J = 
7.2, 13.2 Hz, CHN-CHH-Ph), 3.10 (dd, 1H, J = 4.4, 13.2 Hz, CHN-CHH-Ph), 3.95 and 4.73 (m, 1H, 
CHN), 4.12 and 4.92 (m, 1H, CHO), 5.15 (bs, 1H, NH), 5.21 (s, 2H, OCH2Ph), 5.83 (m, 1H, CHN-
CH2Ph), 7.12-7.40 (m, 10H, Ph). 
 
General method for the derivatives 47. 
To a stirred solution of NaH (60% in mineral oil, 1.4 mmol, 55 mg) in dry THF (3 mL) was added 
benzyl malonate (1.05 mmol, 0.27 g) at 0 °C and the mixture was stirred 30 min. Then Boc-Xaa-O-
Succinimide (0.7 mmol) was added in one portion at 0 °C and the mixture was stirred for 2 h at 
room temperature. Then THF was removed under reduced pressure and replaced with ethyl 
acetate. The mixture was washed with water (2×30 mL), dried over sodium sulfate and 
concentrated in vacuo. The product was obtained pure after silica gel chromatography 
(cyclohexane/ethyl acetate 8:2 as eluant). 
 
Benzyl 1-tert-butoxycarbonylamino-2-benzoxycarbonyl-3-oxobutanoate 47a. 
Yield: 75%; m. p. = 99 °C; IR (CH2Cl2, 3 mM): ν 3446, 1752, 1719 cm
-1; 1H NMR (400 MHz, CDCl3; 
keto/enol, 50:50): δ 1.36 (s, 9H, tBu), 3.39 (s, 0.5H, CH(CO)3, keto), 4.07 (d, J=4.0 Hz, 1H, CH2, 
keto), 4.17 (d, J=4.0 Hz, 1H, CH2, enol), 4.99 (br s, 1H, NH), 5.10-5.27 (m, 4H, 2× OCH2Ph), 7.16-7.32 
(m, 10H, 2× Ph); 13C NMR (100 MHz, CDCl3): δ 28.3, 41.5, 49.9, 67.2, 68.2, 128.0, 128.3, 128.4, 
128.5, 128.6, 134.5, 135.1, 168.8, 166.2. 
 
(S)-Benzyl 5-phenyl-4-tert-butoxycarbonylamino-2-benzoxycarbonyl-2-benzoxycarbonyl-3-
oxopentanoate 47b. 
Yield: 73%; m. p. = 167 °C;     
   = +23.4 (c 0.15, CHCl3); IR (CH2Cl2, 3 mM): ν 3436, 1761, 1720, 
1650 cm-1; 1H NMR (400 MHz, CDCl3): δ 1.35 (s, 9H, tBu), 2.97-3.06 (m, 1H, CHHCH), 3.07-3.17 (m, 
1H, CHHCH), 3.40 (s, 1H, CH(CO)3), 4.46-4.59 (m, 1H, CHCH2), 4.98 (br s, 1H, NH), 5.10 (s, 4H, 2× 
OCH2Ph), 7.08-7.39 (m, 15H, 3× Ph); 
13C NMR (100 MHz, CDCl3): δ 24.7, 25.4, 28.3, 33.4, 49.8, 
128.0, 128.3, 128.4, 128.6, 129.1, 129.2, 129.4, 135.2, 166.2. 
 
Benzyl 4-tert-butoxycarbonylamino-2-benzoxycarbonyl-3-oxopentanoate 47c. 
Yield: 80%; m. p. = 141 °C; IR (CH2Cl2, 3 mM): ν 3514, 3451, 1816, 1787, 1744, 1713 cm
-1; 1H NMR 
(400 MHz, CDCl3): δ 1.46 (s, 9H, tBu), 2.71-2.87 (m, 2H, NHCH2CH2), 3.50 (s, 1H, CH(CO)3), 3.27-3.53 
(m, 2H, NHCH2CH2), 4.96 (br s, 1H, NH), 5.10-5.35 (m, 4H, 2× OCH2Ph), 7.15-7.59 (m, 10H, 2× Ph); 
13C NMR (100 MHz, CDCl3): δ 28.3, 30.9, 34.4, 41.5, 67.3, 128.3, 128.4, 128.6, 135.2, 166.2. 
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(S)-Benzyl 5-phenyl-5-tert-butoxycarbonylamino-2-benzoxycarbonyl-2-benzoxycarbonyl-3-
oxopentanoate 47d. 
Yield: 76%; m. p. = 101 °C;     
   = -19.4 (c 0.55, CHCl3); IR (CH2Cl2, 3 mM): ν 3436, 3362, 1761, 
1708, 1646, 1601 cm-1; 1H NMR (200 MHz, CDCl3): δ 1.44 (s, 9H, tBu), 2.83-3.09 (m, 1H, CHH), 3.10-
3.32 (m, 1H, CHH), 4.97-5.34 (m, 5H, 2× OCH2Ph+CHCH2), 5.74 (br s, 1H, NH), 7.01-7.45 (m, 10H, 2× 
Ph); 13C NMR (50 MHz, CDCl3): δ 28.3, 40.9, 41.5, 67.3, 67.4, 100.9, 125.9, 126.1, 127.3, 128.1, 
128.3, 128.3, 128.5, 135.2, 155.1, 166.1, 170.8, 180.9. 
 
General method for the preparation of 4-hydroxy-2-oxo-1H-pyrrole-1,3(2H,5H)-dicarboxylates or 
4-hydroxy-2-oxo-5,6-dihydropyridine-1,3(2H)-dicarboxylates 48. 
To a stirred solution of compound 48a-d (0.12 mmol) in benzyl alcohol (1 mL) was added 2 M 
NaOH (20 mmol, 1 mL) and the mixture was stirred at room temperature for 2 h. Then water was 
removed under reduced pressure and the product was obtained pure after silica gel 
chromatography (cyclohexane/ethyl acetate 1:9→pure ethyl acetate as eluant) to remove benzyl 
alcohol and by-products. 
 
Benzyl 1-tert-butyl 4-hydroxy-2-oxo-1H-pyrrole-1,3(2H,5H)-dicarboxylates 48a. 
Yield: 60%; m. p. = 190 °C; IR (CH2Cl2, 3 mM): ν 3595, 1752, 1650, 1605 cm
-1; 1H NMR (400 MHz, 
CD3OD): δ 1.55 (s, 9H, tBu), 3.83 (s, 2H, CH2), 5.27 (s, 2H, OCH2-Ph), 7.22-7.49 (m, 5H, Ph); 
13C NMR 
(100 MHz, CD3OD): δ 30.9, 56.2, 67.6, 131.0, 131.1, 131.8, 193.5. Anal. Calcd for C17H19NO6: C, 
61.25; H, 5.75; N, 4.20. Found: C, 60.21; H, 5.79; N, 4.23. 
 
4.2.2.2. (S)-3-Benzyl 1-tert-butyl 5-benzyl-4-hydroxy-2-oxo-1H-pyrrole-1,3(2H,5H)-dicarboxylates  
48b. 
Yield: 52%; m. p. = 101 °C;     
   = -32.0 (c 1.0, CH3OH); IR (CH2Cl2, 3 mM): ν 1736, 1677, 1640 cm
-1; 
1H NMR (400 MHz, CD3OD): δ 1.56 (s, 9H, tBu), 3.10-3.31 (m, 2H, CH2-Ph), 4.14 (s, 1H, CHCH2), 5.09 
(s, 2H, OCH2-Ph), 6.89-7.06 (m, 5H, Ph), 7.17-7.35 (m, 5H, Ph); 
13C NMR (100 MHz, CD3OD): δ 24.2, 
28.2, 28.5, 30.7, 36.0, 64.7, 126.2, 126.9, 127.5, 127.9, 129.6. Anal. Calcd for C24H25NO6: C, 68.07; 
H, 5.95; N, 3.31. Found: C, 68.01; H, 5.92; N, 3.33. 
 
(R)-3-Benzyl 1-tert-butyl 4-hydroxy-2-oxo-6-phenyl-5,6-dihydropyridine-1,3(2H)-dicarboxylate 48d. 
Yield: 26%; m. p. = 110 °C;     
   = -27.9 (c 0.4, CHCl3); IR (CH2Cl2, 3 mM): ν 3491, 3437, 3325, 1748, 
1711 cm-1; 1H NMR (400 MHz, CD3OD): δ 1.29 (s, 9H, tBu), 2.56-2.62 (m, 2H, CH2CH), 4.87-4.98 (m, 
1H, CH2CH), 5.08 (s, 2H, OCH2-Ph), 7.06-7.32 (m, 10H, 2× Ph); 
13C NMR (50 MHz, CDCl3): δ 26.9, 
28.2, 29.7, 41.4, 51.2, 67.3, 80.0, 126.1, 127.3, 128.3, 128.6, 141.4, 155.6, 176.0. Anal. Calcd for 
C24H25NO6: C, 68.07; H, 5.95; N, 3.31. Found: C, 68.10; H, 5.97; N, 3.29. 
 
General method for the preparation of compounds 49. 
To a stirred solution of NaH (60% in mineral oil, 1.75 mmol, 69 mg) in dry THF (3 mL) was added 
benzyl malonate (1.05 mmol, 0.27 g) at 0 °C and the mixture was stirred 30 min. Then Boc-AA-AA-
O-Succinimide (0.7 mmol) was added in one portion at 0 °C and the mixture was stirred for 16 h at 
room temperature. Then THF was removed under reduced pressure and replaced with ethyl 
acetate. The mixture was washed with water (2×30 mL), dried over sodium sulfate and 
concentrated in vacuo. The product was obtained pure after silica gel chromatography 
(cyclohexane/ethyl acetate 1:9→pure ethyl acetate as eluant). 
 
(S)-Benzyl 1-(2-((tert-butoxycarbonyl)amino)-3-phenylpropanoyl)-4-hydroxy-2-oxo-2,5-dihydro-1H-
pyrrole-3-carboxylate 49a. 
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Yield: 63%; m. p. = 159 °C;     
   = +45.4 (c 0.6, CHCl3); IR (CH2Cl2, 3 mM): ν 3427, 3364, 1702, 
1675, 1645 cm-1; 1H NMR (400 MHz, CD3OD): δ 1.23 (s, 9H, tBu), 2.49-2.67 (m, 1H, CHH-Ph), 3.06-
3.16 (m, 1H, CHH-Ph), 3.73 (AB, 2H, J=10.0 Hz, CH2), 5.16 (s, 2H, OCH2-Ph), 6.95-7.50 (m, 10H, 2× 
Ph); 13C NMR (100 MHz, CD3OD): δ 24.6, 24.8, 27.0, 27.2, 37.9, 50.9, 55.4, 63.7, 79.0, 126.0, 127.0, 
127.2, 127.7, 127.8, 129.2, 137.3, 137.7. Anal. Calcd for C26H28N2O7: C, 64.99; H, 5.87; N, 5.83. 
Found: C, 65.03; H, 5.89; N, 5.80. 
 
(S)-Benzyl 5-benzyl-1-((S)-2-((tert-butoxycarbonyl)amino) propanoyl)-4-hydroxy-2-oxo-2,5-dihydro-
1H-pyrrole-3-carboxylate 49b. 
Yield: 50%; m. p. = 140 °C;     
   = -54.5 (c 0.6, CHCl3); IR (CH2Cl2, 3 mM): ν 3425, 3357, 1718, 1679, 
1650 cm-1; 1H NMR (400 MHz, DMSO-d6): δ 1.11 (d, 1H, J=8 Hz, CHCH3), 1.39 (s, 9H, tBu), 3.20-3.31 
(m, 2H, CH2-Ph), 3.40 (S, 1H, CHCH2), 5.00 (s, 2H, OCH2-Ph), 5.20-5.30 (m, 1H, CHCH3), 6.95-7.37 
(m, 10H, 2× Ph); 13C NMR (100 MHz, DMSO-d6): δ 17.8, 28.2, 34.2, 49.5, 62.4, 77.7, 125.9, 126.8, 
127.1, 127.5, 128.1, 128.3, 128.9, 129.7, 130.0, 136.1, 137.9, 155.0, 173.5. Anal. Calcd for 
C27H30N2O7: C, 65.57; H, 6.11; N, 5.66. Found: C, 65.54; H, 6.08; N, 5.70. 
 
(S)-Benzyl 1-(2-((tert-butoxycarbonyl)amino)-3-phenylpropanoyl)-4-hydroxy-2-oxo-1,2,5,6-
tetrahydropyridine-3-carboxylate 49c. 
Yield: 47%; m. p. = 119 °C;     
   = +4.9 (c 1.4, CHCl3); IR (CH2Cl2, 3 mM): ν 3424, 3315, 1749, 1726, 
1667 cm-1; 1H NMR (400 MHz, CDCl3): δ 1.31 (s, 9H, tBu), 1.82-1.91 (m, 1H, NCH2CHH), 2.19-2.31 
(m, 1H, NCH2CHH), 2.92 (S, 2H, CH2-Ph), 3.40 (S, 1H, NCH2CH2), 4.51 (s, 1H, CHCH2), 5.09 (s, 2H, 
CH2-Ph), 5.43 (br s, 1H, NH), 6.99-7.55 (m, 10H, 2× Ph); 
13C NMR (100 MHz, DMSO-d6): δ 24.8, 25.5, 
28.2, 33.6, 39.1, 41.6, 49.3, 67.3, 68.7, 126.9, 128.3, 128.4, 128.5, 128.6, 128.7, 129.3, 135.2, 
136.6, 157.4, 161.2, 171.5. Anal. Calcd for C27H30N2O7: C, 65.57; H, 6.11; N, 5.66. Found: C, 65.59; 
H, 6.14; N, 5.68. 
 
Benzyl 1-(3-((tert-butoxycarbonyl)amino)propanoyl)-4-hydroxy-2-oxo-1,2,5,6-tetrahydropyridine-
3-carboxylate 49d. 
Yield: 80%; m. p. = 180 °C; IR (CH2Cl2, 3 mM): ν 3441, 3314, 1750, 1734, 1704, 1670 cm
-1; 1H NMR 
(400 MHz, CDCl3): δ 1.34 (s, 9H, tBu), 2.16-2.33 (m, 2H, COCH2CH2), 2.44-2.49 (m, 1H, NCH2CHH), 
2.71-2.76 (m, 1H, NCH2CHH), 3.22-3.35 (m, 2H, COCH2CH2), 3.36-3.49 (m, 2H, NCH2CH2), 5.01-5.32 
(m, 2H, OCH2-Ph), 6.07-6.31 (m, 1H, NH), 6.94-7.38 (m, 10H, 2× Ph); 
13C NMR (100 MHz, CDCl3): δ 
14.2, 21.0, 24.9, 28.3, 33.9, 36.2, 36.8, 41.5, 60.4, 67.4, 68.2, 79.2, 128.0, 128.3, 128.4, 128.5, 
128.6, 128.7, 135.2, 156.0, 164.1, 166.2, 171.4. Anal. Calcd for C21H26N2O7: C, 60.28; H, 6.26; N, 
6.69. Found: C, 60.31; H, 6.74; N, 6.66. 
 
Benzyl 1-(3-((tert-butoxycarbonyl)amino)propanoyl)-4-methoxy-2-oxo-1,2,5,6-tetrahydropyridine-
3-carboxylate 50. 
To a solution of compound 49d (0.2 mmol, 70 mg) in dry THF (10 mL) was added LiHMDS (1 M 
solution in THF, 0.24 mmol, 0.24 mL) under nitrogen atmosphere, then the mixture was stirred at 
room temperature for 10 min and (trimethylsilyl)diazomethane (2 M solution in diethyl ether, 2.0 
mmol, 1 mL) was added and the mixture was further stirred for 3 h at room temperature. Then the 
volatiles were removed under reduced pressure and replaced with ethyl acetate. The mixture was 
washed with 1 N aqueous HCl, dried over sodium sulfate and concentrated in vacuo. Cyclohexane 
was added to the residue and the mixture was sonicated for 20 min. The product 50 was obtained 
pure after concentration of the cyclohexane mother liquid in 50% yield (37 mg) as a waxy solid. IR 
(CH2Cl2, 3 mM): ν 3444, 1749, 1733, 1708, 1672 cm
-1; 1H NMR (400 MHz, CDCl3): δ 1.36 (s, 9H, tBu), 
2.29 (t, 2H, J=6.4 Hz, MeO-C-CH2-CH2-N), 2.46 (t, 2H, J=6.0 Hz, CH2-CH2-NHBoc), 3.31 (t, 2H, J=6.4 
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Hz, MeO-C-CH2-CH2-N), 3.63 (s, 1H, OMe), 3.44 (q, 2H, J=6.0 Hz, CH2-CH2-NHBoc), 5.10 (s, 2H, 
OCH2Ph), 6.19 (br s, 1H, NH), 7.20-7.30 (m, 5H, Ph); 
13C NMR (100 MHz, CDCl3): δ 25.9, 27.4, 32.8, 
33.8, 40.6, 66.3, 114.3, 119.2, 127.3, 127.4, 127.6, 128.5, 134.2, 155.1, 165.3. 
 
1-(3-((tert-Butoxycarbonyl)amino)propanoyl)-4-methoxy-2-oxo-1,2,5,6-tetrahydropyridine-3-
carboxylic acid 51. 
Compound 50 (0.1 mmol, 37 mg) was dissolved in MeOH (5 mL) under nitrogen. Pd/C (3 mg, 10% 
w/w) was added under nitrogen. Vacuum was created inside the flask using the vacuum line. The 
flask was then filled with hydrogen using a balloon (1 atm). The solution was stirred for 16 h under 
a hydrogen atmosphere. The product was obtained pure in quantitative yield (30 g) after filtration 
through a Celite pad using ethyl acetate and concentration in vacuo. 1H NMR (400 MHz, CD3OD): δ 
1.43 (s, 9H, tBu), 2.34 (t, 2H, J=6.8 Hz, MeO-C-CH2-CH2-N), 2.53 (t, 2H, J=6.8 Hz, CH2-CH2-NHBoc), 
3.28 (t, 2H, J=6.8 Hz, MeO-C-CH2-CH2-N), 3.43 (t, 2H, J=6.8 Hz, CH2-CH2-NHBoc), 3.67 (s, 3H, OMe), 
4.51 (s, 1H, CHCH2). 
 
(S)-Methyl 2-(1-(3-((tert-butoxycarbonyl)amino)propanoyl)-4-methoxy-2-oxo-1,2,5,6-
tetrahydropyridine-3-carboxamido)propanoate 52. 
A solution of compound 51 (0.1 mmol, 30 mg) was dissolved in dry acetonitrile (5 mL) together 
with HBTU (0.11 mmol, 40 mg). Then a solution of HCl·H-L-Ala-OMe (0.1 mmol, 15 mg) and TEA 
(0.3 mmol, 40 μL,) in dry acetonitrile (2 mL) was added dropwise to the mixture. The solution was 
stirred for 50 min under nitrogen atmosphere, then acetonitrile was removed under reduced 
pressure and replaced with ethyl acetate. The mixture was washed with water, dried over sodium 
sulfate and concentrated in vacuo. The product 52 was obtained pure after silica gel 
chromatography (cyclohexane/ethyl acetate 1:1→2:8 as eluant) in 70% (21 mg) overall yield.     
   
= -9.0 (c 0.1, CHCl3); IR (CH2Cl2, 3 mM): ν 3436, 3334, 1736, 1709, 1671 cm
-1; 1H NMR (400 MHz, 
CDCl3): δ 1.41 (s, 9H, tBu), 1.42 (d, 3H, J=6.0 Hz, Me-Ala), 2.37 (t, 2H, J=6.4 Hz, C
5H2), 2.53 (t, 2H, 
J=6.0 Hz, CαH2-βAla), 3.37 (t, 2H, J=6.4 Hz, C
6H2), 3.51 (q, 2H, J=6.0 Hz, CβH2-βAla), 3.26 and 3.68 (s, 
1H, OMe), 3.73 (s, 1H, COOMe), 4.55 (dq, 1H, J=6.8 Hz, CαH-Ala), 6.35 (br s, 1H, NH-βAla), 7.42 (d, 
1H, J=6.8 Hz, NH-Ala); 13C NMR (100 MHz, CDCl3): δ 17.8, 28.4, 33.7, 34.9, 36.3, 42.3, 48.3, 51.8, 
52.5, 112.5, 114.9, 156.2, 166.8, 171.6, 172.9, 173.0. Anal. Calcd for C19H29N3O8: C, 53.39; H, 6.84; 
N, 9.83. Found: C, 53.42; H, 6.85; N, 9.85. 
 
 
